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Abstract
The detection of disease and abnormal pathology by magnetic resonance imaging (MRI)
has been aided significantly by the use of gadolinium (Gd3+)-based contrast agents (CAs)
over the past three decades. MRI and MRI CAs play a critical role in diagnosing tumors
and diseases of the central nervous system. The agents used clinically have been shown
to safely increase MRI contrast despite the toxicity of Gd3+, owing to the high kinetic and
thermodynamic stability of these chelates. However, current CAs enhance contrast at a
small fraction of what is theoretically possible. This leads to the necessity of introducing
high CA doses in practice in order to afford sufficient contrast. Lanthanide (Ln3+)
chelates based on 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetate (DOTA) have
been shown to be particularly stable and effective. Chelates of DOTA exist in two
interconverting coordination geometries which have varying water exchange rates.
Researchers have envisioned a way to increase the per-dose efficacy both by control of
the Gd3+-inner-sphere water exchange rate and via binding specificity (i.e. to tumors).
The efficacy gains using these approaches have thus far been modest.
A thorough structural characterization of europium (Eu3+) chelates of a DOTA-derivative
which cannot undergo conformational exchange was carried out. These studies show that
a single enantiomer of the ligand (S)-2-(4-nitrobenzyl)-1,4,7,10-tetraazacyclododecane1,4,7,10-tetra(α-methyl)acetate (NB-DOTMA) can yield chelates which are both
diastereoisomeric (previously reported) and regioisomeric (not previously speculated).
Molecular mechanics simulations generated from the characterization data indicate that
the nitrobenzyl (NB) substituent is oriented in different directions for the two possible

ii
regioisomers. The NB group can be chemically converted to confer macromolecular
binding capability, and the orientation of the NB substituent may have a significant
impact on the binding and/or relaxation behavior of a prototypical CA.
The nuclear magnetic resonance (NMR) spectra of Eu-NB-DOTMA at various
temperatures were compared.

Unexpectedly, the chelates showed time-averaged

structures which differ with a change in water exchange rate – the faster the rate, the
greater the deviation from the expected structure. Consideration of the structures of Ln3+
chelates without accounting for their dynamic behavior does not yield an accurate value
for the time-averaged hydration state. These observations suggest the “optimal” water
exchange rate calculated using Solomon-Bloembergen-Morgan (SBM) theory may not
lead to the highest-efficacy CAs. Binding and relaxometric studies of macromoleculetargeting derivatives of Gd-NB-DOTMA both by the author and in another lab showed
that the coordination isomer with the slower water exchange rate should lead to more
effective contrast, in direct opposition to the prevailing view of water exchange in the
MRI community. Preliminary data do not indicate that regioisomeric chelates have
significantly different relaxivity or macromolecular binding behavior.
The ratios between regioisomeric Ln-NB-DOTMA chelates formed were shown to be
dependent on the concentration and pH of the chelation reaction, but conditions were not
found which led to the production of a single regioisomer. Attempts to carry out an
efficient synthesis of a Ln3+ chelate with no potential for regioisomerism were
unsuccessful.
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CHAPTER 1. INTRODUCTION
1.1 Magnetic resonance imaging: a safe, effective, versatile mode of medical imaging
1.1.1 Comparison of medical imaging techniques
Medical imaging encompasses a range of techniques that are minimally invasive and
allow rapid and accurate diagnosis of a broad spectrum of diseases, disorders, and other
health concerns. The field of medical imaging is experiencing significant growth in
imaging power, utility, and the ability to diagnose and even to treat disease.1 The most
commonly employed imaging modalities are X-rays and computed tomography (CT,
which uses X-rays), at 62 million scans/yr as of 2007.2 The other most prevalent types
are magnetic resonance imaging (MRI) and ultrasound. X-ray techniques are useful due
to their high sensitivities and rapid imaging time. However, X-rays and particularly CT
(which involves a higher dose of ionizing radiation) can increase the risk of DNA damage
and of developing some forms of cancer.2-4 Ultrasound, another popular modality, uses
sound waves instead of electromagnetic radiation. The risks associated with ultrasound
are very low and the technique has excellent temporal resolution, but poor spatial
resolution. The use of MRI is very attractive as MRI eliminates the problems associated
with radioactive tracers and ionizing radiation.

In comparison with other imaging

techniques, MRI has superior spatial resolution and greater utility in early detection and
diagnosis of restricted blood flow (risk for heart attack, stroke)5,6 and of tumors.7-9 MRI
excels at distinguishing between body tissues, but scans typically last significantly longer
than for the types of imaging above. Because of the complementary nature of these
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techniques, a combination of medical imaging analyses is often utilized for optimal
diagnosis and treatment.
1.1.2 History and Benefits of MRI
A method for using magnetic resonance to generate images was first devised by Paul
Lauterbur in 1973,10 who along with Peter Mansfield was awarded the Nobel prize in
Physiology or Medicine in 2003 for the discovery. Around the same time, magnetic
resonance had been tested in vivo11 and was eventually extended to human imaging,
pioneered by Damadian, Hinshaw and others.12-14 These momentous discoveries, in
combination with two-dimensional and Fourier-transform techniques developed by Ernst
and colleagues,15 made possible the use of MRI as a versatile and ubiquitous diagnostic
for disease and abnormal pathology today.16,17
In an MRI exam the subject is placed in a strong (typically 0.5 T or greater),
homogeneous magnetic field (B0). For any atomic nucleus in this magnetic field having
spin state > 0, its nuclear magnetic moment will tend to align with or against the direction
of the field according to the Boltzmann equation (Equation 1.1). A nuclear magnetic
moment can be thought of as a miniature magnet that nutates (spins) about the direction
of the B0 axis.
The Boltzmann population distribution causes a net magnetization aligned parallel to B0
and is directly proportional to field strength. The population difference is only a few
parts per million, however, inherently making MRI a less sensitive technique18 compared
with other imaging modes.
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N anti
 e  B0 h / kT
N ||

Equation 1.1: The Boltzmann distribution of spins, where Nanti is the population of
nuclear spin momenta aligned against the field, N|| is the population aligned with the
field, γ is the magnetogyric ratio of the nucleus in question, B0 is the magnetic field
strength, h is Planck’s constant, k is Boltzmann’s constant, and T is absolute
temperature

In an MRI, a gradient field is applied on top of the B0 field, which causes spins to
resonate at different frequencies dependent upon their spatial location within the gradient
field. This relationship between resonance frequency and spatial location is the basis for
the construction of a three-dimensional image. The nuclei are then perturbed by a
sequence of radio frequency (RF) pulses which induce a magnetic field (B1)
perpendicular to the main field. The B1 field is much weaker than the main magnetic
field B0 (on the order of 1:104). However, the RF pulses are sufficient to transfer the net
magnetization into the plane perpendicular to B0 and manipulate this magnetization so
that it can be detected. The RF field induces the nuclear spins to rotate about B0
coherently (in phase, instead of having their momenta point in random directions in the
B1 plane). The RF field is turned off and two relaxation processes return the population
of spins to their equilibrium alignment with B0. The net magnetization in the B1 plane
returns to the Boltzmann distribution in the B0 direction (termed longitudinal relaxation,
T1). In a separate process, the spins lose their coherence in the B1 direction (termed
transverse relaxation, T2). The relaxation times of nuclei vary within the body based on
local environment and this variation is observed by the detector (which is also an RF
coil). The signal is processed such that the density of spins and their relaxation time in
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each volume element (typically on the order of 1 mm3) is assigned a relative brightness,
making differences between tissue types apparent in image contrast. MR images are
nearly always acquired based on the nuclear magnetic resonance of water protons, the
most abundant nuclei in vivo.
1.1.3 Utility and safety considerations of MRI contrast agents
To compensate for the sensitivity limitations, MRI can be complemented by a minimally
invasive injection of an extracellular contrast agent (CA). Data from 2007 showed that
43% of the 27 million MRI scans performed that year in the US employed a contrast
agent.19 CAs are most useful when one cannot easily differentiate adjacent tissue types.20
Diseases of the central nervous system (CNS) and cancer are major areas where contrast
agents have proven useful.20,21 Paramagnetic atoms or molecules are known to affect
nuclear spin relaxation.

The introduction of paramagnetic ions to study biological

systems, including nucleic acids22 and proteins23, dates back 50 years.

Unpaired

electrons which take longer to relax in a magnetic field can affect more nuclear spins at a
given concentration. The paramagnetic gadolinium ion (Gd3+) has 7 unpaired f electrons
and a long electronic relaxation time, making Gd3+ an ideal basis for CAs. Gd3+-based
contrast agents (Figure 1.1) are widely used in conjunction with MRI and have been
shown to confer excellent contrast enhancement in the tissues in which they are
distributed.24
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Figure 1.1: Contrast agents approved for clinical use, with common and brand names,
respectively.

In order to be useful clinically, a contrast agent must be well tolerated in the body: nontoxic, stable, rapidly and fully eliminated, and effective in dosing and formulation which
must be carefully administered to compensate for their high osmolality. For in vivo use,
an organic multidentate ligand is first bound to the Gd3+ ion generating a highly
thermodynamically stable chelate (log KGdL > 20 for most clinical agents).25 While
thermodynamic stability tends to receive more attention, the more clinically relevant
parameter is a CA’s kinetic stability – particularly in relation to transmetallation by Ca2+,
Cu2+ and Zn2+.26,27 A Mn2+-based CA (Teslascan) with inferior kinetic stability was
approved for liver imaging and used clinically.28 Manganese (in the form of Mn2+) has a
lower magnetic moment but an even longer electronic relaxation time than Gd3+.
However, the contrast mechanism for Teslascan relies on the slow release of Mn2+ ions
from the polydentate chelate, and the marketing of this CA was discontinued by 2005 in
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Gd3+ on its own leads to significant contrast

enhancement, but non-chelated lanthanide (Ln3+) ions, or those in kinetically labile
chelates, are toxic30 as they mimic Ca2+ and disrupt various ion pumps. Furthermore,
Ln3+ ions have a long residence time in the body, eventually leading to skin and bone
deposition. Clinically approved MRI CAs, which are all polyaminocarboxylate Gd3+
chelates (Figure 1.1), must be eliminated from the body at a rate much faster than their
dissociation rate.31

Optimizing the contrast-generating ability and the kinetic and

thermodynamic stabilities of Gd-based CAs requires knowledge of the unique chemistries
of the lanthanides.
1.2 Chemistry of the lanthanides and their DOTA chelates

Figure 1.2: Lanthanides on the periodic table32

Lanthanides (abbreviated Ln) are the series of elements 57-71 (Figure 1.2).

Their

electronic configurations are that of [Xe]6s25d14fn, varying only by the number of
electrons in the 4f shell. The 4f electrons are highly shielded by the 5s and 5p electrons
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and interact only minimally with other ions or ligating groups. Lanthanides are almost
universally found in the (3+) oxidation state, due to the low energies of ionization of the
6s and 5d electrons. Due to the identical oxidation state and increased nuclear charge
across the series, lanthanide ions contract linearly from La3+ (about 105 pm ionic radius)
to Lu3+ (about 85 pm). These ionic radii are large, leading to high coordination numbers
(typically 8 or 9). The high oxidation state and limited accessibility of valence electrons
make Ln3+ ions hard Lewis acids. Ln3+ ions form coordination compounds mainly with
hard bases such as water, hydroxide, nitrate, triflate, acetate, phosphate, and some
halides.

These compounds are formed mainly due to electrostatic (charge/dipole)

interactions, and ligand exchange is very rapid (the ligands are labile). The lack of strong
electronic orbital overlap between Ln3+ 4f electrons and ligands gives the complexes
more geometric flexibility than complexes of d block metals. As ligand displacement is
accompanied by a distortion in geometry, the less a ligand is able to distort, the more
stable the chelate. Due to entropic effects, the greater the denticity of a ligand, the less
labile the chelate becomes and the more constrained its coordination geometry becomes.
Coordination compounds of Ln3+ generally adopt tri-capped trigonal prismatic (TTP)
geometry. Exceptions to TTP geometry arise from the structural rigidity of certain
polydentate ligands. The lack of interaction between the 4f electrons and ligands also
means that compounds of Ln3+ across the series are effectively isostructural. Thus, the
chemistries of the lanthanides are extremely similar.33 The physical properties, rather
than the chemical properties, of an individual lanthanide are the source of interesting
behavior and applications.
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1.2.1 Synthesis of the macrocyclic ligand DOTA
CAs based on macrocyclic ligands are more rigid and much more stable than those of
their acyclic counterparts.34

The macrocyclic ligand 1,4,7,10-tetraazacyclododecane-

1,4,7,10-tetraacetic acid (H4DOTA) is the starting point for our CA design and research
efforts. It forms some of the most stable Ln3+ chelates ever observed.35 Chelates of
DOTA have been thoroughly studied to date.36-42

1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (H4DOTA)

The main challenge in preparing 12-membered tetraaza crowns (as seen in the structures
of Dotarem, ProHance, Gadovist, and in the study of many non-clinical Ln3+ chelates) is
the

kinetic

unfavorability

of

macrocyclic

ring

closure.

Cyclen

(1,4,7,10-

tetraazacyclododecane) was produced previously on a commercial scale using the
synthesis method published by Richman and Atkins,43 shown in Scheme 1.1 below.

Scheme 1.1: Richman-Atkins synthesis of cyclen
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This approach employs bulky tosyl protecting/activating groups which led to low atom
economy. Furthermore, relatively high dilutions were necessary in the cyclization step,
which meant that the product had to be recovered from large volumes of
dimethylformamide. Today cyclen is produced by a more effective route, which was
developed by Kiefer and Athey44, and is shown in Scheme 1.2. Upon commercial
implementation of the Kiefer/Athey method, the price of cyclen as a reagent dropped
substantially.

Scheme 1.2: Kiefer/Athey route to cyclen

A second high efficiency route to cyclen was developed by Weisman and co-workers,
although this procedure is less amenable to large scale reactions (Scheme 1.3).45

NH2
S

S

CH3CH2Br
EtOH

NH2

N

N

N

N

2Br-

NH2+

S

NH

NH2

NH

NH2

S
EtOH

NH2+

1) DIBAL-H, toluene
reflux 15h
2) NaF, H2O

NH HN
NH HN

Scheme 1.3: Weisman synthesis of cyclen
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Attachment of the carboxylate pendant arms is accomplished by nucleophilic
displacement by the ring nitrogens (such as in Scheme 1.4) and is comparatively simple.

Scheme 1.4: Alkylation of cyclen by nucleophilic substitution to yield DOTA

An efficient synthesis of the macrocyclic ligand is critical for cost-effective preparation
of any novel CA with potential commercial application.
1.2.2 Chelation mechanism of Ln[DOTA]The reaction of inorganic Ln3+ salts with H4DOTA was studied and found to be slow
overall in the pH range 3-5.39 The reaction was monitored by pH and UV absorption. In
the formation of Ce[DOTA]-, half of the [H+] increase measured occurred within 30
seconds of combining metal and ligand, and the pH stabilized completely after 24 hours.
When the reaction was analyzed at pH 6.2 (where the ligand was in H2DOTA form),
there was little to no initial, rapid pH decrease from H+ displacement. The initial abrupt
drop in pH was found to result from protons that are released from 2 carboxylate groups
(in H4DOTA) that ligate the metal. Then there is a second decrease in pH as the metal
drops down to coordinate to the amines, displacing a further 2H+. The UV-Vis. data
show a new absorption peak immediately upon mixing which eventually disappears, and
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the end product has a separate absorption peak which grows in gradually. The rate data
indicate overall first-order kinetics of formation. There is therefore a rapid formation of
an intermediate chelate H2LnL+, where only the four oxygen atoms bind to the metal,
partially encapsulating it. A slower step involves the metal “dropping into the cage” so it
coordinates to the nitrogen atoms of the ligand, which is then fully deprotonated (Figure
1.3).

Figure 1.3: Chelation mechanism of Ln[DOTA]-27

The formation of H2LnL+ is slower for conformationally rigid systems.38
1.2.3 Coordination geometry of Ln[DOTA]- and conformational exchange
The coordination geometry of Ln[DOTA]- is shown in Figure 1.4. The four nitrogen
atoms are coplanar, as are the four coordinating oxygen atoms. The Ln3+ atom is located
between the two planes, and a single coordinated water molecule is located axially above
the ligand oxygen atoms’ plane (Fig. 1.4a). The macrocyclic cyclen ring adopts a square
[3333] arrangement46 (Fig. 1.4b) – each side of the square is formed by 3 bonds (2 C-N
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and 1 C-C).47 The ethylene bridges on the macrocyclic ring can adopt one of two chiral
(helical, δ or λ) configurations (Fig 1.4c).

a)

b)

c)

Figure 1.4: Structure and geometry of Ln[DOTA]-, where a) shows the position of the
metal ion between the nitrogen and oxygen planes and the position of the water
molecule, b) shows the square arrangement of the macrocycle, and c) shows the
possible helicities of the chelate rings formed by the pendant arms (top) and of the
ethylene bridges (bottom)

For a Ln3+ chelate of DOTA, the ethylene bridges all adopt the same helicity (δδδδ or
λλλλ, Fig. 1.4c, bottom).48,49 The chelate rings formed from Ln3+ binding to the arms
also have helical chirality. The arms wrap around the metal cooperatively (they also all
have the same helicity), and the two resulting isomers are denoted as Δ or Λ (Fig. 1.4c,
top). These elements of helical chirality mean that for Ln[DOTA]-, more than one
stereoisomer is available in solution. Two coordination geometries are available to
DOTA-based chelates – square antiprism (SAP) and twisted-square antiprism (TSAP) as
seen in Fig. 1.5.37,50 TSAP geometry results from the arms and the bridges adopting the
same helicity (i.e., Λ(λλλλ)), and SAP geometry results from the arms and the bridges
adopting opposite helicities.
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Figure 1.5: Structures of the coordination geometries available to Ln[DOTA]- chelates51

The two main differences between SAP and TSAP are the twist angle (ω) between the
nitrogen (N4) and oxygen (O4) planes and the distance (d) between the two planes
(greater in TSAP). There is a modest difference in the “openness” (ψ, also referred to as
the “bite” angle) of the O4 plane that is related to how closely a water molecule can
approach the metal ion. SAP and TSAP isomers cannot be isolated from one another in
Ln-DOTA as the energy barriers to conformational isomerism (the processes of reversing
helicity via ring inversion and arm rotation) are too low under physiological conditions
(Figure 1.9). The possible coordination geometries Λ(λλλλ), Λ(δδδδ), Δ(λλλλ), and
Δ(δδδδ) are two enantiomeric pairs. A reversal of helicity of either the four ethylene
bridges or of the four pendant arms will convert a SAP isomer to a TSAP or vice versa.
A particular conformation can be converted to its geometric pair (SAP-to-SAP or TSAPto-TSAP) by a dual arm-flip, ring-inversion process. This exchange has been observed
by exchange NMR spectroscopy (EXSY).50,52 It should be noted that this conversion will
move a carbon which was previously on the corner of the [3333] macrocyclic ring (Fig.
1.6) to a position on the side of the ring. These 2 carbons are not chemically equivalent if
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chemical substitution on the basic DOTA ligand restricts the conformational equilibria, or
breaks the 4-fold symmetry of the chelate.

Figure 1.6: Conformational equilibria of Ln[DOTA]- chelates in solution53
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1.3 The efficacy of Gd3+ chelates as CAs
Presently, Gd3+-based CAs require high intravenous doses (0.03 – 0.1 mmol/kg) to
improve MR contrast appreciably. These doses of Dotarem™ (Gd[DOTA]-) and other
market-established macrocyclic Gd-based CAs are considered safe.54 However, the doses
of CAs could be much lower – these clinically approved CAs enhance contrast by a small
fraction of what is theoretically possible.

To understand optimization of per-dose

efficacy in CAs, it is necessary to consider the prevailing theory of paramagnetic
relaxation of nearby nuclear spin momenta.
1.3.1 Relaxivity of Gd3+ chelates as a measure of MRI CA efficacy
Our understanding of how paramagnetic CAs function is based on SolomonBloembergen-Morgan (SBM) theory.55-59 R1, the longitudinal relaxation rate observed
(R1 = 1/T1), changes from its base value (that of pure water) when a reorientation
restriction (such as a solution with high concentration of macromolecule, which increases
the solution viscosity) or an ion or compound which interacts strongly with nuclear spins
(i.e., a paramagnetic species) is introduced. R1 differences in the magnetic behavior of
nuclei as a function of local molecular environment are exploited for imaging purposes.
A tissue sample with more “restricted” water will have a shorter T1. Thus, if appropriate
imaging protocols are used, contrast is inherently apparent. However, the image quality
is often greater with a contrast agent. The superior contrast provided by Gd3+ agents
stems from the agents’ effect on the longitudinal relaxation rate of nuclear magnetic
momenta of nearby water protons; contrast is thus enhanced by an indirect mechanism.
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R1 of an aqueous solution is increased upon the addition of a CA. This relaxation
enhancement “arises from time fluctuation of the dipolar coupling between the electron
magnetic moment of the metal ion and the nuclear magnetic moment of the solvent
nuclei.”20,60 The primary measure of the efficacy of a magnetic resonance contrast agent
is its relaxivity, the per-millimolar concentration (of Gd3+) decrease of longitudinal
relaxation time (T1) of protons in the system. Typically, in the context of MRI CAs, the
longitudinal component of relaxivity (r1) is measured and reported.61 The relationship
between R1 and paramagnetic relaxivity (r1p) is described in Equation 1.2.
R1obs  [CA]r1 p  R1w
Equation 1.2: The observed relaxation rate is a function of the contrast agent
concentration and its experimentally determined relaxivity. R1w is the relaxation rate of
the water protons prior to introduction of a paramagnetic species.

1.3.2 The central role of water (solvent) exchange in Ln3+-chelate CAs in generating
contrast
In order to mathematically describe the behavior of a particular type of water proton and
how it is affected by paramagnetic relaxation, SBM theory treats water molecules
associated with a paramagnetic chelate as divided into three distinct “spheres” (Figure
1.7).
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Figure 1.7: Water exchange of Ln[DOTA]-type chelates51

An inner-sphere water molecule is directly bound to the gadolinium ion in a CA. Water
molecules in the second sphere are closely associated with the metal ion but not directly
coordinated; these have hydrogen bonding interactions with the oxygen atoms of the
chelate. There is a third “shell” of pre-organized water associated with the chelate,
known as the outer sphere, where the water molecules have weak bonding interactions
with those in the second sphere.

There are inner-, second-, and outer-sphere

contributions to relaxivity (Equation 1.3). The second- and outer-sphere contributions to
relaxivity arise from water protons not directly coordinated to Gd3+ but sufficiently close
for their spin states to be affected. These contributions, though significant (up to 10-30%
of the overall relaxivity, depending on the agent and its surroundings)62, are difficult to
improve upon through rational design, so researchers typically focus on the inner sphere.
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r1Observed  r1 Inner  sphere  r1 Second  sphere  r1Outer  sphere
Equation 1.3: The longitudinal relaxivity observed contains contributions from each
hydration sphere

Water molecules in each sphere are constantly and rapidly undergoing chemical
exchange. Due to this rapid solvent exchange, the nuclear relaxation times of many water
protons in the vicinity of the agent are affected.

The inner-sphere component of

relaxivity is a function of the number of Gd3+-bound water molecules (q), the rate of
water exchange (1/τM), and longitudinal inner-sphere water proton relaxation time (T1M)
(Equation 1.4). Though relaxivity scales directly with q (the number of inner-sphere
water molecules), clinical agents are limited to q = 1 due to stability/safety concerns. A
few chelates have been studied in the laboratory that may prove sufficiently stable with q
> 1.63,64 DOTA and its derivatives are octacoordinate, leaving a single free coordination
site available for water to bind.

The exchange of inner-sphere water molecules in

DOTA-type chelates of all but the largest lanthanides is known to occur by a dissociative
mechanism.65-68

r1 p 

1
q  1


55.6  T1M  M





Equation 1.4: The inner-sphere dependence of paramagnetic relaxivity is a function of
T1M and τM
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1.3.3 Inner-sphere relaxivity and its dependence on molecular reorientation, water
exchange, and electronic relaxation
The overall effect on T1 is governed by a so-called “characteristic correlation time” (τC)69,
which is a function of water exchange, rotational correlation time (related to the size of
the agent), and electron spin relaxation. This relationship is shown in the SBM equations
1.5 and 1.6. τC is a time constant (the inverse of a rate constant) and characterizes the
interactions of a given nucleus with other sub-atomic particles with “spin” and how that
nucleus behaves with respect to applied magnetic fields. T1 of the inner-sphere water
molecule (T1M) is proportional to rLn-H-6 and on both the longitudinal (τC1) and transverse
(τC2) correlation time constants.
1
T1M



2
2  H g 2 S ( S  1)  2
15
rLn  H 6


3 c1
7 c 2


2
2
1 +  s 2 c2 2
1   H  c1





Equation 1.5: SBM equation describing the longitudinal relaxation time of a CA-bound
water proton, where γH is the proton magnetogyric ratio, g is an electronic factor usually
close to 2, S is the electron spin quantum number, β is the Bohr magneton, and rLn-H is
the distance between the metal and water proton(s). The terms ωS and ωH are the
electronic and proton Larmor frequencies, respectively. The Larmor frequency is the
frequency at which the nuclear spin momenta resonate in a magnetic field of particular
strength.

1

 ci

1
Tie

1

1

R

M

Equation 1.6: τc is a correlation time constant associated with interactions at the
Larmor frequency. i = 1 (longitudinal relaxation) or 2 (transverse relaxation). Tie, τR,
and τM are the electronic, rotational, and water exchange components, respectively
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The rotational correlation time (τR) is a measure of how rapidly the CA “tumbles” in
solution, reorienting itself continuously with respect to the magnetic field.

τR is a

function of the molecule’s size and shape, and is longer for bulkier compounds. Tie (i = 1
or 2) are the longitudinal or transverse electron spin relaxation times, and Gd3+ has the
longest T1e of any lanthanide.70 The electron spin relaxation component’s effect on τc is
related to the static zero-field splitting (ZFS) interaction (Δ2) and the ZFS modulation
(τv).71 According to empirical findings, SBM theory does not predict Tie effects on
relaxivity with a great deal of accuracy. It has been determined that a more symmetric,
rigid chelate (such as Gd-DOTA, compared with Gd-DTPA) has more favorable
electronic relaxation, particularly for systems with longer τR.72,73 Efforts have been made
recently to better understand the effects of T1e on relaxivity.74,75
Using these equations, the influence of τR and τM on inner-sphere relaxivity have been
modeled holding other relaxation parameters, such as q and rGd-H (or simply r, the
distance between the lanthanide ion and inner-sphere water protons) constant.72,76 A plot
of one such model at a field strength of 0.5 T is shown in Figure 1.8.
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Figure 1.8: Inner-sphere paramagnetic relaxivity (r1is) dependence on τR and τM at 0.5
T imaging field

As is evident from the curve, there is an optimal range for τM. If a water molecule does
not spend enough time close to the paramagnetic Gd3+, the proton spin momenta do not
experience the full effect of T1 reduction. A water molecule which spends too much time
close to the metal ion prevents other water molecules from displacing it to have their own
spin momenta relaxed efficiently. The optimal τM range for CAs has been calculated to
be ~20-40 ns at 0.5 T, and τM values above 1 µs or below 10 ps (which is not physically
attainable in solution) should lead to very poor relaxivity.
Values of τR greater than 1 ns are desirable, which is an order of magnitude larger than τR
values of clinical agents.77 The agents in use clinically today have relaxivities of 4 - 5
mM-1 s-1 at 25°C and 0.5 T.24 Relaxivities of novel compounds which contain Gd3+
chelates are commonly reported at 0.5 T (corresponding to a 1H Larmor frequency of
approximately 20 MHz) for historical comparison, though MR imaging is now performed
largely at 1.5 or even at 3 T. A maximum relaxivity surface has the same basic shape as
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the one in Figure 1.8 at these fields but is shifted slightly towards faster water
exchange.78 The optimal τM value has been calculated to be ~6 ns at 1.5 T, the most
commonly used field strength of MRI instruments for medical diagnosis.79
Because of the large improvements in relaxivity that could be achieved by optimizing
these parameters, the rate of water exchange (1/τM) between a small-molecule,
lanthanide-based agent and the bulk matrix is important to study (and to control, as much
as is feasible). Many researchers in the field of medical imaging are working toward the
goal of molecular imaging, a way to observe the molecular processes indicative of
specific pathologies and diseases. For low molecular weight chelates, water exchange is
not the relaxivity-limiting parameter (τR is limiting), but will play a defining role in the
efficacy of a CA that is bound to a macromolecular target.

The excellent spatial

resolution obtainable by MRI is advantageous for molecular imaging, but chemical
probes available cannot currently be detected by MRI at the concentration of the involved
biological markers.80 This fact demonstrates the need to develop higher-relaxivity (more
effective) agents, which will in part be accomplished by optimizing τM.
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1.4 Structural characterization of Ln3+ chelates and MRI CAs
1.4.1 Measuring relaxivity of CAs over a range of magnetic field strengths by nuclear
magnetic relaxation dispersion (NMRD)
Nuclear magnetic relaxation dispersion (NMRD) is the standard technique for measuring
relaxivity as a function of magnetic field strength, and is useful in comparing the likely
efficacy of existing and potential CAs.81,82

Measuring the relaxation properties of

paramagnetic species in solution by NMRD yields information about both electronic and
nuclear relaxation rates (Figure 1.9). These rates can provide insight about the relaxation
mechanism and which factor(s) are the prime determinant(s) of relaxation rate under
specific conditions. The wide range of magnetic field strengths probed in NMRD allows
the experimenter to analyze how the factors that govern relaxation behavior vary over
this range, as described in Table 1.1. By looking at the shape of an NMRD curve, the
experimenter can narrow down which parameter or parameters limit the relaxivity for a
given magnetic field strength range. The most influential factors are conformational or
coordination changes (including τM), reorientation (τR), and electron-spin relaxation (T1e).
The fastest of the above processes will dominate (and limit) the relaxation rates observed,
and the field dependence of relaxivity can allow estimation of the relaxation rate due to
that parameter alone.
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Figure 1.9: NMRD profile of a non-specified, typical Gd3+ chelate with varying τR
values61

It is important to note that the relaxivity measured has contributions from all protons in
the sample that undergo rapid diffusion and chemical exchange. The inner- and outersphere contributions to relaxivity cannot be separated in an NMRD fit. In practice, an
assumed value for outer-sphere relaxivity is fixed based on the profile of a q = 0 Gd3+
chelate. A diamagnetic equivalent of the chelate of interest is free from a substantial T1e
contribution and its relaxivity is dominated by τR for small molecules.

τR can be

estimated from the NMRD profile of such a diamagnetic species, using Y3+, La3+, or Lu3+
in place of a paramagnetic Ln3+. Electronic relaxation due to Gd3+ is longer in viscous
solutions, or when Gd3+ is bound to a species with long τR, which leads to a peak or
“hump” in the NMRD profile at a field strength of approximately 20-50 MHz (Figures
1.9, 1.10).83
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Figure 1.10: NMRD profile of Gd(H2O)93+ in ethylene glycol using two different electron
relaxation fitting values a and b.84

There are many parameters necessary to account for when generating a fit to the
experimental NMRD data, and these all must be fit to values that have physical meaning.
The universally used approach is to constrain certain parameters to values previously
and/or independently measured for related systems, and to vary one or a few parameters
that the experimenter believes characterize his or her unique system. The parameters that
receive the most attention due to their strong influence on relaxivity are summarized in
Table 1.1. A recent review on the search for improved Gd-based contrast agents was
used to construct this table.20
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Independent measurement
technique

Accepted range of
values for Gd3+
chelates

B0 field
dependence

0,1*, rarely 2 or 3

Relaxivity scales
linearly with q at
low field (<0.05 T)

Luminescence lifetime of
Eu3+ or Tb3+ chelate85,86
q

Dy3+-induced 17O NMR shift87
Variable-temperature Eu3+
UV-Vis. absorption77

rGd-H

None, assumed values from
X-ray crystallography are
typically used.‡88

2.9 - 3.25 Å,
typically 3.1 Å

Relaxivity scales
proportionally to
1/r6 at all fields

τR

Usually determined by
NMRD by trying logical
values for τR once all other
parameters have been
established/fixed, or by Curie
relaxation§

0.1 ns for small
chelates, up to 30
ns for large
macromolecular
adducts

A longer τR will
exhibit a larger
peak and at a
lower field due to
T1e limit**

1 ns to 1 ms

For otherwise
analogous
species, the entire
curve will be
offset, but not
proportionally

T1e ≥ 2 x 10-10 s at
25°C70

Only obvious
when τR and τM
are non-limiting

17

τM

T1e and
T2e

Variable-temperature ( O
and Dy3+) NMR shift and T2
89,90

Comparison of EPR, NMR
and NMRD data to obtain
the best fit71,91

≠

Table 1.1: Influence of the most important parameters in fitting experimental NMRD
data. *The empirical value of q is usually a non-integer due to an rLn-H value outside of
what is predicted by Horrocks’ method for calculating q based on luminescent lifetimes.
‡Values extrapolated from ENDOR92 or EXAFS(Gd-O)93 measurements are sometimes
used. §Determined by the Debye-Stokes equation77 if the microviscosity and molecular
radius are known, alternatively by diffusion measurement (DOSY) or 13C T1/NOE
measurements.94 **See examples in Figures 1.9 and 1.10. ≠Not directly obtainable from
NMRD, the parameters τv (zero-field splitting) and ∆2 (mean-square zero-field-splitting
energy) are used instead.
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When a curve that fits poorly to the data results, it is not necessarily obvious which
parameter(s) must be adjusted to generate a more optimal fit. Measuring the relaxivityinfluential properties of Ln3+ chelates by independent techniques aids in the optimization
of parametric fitting. By combining NMRD with as many complementary studies as are
feasible, it is possible to measure how effective a putative CA will be and ascertain how
to potentially improve the agent further. Relaxivities obtained from NMRD are in good
agreement with R1 values and contrast enhancement measured for CAs in biological
systems, including in vivo studies.

The relationship between r1, field strength, and

contrast agent dose has also been studied in vivo.95
1.4.2 Probing structure by taking advantage of lanthanides’ electronic properties
Crystallography is a valuable tool for studying the structures of Ln3+ chelates. However,
solid-state techniques, including crystallography and ENDOR (electron-nuclear double
resonance), cannot provide a complete picture of the critical dynamic processes described
by τR and τM. It is difficult to study the structures of Gd3+ chelates in solution directly
due to their unique electronic properties. As Ln3+ chelates of a particular ligand are
practically isostructural, other lanthanides with more favorable electronic behavior are
used as surrogates in structural characterization of chelates of the ligand(s) of interest. It
is preferable to use Ln3+ whose atomic radii are closest to Gd3+ (Eu3+ and Tb3+) for the
most accurate structural comparison, although there are drawbacks to using these
particular lanthanides as well.

NMR is a valuable technique for structural

characterization in solution, and allows the determination of distances (from Ln3+) and τR
for individual nuclei in a chelate, particularly protons.
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For the lanthanides, the ligand field in their chelates is much smaller in energy in
comparison with their spin-orbit coupling, a coupling between the electronic orbital
angular momentum L and spin angular momentum S.96 An approach to describe the
combination of spin and orbital angular momenta into one term symbol J is known as
Russell-Saunders coupling, which explains and predicts the electronic behavior of
lanthanides to a good approximation. This approach assigns each lanthanide a specific
ground state electronic configuration and allows the effective magnetic moment of each
ion to be calculated. The effect of the electronic configuration and magnetic moment of a
Ln3+ ion on nearby nuclei can be broken down into three contributions: diamagnetic,
contact (δc) and pseudo-contact or dipolar (δd). The diamagnetic contribution is small for
nuclei not directly coordinated to the Ln3+. Through-bond transmission of unpaired
electron spin density to a nucleus produces δc. Through-space dipole-dipole interaction
between nuclear and electronic magnetic momenta is the cause of the δd contribution.
The sum of these contributions will affect the nuclear spin properties of a given proximal
nucleus and induce a particular NMR shift.97 The paramagnetic contributions to an NMR
shift are expressed by proportionality constants particular to the lanthanide and
independent of ligand(s) in Equations 1.7 and 1.8.
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Equation 1.7:  C ppm
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and <Sz> is a constant (the reduced value of the average spin polarization), β is the Bohr
magneton, k is Boltzmann’s constant, T is absolute temperature, γI is the magnetogyric
ratio of the nucleus acted upon, A/ħ is a hyperfine coupling constant, and g is the Landé
factor.

Equation 1.8:  d
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Where Cj, Bleaney’s constant, is equal to g 2 J J

r 2 A 2 sin 2  cos2
r3
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characteristic to the lanthanide ion. <r2>A20 and <r2>A22 are the zero and second order
ligand field coefficients, r, θ, and ψ are the polar coordinates of the ligand nucleus with
respect to the principal magnetic axis of the complex with the lanthanide ion at the origin,
and <J|a|J> is a numerical coefficient

The constants Cj98 and <Sz>99 and g factors have been determined for each of the
paramagnetic lanthanides.
1.4.3 Structure determination by NMR
The spin density of the electrons is primarily centered on the metal ion and not in the
bonds or donor ligand atoms, so the contact contribution is relatively small in magnitude.
Most of the lanthanide ions are known to cause large chemical shifts in nearby nuclei in
NMR experiments.100

For this type of shift to occur, the lanthanide must have an

anisotropic g factor in the liquid at room temperature as first described by Bleaney et
al.98,101 This means that the paramagnetic energy levels must be degenerate in the
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absence of a magnetic field, and that the Zeeman interaction of the levels depends on the
orientation of a magnetic field relative to the local axis of the paramagnetic complex.
This interaction only leads to large dipolar (δd) shifts when the ligand field is asymmetric.
Gd3+ has an isotropic ligand field, so its chelates cannot be used for the study of
relaxation of individual ligand protons. This magnetic dipole interaction is strongly
distance- (r-3) and temperature dependent (T-2, except for Sm3+ and Eu3+, when it is
between T-1 and T-2). The exceptions for Sm3+ and Eu3+ arise due to the population of
low-lying electronic excited states for these ions. The sign and magnitude of the induced
shifts stem from the spin angular momenta of the unpaired electrons and the local
magnetic field they produce. Analysis of these shifts can yield important structural
details about the chelate of interest.102,103
The dipolar shift component is non-zero for an anisotropic electron configuration (all
paramagnetic lanthanides except Gd3+), and for those Ln3+ it is the dominant contributor
to induced NMR shift. By assuming that the ligand field does not vary across the
lanthanide series, the <r2>A2 terms can be neglected. The chelates of interest are axially
symmetric or nearly enough so that the ψ term (polar coordinate, not the O4 plane
opening angle) can be discounted as well.
lanthanide-induced shifts (LIS) to   D

This reduces the major contribution of

3 cos

2

r

  1

3

, where D is a lanthanide-dependent

proportionality constant and r and θ are polar coordinates.
SAP and TSAP chelates can be distinguished from one another by any technique which
probes the magnitude of the axial ligand field, A20.104-106 This parameter is larger for
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SAP chelates, and the Ln3+ ion induces a wider frequency range of shifts in the spectra of
SAP chelates than in the TSAP analogues in the case of Eu3+ and Yb3+. The geometry is
identifiable by the large downfield shift of the protons positioned axially on carbons on
the sides (axS protons) of the macrocyclic ring. These axS protons have the largest
induced downfield chemical shift due to their proximity to the principal magnetic axis in
the chelates.40,107 However, 2-dimensional spectroscopy is necessary to characterize
multiple isomers of the same geometry. Quantitative structural analysis108,109 is possible
for those lanthanides for which Cj is large (the later lanthanides, such as Yb3+), but the
contact and diamagnetic contributions cannot be neglected for lanthanides where Cj is
small, or for lanthanides that have populated electronic excited states at ambient
temperature (Sm3+ and Eu3+).

In the case of these elements we are restricted to

qualitative interpretation.
The width of a proton resonance gives a relative measure of relaxation time in the
absence of chemical exchange, and line-width at half height can be used to approximate
T2 of a particular resonance. T2 also has a strong spatial dependence relative to Ln3+, and
can inform on the relative symmetry and electronic relaxation of a chelate.
1.4.4 Determination of q and τM
Direct excitation of the f-f electronic transitions of Ln3+ ions gives rise to distinctive
luminescence emission. The luminescent lifetimes are long (on the order of ms) because
these transitions are parity-forbidden. The vibrational energy of -OH oscillators in water
is very close to the energy of the 5D0-7FJ (ΔJ = 0-6) f-f transitions in Eu3+. Using the
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similarity of these energy levels as a basis, Horrocks and co-workers developed a
luminescence-based method to measure the number of water molecules interacting with
Eu3+ or Tb3+.110,111 The Ln3+ excited electrons can return to their ground state via nonradiative energy transfer to the -OH bonds, where the degree of vibrational quenching is
proportional to the number of proximal oscillators. The quenching by water is far more
efficient than that by D2O, whose vibrational energies do not match up as closely with f-f
transitions.

A plot of the mole fraction of water in D2O against the difference in

quenching rate by D2O and H2O (Δk) yields a straight line. The value of q can be
determined based on the slope (A) of the line where q = A·Δk. There is a degree of error
in this determination due to outer-sphere quenching, which can be corrected for.86,112 It
has been shown that rEu-O is fairly consistent among crystal structures of Eu3+ complexes
with varying charge and number of inner-sphere water molecules, approximately 2.45 ±
0.4 Å.49,113-115 A q value between 0 and 1 is reported when a water molecule has been
determined to be in the vicinity of the metal, but with a longer Gd-H distance (greater
than ~2.9 Å) than the accepted rLn-H for inner-sphere water.86 Based on known q values
of various Ln3+ chelates, the magnitude of Δk due to non-inner-sphere interactions was
determined.
The measurement of inner-sphere water exchange rates (kex) and water residence lifetime
(τM) by variable-temperature

17

O NMR methods was first published by Swift, Connick,

and co-workers,116,117 using the Bloch equations modified for chemical exchange as
described by McConnell.118

These methods were later extended to gadolinium

complexes.119 The measured shift difference (Δω) between inner-sphere water and bulk
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water is a function of T2, τM, and an outer-sphere contribution that can be neglected.
These parameters and others which describe the system (including electronic relaxation
parameters, which can be determined from electron paramagnetic resonance (EPR)) are
fit in a way analogous to NMRD to yield plots 1/T1, 1/T2, and Δω vs. temperature-1.120,121
From these data, accurate values of kex and τM can be obtained.
1.4.5 Examination of the motion and angle of a coordinated water molecule with respect
to the lanthanide
The “internal motion” of an inner-sphere water molecule has been examined recently by
Dunand et al.122

Based on the Curie (dipolar) relaxation of Tb3+ and quadrupolar

(contact) relaxation of 17O and 2H of Eu-bound water, τR values of Ln-O and Ln-H were
calculated for DOTAM chelates. The calculation of τR relies on several assumptions,
including that rLn-H in solution is the same as in the crystal. The justifications for this
assumption are based on data from a paper by Aime et al.,123 discussed below, and on Xray absorbance spectroscopy (XAFS or EXAFS) determination in solid state and solution
by Bénazeth et al.124
The Ln-H distances of the 6 types of ligand proton in DOTA were calculated for Tb, Dy,
and Ho[DOTA]-.123 These are based on T2 determinations from the line-widths of the
proton peaks at half height. Due to the geometric exchange processes in DOTA, though,
the lines could be broadened by non-T2 factors. The authors neglect the contributions to
the line-widths from the minor TSAP isomer observed in the NMR spectra. The Ln-H
values determined also rely on calculated τR values from NMRD, 13C T1 and NOE data.
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Data underlying the calculations of τR are based on an incomplete description of sources
of line-broadening, which leads to systematic errors in the calculations.
The Ln-H distances were also calculated separately by measuring the line-widths at 3
different magnetic fields and plotting line-width vs. the square of the field. The linewidth of an internal standard (t-butanol) was subtracted from the line-width of each of the
DOTA shifts. The authors acknowledge that a chemical exchange process may affect the
shifts, and measure them at different temperatures. Good agreement of calculated rLn-H
values is claimed at 3 temps: 275, 285, 295 K. In this study, Ln-H was measured only for
the DOTA ligand hydrogen atoms, not for bound water.
Dunand et al. took Ln-H distances directly from the crystallographic data and postulated
2 different orientations of the water molecule with respect to Ln: H’s oriented upward,
furthest from the Ln3+, and H’s angled downward, somewhat towards the Ln3+ (Figure
1.11).
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Top view

Side view

Figure 1.11: Distances and angles calculated for crystal structures of Gd[DOTA]- with
the water molecule positioned A) such that the protons are furthest from the metal ion,
and B) such that the protons are angled downward slightly towards the metal.122

They determined τR values for rLn-H and rLn-O, and τR ratios of rLn-H/rLn-O were calculated
to be 1 and 0.6 respectively using the 2 angles. They also took quadrupolar relaxation
data by measuring line-widths for the Eu3+ complex, which is expected to be inexact due
to low-lying Eu3+ excited states.
They defend the use of 2.44 Å for rLn-O based on XAFS measurements124 performed in
solution, which gives rLn-O = 2.46 Å (not 2.447 as claimed by Dunand et al. The 2.447
value is from the solid state XAFS data). In a later paper93, there is not an adequate
explanation of why the determined XAFS solution values for Eu-O and Tb-O are 2.5 Å,
but 2.44 Å for Gd-O in Ln[TCE-DOTA].
The assumptions made by Dunand et al. do not invalidate their conclusion that the local
motion of water should not significantly affect relaxivity in compounds with long τR.
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However, the data cited from the other work to support the assumed Ln-O and Ln-H
distances does not seem wholly applicable. There are small rLn-O differences between
solid and solution state structures, leading to a small degree of error in using the Ln-O
distance as a fixed parameter. There is a great deal of uncertainty about the Ln-H
distance due to the unknown “tilt” angle of the water molecule, and the low degree of Hatom position prediction in crystallography. The two Ln-H distances calculated (3.21 vs.
2.95 Ǻ) as shown in Figure 1.11 might reasonably be expected to be the possible
maximum and minimum. However, the “tilt” angle of the water molecule is likely
fluctuating between these extremes due to the continual motion of water (including water
exchange). A thorough structural characterization of any Ln3+ chelate proposed for study
as an MRI CA is prudent for measuring and optimizing parameters including τM, though
with techniques available today we are still limited to educated guesses with respect to
values for rLn-H for inner-sphere water.
1.5 The scope of this work: increasing the efficacy of MRI CAs
The scope of this work is to design, synthesize, and test the properties of relaxivityoptimized Ln3+ chelates having high kinetic stability.
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1.5.1 Strategy for decreasing τM via coordination isomer selection
Since rLn-H cannot be measured directly, rLn-O is measured in many studies of CAapplicable chelates and the two r values are assumed to be proportional. A greater GdOH2(inner-sphere) distance (r) has a strong correlation with faster water exchange. Strategies
to accelerate water exchange have been pursued by a number of researchers in efforts to
prepare more effective contrast agents. These strategies mainly involve modifying the
overall charge of the chelate and/or increasing steric hindrance about the water
coordination site.66,125-127 The results, however, have been disappointing – the resultant
relaxivities have not increased as much as would be predicted by SBM theory.80,128,129
Many of these studies are complicated by the existence of multiple coordination
geometries and/or conformations for a given chelate, making it difficult to isolate the
effects of τM on relaxivity.
τM for Gd[DOTA]- has been determined to be 244 ns, which is much slower than optimal
according to SBM theory. It has been demonstrated that water exchange rates depend
strongly on the coordination geometry of the chelate.73,130 The TSAP isomer has water
exchange kinetics in the optimal range predicted by SBM theory. However, the SAP
isomer is the major isomer (~85%) in solution under physiological conditions, and its
water residence lifetime is approximately 50 times longer.131
It would be advantageous to synthesize a DOTA derivative with only the coordination
geometry yielding the desired water exchange kinetics. To do this, chiral substituents on
the arms and on the ring can be added to increase steric hindrance to reversal of helicity
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(Figure 1.12). These steric modifications should increase the energy barriers to arm
rotation and ring inversion.132-134

Figure 1.12: Examples of DOTA derivatives with arm (R) and ring (R’)
substituents.115,134-137

Synthesis of the DOTA derivative TCE-DOTA with chiral arms has been described.132
The ratio of TSAP and SAP isomers have been measured in solution, and the chelates
were mostly SAP, with pendant arms having mixed chiralities (RSRS-, etc.) leading to a
minor isomer in TSAP form. The chelates with greater percent TSAP geometry had
faster water exchange.137 When both bulky ring and arm substituents were added, these
were found to “lock” the chelate into a single conformational isomer in solution.53 A
specific configuration at each substituted carbon was found to be necessary to select for a
given helicity; racemic mixtures led to multiple products and geometries.
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Understanding the isomeric preference and/or interconversion is crucial to preparative
efforts and potential clinical use of the relaxivity-optimized isomer for a particular
macrocyclic chelate. If τR of DOTA-type chelates were made longer (i.e. by binding to a
macromolecule), the relaxivities would be limited by τM unless the geometry is TSAP,
according to the SBM model in Figure 1.8. By carefully selecting the chirality at the
stereogenic centers in arm and ring substituted DOTA-type chelates, we attempted to
prepare τM-optimized chelates and to study their structural and relaxometric properties.
1.5.2 Strategies for increasing relaxivity based on τR
All clinical MRI CAs are extracellular and non-specific, exhibiting a distribution within
the vasculature.138

Of particular current interest in CA development are potential

diagnostic agents that are administered as low molecular weight agents and bind to
macromolecules in blood or tissue or are covalently conjugated to macromolecules, both
leading to more optimal τR. For example, MS-325 (marketed as Ablavar™) has a Gd3+
chelate covalently linked to a lipophilic, human serum albumin-binding moiety139 and has
been approved in the E.U. and other countries as a MR blood-pool agent. The smallmolecule agent circulates freely in the blood until its bicyclohexyl group binds to
albumin, enhancing relaxivity by slowing τR (due to restricted local and global rotation)
of the agent.140-142
Dendrimer, nanoparticulate, micelle, or liposome-based formulations of Ln-based CAs
have been envisioned and show great promise for imaging.143-147

Their large size

increases τR (at least due to the global rotation limitation), but there are concerns that
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Also, the larger size changes the

biodistribution and pharmacokinetics compared with the parent chelate.36,148,149 In order
to maximize the relaxivity gains from this slower tumbling, extracellular water must be
able to diffuse to, and exchange freely with, the inner-, second-, and outer-sphere water
molecules for all Gd3+ sites, most of which are on the inside of nanoparticles or
liposomes by design. Alternatively, the Ln-water exchangeable sites could be placed on
the surface of the large particles. It would be valuable to know whether the rate of water
exchange between the inner-sphere and bulk water limits the observed relaxivity of these
putative agents. In micelles, the local concentration of Gd3+ may even be too high,
leading to disruption of the water relaxation mechanism.150,151
No clinical agents are currently available with the capability of targeting specific
pathologies, such as a CA which binds only to certain types of extracellular protein (for
example, on the outside of tumor cells). Work on a macrocycle with phosphonate
monoester pendant arms by another lab has shown that its Tb3+ chelate binds selectively
to certain types of tumor cells.152 Assuming rapid, pervasive biodistribution and high
specificity, this targeted binding approach would provide contrast enhancement only at
that site, reducing the required dose. The research of cancer-cell-targeting MR agents is
starting to receive a great deal of interest. Injecting a CA that is as stable as possible is
particularly important when designing an agent which will bind to a molecular target, due
to the increased residence time in the body.153-155 We attempted to prepare Gd3+ chelates
with macromolecular binding capability and to study their properties when bound to a
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slowly tumbling target. One of these chelates could become the active component in a
potential CA.
Arm and ring substituted DOTA chelates are characterized by fast water exchange and
are interesting candidates for high relaxivity. Though chelates of NB-DOTMA (2) have
been synthesized and studied before,53,106,137 there seemed to be merit in further
characterization of these systems.

In particular, the structure and subtle structural

variations between isomeric chelates were targeted for study. Questions concerning the
origin of multiple isomers in this system, which had implications for relaxivity behavior,
had remained unanswered prior to this work. Chelates of 2 also are very similar to those
of NB-DO3MA-1A (3), whose relaxometric properties when bound to slowly tumbling
species have previously been investigated.156

Ligands whose chelates were studied in this work
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(134) Häussinger, D.; Huang, J.-r.; Grzesiek, S. Journal of the American Chemical
Society 2009, 131, 14761.
(135) Brittain, H. G.; Desreux, J. F. Inorganic Chemistry 1984, 23, 4459.
(136) Comblin, V.; Gilsoul, D.; Hermann, M.; Humblet, V.; Jacques, V.; Mesbahi, M.;
Sauvage, C.; Desreux, J. F. Coordination Chemistry Reviews 1999, 185-186, 451.
(137) Woods, M.; Kovacs, Z.; Zhang, S.; Sherry, A. D. Angewandte Chemie
International Edition 2003, 42, 5889.
(138) Bottrill, M.; Kwok, L.; Long, N. J. Chemical Society Reviews 2006, 35, 557.
(139) Lauffer, R. B.; Parmelee, D. J.; Dunham, S. U.; Ouellet, H. S.; Dolan, R. P.; Witte,
S.; McMurry, T. J.; Walovitch, R. C. Radiology 1998, 207, 529.
(140) Muller, R. N.; Radüchel, B.; Laurent, S.; Platzek, J.; Piérart, C.; Mareski, P.;
Vander Elst, L. European Journal of Inorganic Chemistry 1999, 1999, 1949.
(141) Caravan, P.; Cloutier, N. J.; Greenfield, M. T.; McDermid, S. A.; Dunham, S. U.;
Bulte, J. W. M.; Amedio, J. C.; Looby, R. J.; Supkowski, R. M.; Horrocks, W. D.;
McMurry, T. J.; Lauffer, R. B. Journal of the American Chemical Society 2002,
124, 3152.
(142) Zhou, X.; Caravan, P.; Clarkson, R. B.; Westlund, P.-O. Journal of Magnetic
Resonance 2004, 167, 147.
(143) Løkling, K.-E.; Fossheim, S. L.; Klaveness, J.; Skurtveit, R. Journal of Controlled
Release 2004, 98, 87.
(144) Gianolio, E.; Porto, S.; Napolitano, R.; Baroni, S.; Giovenzana, G. B.; Aime, S.
Inorganic Chemistry 2012, 51, 7210.
(145) Kielar, F.; Tei, L.; Terreno, E.; Botta, M. Journal of the American Chemical Society
2010, 132, 7836.
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CHAPTER 2. REGIOISOMERISM IN CONFORMATIONALLY RIGID NB-DOTATYPE CHELATES
2.1 Utility of conformationally rigid chelates for probing subtle, structurally related
differences in solution behavior
Most studies of contrast agents and prototypical agents have been performed on chelates
that undergo conformational exchange. The presence of multiple conformational isomers
and coordination geometries makes it difficult or impossible to separate the effects of the
various structural contributions to the relaxation properties of the compound of interest.1
It is often the case that the properties which govern relaxivity can only be determined as
weighted averages in the case of a sample with two or more isomers. Deconvolution of
these weighted averages requires that we know the distribution of coordination isomers,
which is not always possible. It has been found that many important properties of Gd3+
chelates differ greatly between conformational and geometric isomers. Isomer ratios and
rates of interconversion can be heavily dependent on temperature2, solvent3, pH4, counter
ion5, and concentration. In order to understand the relationship between structure and
MRI-relevant properties in detail, it is advantageous to use conformationally rigid Ln3+
chelates for which it is possible to extract small differences between fully resolved,
isomeric structures. The arm- and ring-substituted DOTA derivative Ln[NB-DOTMA](2) (in Scheme 2.1), which is characterized by a single coordination geometry and rapid
water exchange6, is the focus of these studies.
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Scheme 2.1: Structures of ligands and chelates referenced in this chapter

The nitrobenzyl (NB) group is an important modification to the DOTA scaffold due to its
ability to “lock” the helicity of the macrocyclic ring. In addition, the nitro group can be
converted to the isothiocyanate via facile synthesis without affecting the rest of the
chelate, enabling the attachment of a covalent linker that can bind to a macromolecular
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target. This functionizable group allows for a “bifunctional” chelate – one with relaxivity
enhancing and targeted binding potential.7,8

When a prototypical agent binds to a

macromolecular target, τR should increase as described above.9,10

This binding

interaction slows molecular tumbling for the agent and increases accumulation of the
agent, producing greater contrast per total injected dose at the site of interest. Because of
its aromaticity, the nitrobenzyl group is also useful as a chromatographic handle
throughout synthesis and purification. An aromatic ring can act as an “antenna” for
directing lanthanide luminescence (another potential way of generating contrast in vivo)
as well.11,12
2.2 Rationalizing the appearance of multiple isomers in a conformationally rigid
chelate of single stereochemistry
In the synthesis of Ln-S-RRRR-2, the arm- and ring-substitution locks the chelate into
only one coordination geometry. If the ligand is S-RRRR, only the SAP geometry should
be possible. It was expected that only one isomer would be obtained, yet two isomers of
Yb-S-RRRR-2 were isolated by HPLC purification.13,14 These isomers had identical mass
and elemental analyses. NMR spectra for the two isomers had peaks in the axS region
indicating SAP geometry (Figure 2.1).
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Figure 2.1: Partial 1H NMR spectra of the two isomers of Yb-S-RRRR-2 showing the axS
resonances. Both spectra have axS shifts which indicate SAP geometry.

In the synthesis of 2 (Scheme 2.2), alkylation of the amines in NB-cyclen is
accomplished by nucleophilic substitution on the α-carbon of an ester. This substitution
proceeds via an SN2 reaction and complete inversion of configuration at this carbon, i.e.
an R- configuration of the alkylating agent (1) is required to form SSSS-2.

Scheme 2.2: Nucleophilic substitution to alkylate nitrobenzyl cyclen amine groups during
synthesis of 2, X=leaving group (bromide or triflate)

NB-cyclen will react to form only the tri-alkylated macrocycle with four equivalents of
alkylating agent 1, even with a triflate (a highly labile leaving group), if the reaction is
performed at room temperature. To yield the tetra-alkylated product, extended heating
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and reaction times are required. The nitrogen in the 1-position is the poorest nucleophile
due to steric crowding from the nearby NB substituent, possibly giving the substitution at
that position more SN1 character. In these syntheses of 2, two isomers of the tetraester
precursor 7 (Scheme 2.3) were identified by NMR and could not be separated at this
stage.

The authors modified the synthetic procedures leading to Yb-S-RRRR-2 by

changing the leaving group for N-alkylation and changing the solvent, but two isomers
were obtained in each case.
In this same work14, it was speculated that racemization (of the chiral carbon on the (2methyl)acetate arm adjacent to the NB group) occurred during ligand synthesis, leading
to the observation of two isomeric chelates, assigned as Yb-S-RRRR- and Yb-S-SRRRNB-DOTMA (Scheme 2.3).

Scheme 2.3: Racemization of a (2-methyl)acetate arm leading to two chelates, X = Br,
OTf

To overcome this synthetic challenge, a ligand (3) without the potential for
stereoisomerism in the 1-N position was synthesized and its Ln3+ chelates were prepared.
Only 3 pendant arms are required to have appropriate chiral substituents to lock the
coordination geometry.15 Both S-SSS- and S-RRR-3 were synthesized and did not show
multiple isomers at the time of publication.
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Due to the apparent poor nucleophilicity of the 1-aza position, racemization was put forth
as the likeliest explanation for the observation of two isomeric chelates, where matters
stayed until we revisited Ln-2 in this work.
2.3 Structural characterization of regioisomeric chelates by correlational NMR
spectroscopy (COSY)
Recent observations have led us to question the racemization explanation. A previous
study on isomers of Yb-2 noted that for the isomer previously assigned as the S-RSSS
isomer, the NB group appeared to be located on a carbon on the side of the ring based on
2D NMR and modeling data.16 Analysis of the COSY NMR spectra of resolved Yb-2
isomers showed that axial protons were missing an expected geminal couple to a proton
on a carbon on the corner and on a carbon on the side of the macrocyclic ring,
respectively. Unfortunately, a complete assignment of the cross peaks of both isomers
was not made in previous studies of Yb-2. Additionally, later syntheses of Ln-3 afforded
two isomers of single coordination geometry (unpublished data).
2.3.1 Previous studies of two-dimensional NMR spectra of arm- and ring-substituted
DOTA-type chelates
Crystallography is a convenient method for understanding conformation and structure.
To probe the nature of the two isomers directly, it would be beneficial to examine crystal
structures of the resolved chelates. However, crystal structures of NB-DOTA or NBDOTMA chelates have never been obtained; these ligands and their chelates could not be
induced to crystallize. Instead, they form amorphous solids. Nonetheless, a great deal of
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structural information can be extracted from the NMR spectra of conformationally rigid
chelates in solution.
Desreux and colleagues proposed the existence of regioisomers for structures of
conformationally rigid chelates.17

Chelates of the highly rigid, symmetric ligand

M4DOTMA were synthesized. The substitutions of each type of ring proton with a
methyl

substituent

group

were

modeled

individually

and

the

lowest-energy

conformations were determined. The methyl group could occupy an equatorial position
either on the corner or the side of the ring, but the difference in energies between these
indicated only 1 species should be observed in solution.

The correlational NMR

spectroscopy (COSY) spectrum of Yb-M4DOTMA includes only one peak for each type
of ring substituent (3 proton peaks and a peak for the methyl group) and arm substituent
(1 proton on the arm and 1 peak for the methyl arm substituent). This indicates that only
one isomer is present.

In the spectrum of YbM4DOTA, the two geometries available

(due to ring inversion) appear. The peaks for these structures broaden and coalesce as the
temperature is increased. No cross-coupling peaks between the two sets of resonances
are observed. These spectral features show that the structures are distinct from one
another but interconvert, and that the rate of exchange is fast on the NMR time-scale at
elevated temperatures. The methyl arms on the ring are assigned as being positioned in
the eq corner position. However, a third set of shifts is apparent in the spectrum of
YbM4DOTA that are not in exchange with the shifts of the first two structures. This
spectrum is assigned as having the arm substituents in the eq side position. Isomers with
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eq substitution on the corner and side were observed in the spectrum of YbMDOTA as
well.
An alternative explanation for the production of two isomers of Yb-S-RRRR-2 is as
follows. On the cyclen ring, the configuration of the NB carbon is S-, and the more
favorable conformation (δδδδ) places the large ring substituent into an equatorial
position. There are two chemically distinct carbon atoms in a 12-N-4 crown, carbons on
the corner and carbons on the side of the ring. The equatorial protons on both the carbons
on the corner and the side of the [3333] macrocyclic ring are pro-S in a δδδδ
conformation. This means that a ring substituent of single configuration could occupy
one of two chemically distinct positions and still adopt an equatorial conformation
(Figure 2.2). Thus, for any singly substituted cyclen there are two possible regioisomeric
structures, referred to hereafter as corner and side isomers of Ln-2 (Figure 2.3).
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Figure 2.2: Two possible sites of ring substitution, both pro-S. eq = equatorial proton,
ax = axial. For example, an equatorial proton on a carbon on the side of the ring is
abbreviated eqS

Figure 2.3: Two possible arrangements for the macrocyclic ring in 2

The substituent group positioned equatorially on a “corner carbon” would be evident
from a lack of proton-proton coupling to the axial proton on that same carbon – the axC
proton would not show a geminal coupling when characterized by COSY. One of the
challenges in acquiring NMR spectra, particularly 2-dimensional spectra, of Ln3+
chelates, is the extraordinarily large frequency range of the resulting proton shifts. This
large spectral window necessitates scanning parameters that limit the signal-to-noise for
coupling peaks of interest. Eu3+ gives rise to relatively sharp line-widths and a narrow
frequency range of 1H shifts in its chelates compared with other lanthanides. A more
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complete structural characterization by NMR of individually purified isomers of Eu-2
was undertaken in this work. This work demonstrates evidence supporting structures
with the substituents positioned in both corner and side eq positions as described in the
work of Desreux and colleagues.18
2.3.2 Structural characterization of isomeric Eu-S-SSSS-2 chelates by correlational
spectroscopy (COSY)
Eu-S-SSSS-2 was prepared according to the literature procedures14 and the two isomers
produced were resolved by HPLC. Mass spectrometry was used to confirm that both
compounds had the same molecular mass and 1H NMR was used to confirm that both
isomers had axS shifts indicative of TSAP geometry. COSY spectra were acquired for
the two isomers of Eu-S-SSSS-2 at 278.15 (in the figures that follow) and 313.15 K (data
not shown) at 600 MHz. The wider spectral window of the low temperature data more
readily allows for analysis of individual shifts and their cross-peaks, and is presented
here. The COSY spectrum of the major isomer of Eu-S-SSSS-2 is shown in Figure 2.4.
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Figure 2.4: COSY spectrum of the major isomer of Eu-S-SSSS-2. Off-diagonal peaks
indicate through-bond proton-proton coupling (J-coupling). Cross-peaks assigned to
coupling of the same type of protons are indicated by the same colored arrow. Peaks
that cannot be explained by J-coupling are circled.

Assignments for the cross-peaks in the spectrum of the major isomer of Eu-S-SSSS-2
(Figure 2.4) were made as follows. For Eu-S-SSSS-2, it could not be determined which
ethylene bridge a given set of shifts corresponded to as there is no cross-coupling
observed through the nitrogens on the macrocyclic ring. We can, however, group the
protons for a particular bridge together – each ring proton has a distinct shift owing to the
asymmetry (C1) of the chelate. The axial side (axS) protons exhibit the greatest downfield
shift in the spectrum due to their position close to the z-axis of the electron paramagnetic
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field. Each axial proton on an ethylene bridge can experience J-coupling to the other
three protons: one each with the other axial and the two equatorial protons. The starting
point for the assignment of all cross-peaks begins with J-coupling to the axS peaks. The
geminal (2J) couplings are the strongest (red arrows), so the most intense cross-peaks
correspond to coupling of the axS protons with the equatorial side protons (eqS). The next
strongest cross peaks are axS-axC (axial proton on a corner carbon, green arrows) based
on the Karplus relationship.19 The H-C-C-H angle between axial protons approaches
180° giving a strong vicinal coupling.
The least intense cross-peaks correspond to coupling of the axS protons to the equatorial
proton on a corner carbon (eqC) protons (purple arrows). The axC-eqC couplings (blue
arrows) are assigned based on the cross-peaks from axS to axC and eqC, respectively, and
have intensities similar to the axS-eqS peaks, which have already been assigned. For the
NB group, the two peaks for p-substituted aromatic protons are identified by their slight
downfield shift, 3J coupling to one another, and relative integration area of two. The two
peaks for the benzylic protons (1H, 2J) are identified on the basis of shift as well. The
methyl peaks on the pendant arms are identified by their number (4) and relative
integration areas (3). Each methyl proton is vicinally coupled to its corresponding ac
proton. One of the axC resonances should have a 2J coupling (to an equatorial proton on a
corner carbon) which is notably absent. This observation is consistent with an eqC proton
having been replaced by the S-nitrobenzyl substituent.
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Some peaks were observed in the spectrum that could not be assigned to through-bond
cross-coupling.

Under certain conditions in COSY spectroscopy, cross-peaks are

observed due to the nuclear Overhauser effect (NOE). The NOE arises from dipoledipole interactions between nuclei close together in space. For a system of two nuclei α
and β, there are multiple possible transitions between nuclear spin states (Figure 2.5).

Figure 2.5: Transitions between nuclear spin states which may give rise to NMR peaks
due to the nuclear Overhauser effect20

Each nucleus can have its spin state aligned parallel or antiparallel to the main magnetic
field, resulting in four possible populations – one each with both states parallel and both
states antiparallel, and two states where the nuclei are oppositely aligned.

Upon

irradiation with an RF pulse with sufficient energy to excite the transition, one nucleus
could flip the direction of its spin, leaving the other unchanged (illustrated by ω1, a single
quantum transition). At a different RF frequency, a transition could be excited where the
two nuclei each flip the alignment of their spin momenta (illustrated by ω0 or ω2, either a
net zero quantum transition or a double quantum transition). If the incidences of ω0 and
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ω2 are unequal, and if the dipolar interactions between these two nuclei are the dominant
T1 relaxation pathway, NOE peaks can be observed in an NMR spectrum. The large
frequency range of the COSY spectra of Eu-S-SSSS-2 increases the chances that RF
pulses include the energies leading to the available transitions. The cross peaks arising
from the NOE are through-space interactions indicating protons which are proximal yet
not closely connected through bonds. The presence of a peak resulting from throughspace interaction of a coupled axC proton and a benzyl proton (circled in teal) is one such
NOE peak. This peak indicates a close spatial relationship between the substituted corner
carbon and the NB group.
There are key differences between the COSY spectrum in Figure 2.4 and the spectrum in
Figure 2.6, which was acquired for the minor isomer of Eu-S-SSSS-2.
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Figure 2.6: COSY spectrum of the minor isomer of Eu-S-SSSS-2. Off-diagonal peaks
indicate through-bond proton-proton coupling (J-coupling). Cross-peaks assigned to
coupling of the same type of protons are indicated by the same colored arrow. Peaks
that cannot be explained by J-coupling are circled.

In the COSY spectrum in Figure 2.6, the same number of 1H peaks are observed over
essentially the same spectral window as in Figure 2.4. The shifts, though, are different.
The axS peaks (in the 20-30 ppm region) indicate TSAP geometry, yet based on differing
chemical shifts, a distinctly different chelate from that shown in Figure 2.4. There are the
same number of off-diagonal COSY peaks that arise from through-bond coupling. The
assignments of the cross-peaks are as follows.
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Three of the axS protons have three cross-peaks each of varying intensity. These have
been assigned to geminal (axS-eqS, indicated by red arrows) and vicinal (axS-axC, green
arrows and axS-eqC, purple arrows) couplings based on the cross-peak intensity in the
same manner as described above. axS coupling assignments were used to identify the
corresponding axC-eqC cross-peaks (blue arrows) on the same ethylene bridge.
The peaks at 10.8 and 9.8 ppm are minimally affected by Eu3+ in terms of their shift and
line-width broadening. These peaks each have an integration area of 2H and show a
cross-peak between them. These are assigned as protons on the p-NB aromatic ring (Ar
and Ar'). The peak at 8.4 ppm is similarly narrow and shows a cross-peak to a resonance
hidden under the HOD peak (4.7 ppm). The peak at 8.4 ppm has an integration area of
1H and is assigned to a benzylic proton (Bn').
The fourth and most highly-shifted axS proton shows NOE peaks to an aromatic proton
(orange circle) and a benzylic proton (teal circle). The remaining off-diagonal peak for
this axS proton is assigned as an axS-axC cross-peak (green arrow) based on its intensity.
This assignment is confirmed by an intense eqC-axC peak (blue arrow) on the same
ethylene bridge. Based on these cross-peaks, the location of where the axS-eqC peak
should appear (but does not appear) is indicated by a washed-out purple arrow. No eqS
proton is evident for this ethylene bridge.
The methyl and acetate protons on the pendant arms show cross-peaks and are identified
in the same manner as in Figure 2.4.
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Ethylene bridges with no substituents adopt almost ideal gauche conformations (60°).
Replacing one hydrogen with a bulky NB group could distort the conformation of the
ethylene bridge, increasing the angle between the NB group and the hydrogen
substituents on the vicinal carbon. The more steric strain induced by coordination and
substituent effects, the larger this angle will distort from an idealized gauche geometry
(Figure 2.7). The axS peak with no coupling to equatorial protons is broad and highly
shifted, indicating a close proximity to Eu3+. Its ethylene bridge, if substituted with a NB
group, would show the most torsional strain due to steric interaction and the most
distortion from an ideal gauche conformation. Depending on the angle, distortion could
increase or decrease the intensity of a cross-peak due to the Karplus relationship. This is
the likely explanation for the missing axS-eqC coupling (washed-out purple arrow).

Figure 2.7: Newman projection (not to scale) showing distortion of the dihedral angle
from ideal gauche conformation between adjacent carbons on an eqC-substituted
ethylene bridge

The lack of a cross-peak corresponding to J-coupling between the 30 ppm axS peak and
an eqS proton leads us to conclude that this carbon on the side of the ring has been
substituted by the nitrobenzyl group.
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The spectra and structures in this work were compared to those of Yb-M4DOTMA, M4DOTA, and -MDOTA. This analysis showed that the chelate in Fig. 2.4 is the corner
regioisomer and Fig. 2.6 is the side regioisomer. The evidence from the COSY analysis
demonstrates that the Yb-S-RRRR-2 chelates assigned as diastereoisomers in earlier work
are instead, in fact, regioisomers.
2.3.3 Molecular mechanics simulation of the NB position and orientation based on NOE
peaks observed in the COSY spectra
The are more NOE peaks (circled) observed in the COSY spectrum of the eqS-NBsubstituted chelate in Fig. 2.6 than in the eqC-substituted isomer in Fig. 2.4. There are
proximal through-space relationships in evidence between the axS and benzylic
(Bn)/aromatic protons, and between the other benzylic (Bn') and pendant arm protons (Me
or ac). The NOE peaks observed in the COSY spectra of these chelates enable us to use
MM+ geometry optimization for each chelate. These models were constructed to predict
the approximate time-averaged position of the nitrobenzyl substituent with respect to the
chelate (Fig 2.8).
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Figure 2.8: Molecular models of the proposed regioisomeric structures. a) is the view
from the top of the chelate, looking down the principal axis at the Eu3+ ion. b) is the view
from the side of the chelate. c) shows the two chelates superimposed in the “side” view.
The dotted lines correspond to NOE peaks observed in the COSY spectra (Figures 2.4
and 2.6). Bn-axS interactions are in teal and Bn’-Me interactions are in gold. The nitro
groups are not shown.

In the model, the positions of the substituents relative to the macrocycle are based on the
number and type of cross couplings alone. There is only one NOE peak in the corner
isomer, suggesting that the remaining protons in the NB group are farther away from the
macrocycle. In contrast, from Fig. 2.6, NOE peaks indicate the proximity of axS, Bn/Bn'
and ac protons to the macrocyclic ring. In the model of the corner isomer, this reasoning
led to the placement of the NB substituent above the chelate, oriented away from the
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macrocycle, whereas the location of the NB substituent in the side isomer was placed
facing away from the macrocycle but more or less in plane with the ring. Any deviation
from the idealized 60°C H-C-C-H angle will change the size of the 3JH-H couplings,
according to the Karplus relationship, as observed in Figure 2.6 (washed-out arrows).
Since the torsional angles cannot be determined from the strength of the couplings alone
(particularly for peaks which are absent), it is not possible to take the magnitude of the
distortion of the ring caused by the NB substituent into account in the model. The model
is based on a symmetric, unsubstituted cyclen ring.

Finally, in the COSY spectra

acquired at 313 K, there are no NOE peaks observed. This may reflect either or both
increased intramolecular motion and a slightly different time-averaged chelate geometry,
or a nuclear relaxation mechanism other than dipole-dipole which is dominant. These
findings suggest that the nitrobenzyl group is oriented differently depending on the
substitution position. The NB group appears to be closer to the chelate ring (and to one
of the pendant arms) in the in the side isomer (Figure 2.6) than in the corner isomer
(Figure 2.4).
2.3.4 Structural characterization of isomeric Eu-S-RRRR-2 chelates
Chelates of Eu-S-RRRR-2 were also synthesized and studied. Surprisingly, 4 isomeric
chelates were isolated from purification of the chelate synthesis instead of the expected
two (regioisomers). The COSY spectrum of the chelate isolated in greatest yield is
shown in Figure 2.9. In this spectrum, the 1H peaks are observed over a larger spectral
window than in Figures 2.4 and 2.6. The axS peaks (in the 40-50 ppm region) in each of
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Figures 2.9, 2.10, 2.11 and 2.12 indicate SAP geometry and each spectrum is unique,
indicating a distinct chelate.

The number and type of peaks in Figure 2.9 closely

resemble those observed in Figure 2.4, the corner-substituted isomer of Eu-S-SSSS-2.

Figure 2.9: COSY spectrum of the major isomer of Eu-S-RRRR-2. Off-diagonal peaks
indicate through-bond proton-proton coupling (J-coupling). Cross peaks of the same
type are indicated by the same colored arrow. Peaks that cannot be explained by Jcoupling are assumed to be due to NOE interactions and are circled.

Cross-peaks each of varying intensity have been assigned to geminal (axS-eqS) and
vicinal (axS-axC and axS-eqC) couplings based on the cross-peak intensity in the same
manner as described previously. Each axS peak in Figure 2.9 has an intense cross-peak
that is assigned to a geminal (axS-eqS) coupling. The vicinal (axS-axC) couplings are
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observed for each of the four ethylene bridges as well. Only three axC-eqC peaks are
identified, again consistent with substitution of an eqC proton. Only two axS-eqC vicinal
couplings are observed. The position of where the third should appear based on the axCeqC and axS-axC assignments is shown by a washed-out purple arrow. Steric interaction
causing distortion of this ethylene bridge from an ideal gauche conformation is again the
likely explanation for the missing axS-eqC coupling (washed-out purple arrow).
The peaks at 12.7 and 6.8 ppm show minimal line-width broadening and show crosspeaks to one another. These peaks have an integration area of 1H each and are assigned
to benzylic protons (Bn and Bn'). The methyl and acetate protons on the pendant arms
show cross-peaks and are identified in the same manner as in Figure 2.4.
Due to the missing eqC peak and presence of the remaining expected protons, the
predominant isomer therefore has the NB group positioned on the corner of the ring.
The COSY spectrum (Figure 2.10) of one of the three minor isomers isolated from the
synthesis of Eu-S-RRRR-2 is shown below.
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Figure 2.10: COSY spectrum of a minor isomer isolated from the synthesis of Eu-SRRRR-2. Off-diagonal peaks indicate through-bond proton-proton coupling (J-coupling).
Cross peaks of the same type are indicated by the same colored arrow. Peaks that
cannot be explained by J-coupling are assumed to be due to NOE interactions and are
circled.

Three of the axS protons in this spectrum show two cross-peaks each. A third set of axS
cross-peaks was not observed – the axS-eqC peaks are presumably too weak to be seen
under the conditions tested. The strongest coupling is to a geminal proton, so these are
again assigned as axS-eqS. The next strongest coupling is axS-axC, which was assigned to
the remaining cross-peak for each ethylene bridge. Three of the axC-eqC peaks are
assigned based on their cross-coupling to axS. An additional cross-peak in the same
region of the spectrum (0 to -10 ppm) corresponds to protons with similar peak shape and
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was assigned to the fourth axC-eqC coupling. The aromatic, benzylic, and pendant arm
protons were identified in the same manner as for the above chelates.
Except for the missing axS-eqC peaks, the cross-peaks observed and their assignments are
similar to that of the side isomer of Eu-S-SSSS-2. The chelate which yielded the COSY
in Figure 2.10 is assigned as the side isomer of Eu-S-RRRR-2. The reason for the absence
of these cross-peaks is probably the minimal amount of sample available and the 2D
NMR spectral limitations described above, and not due to any structural differences.
COSY spectra were acquired for the remaining two minor isomers (Figures 2.11 and
2.12).
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Figure 2.11: COSY spectrum of a minor isomer from the synthesis of Eu-S-RRRR-2.
Off-diagonal peaks indicate through-bond proton-proton coupling (J-coupling). Cross
peaks of the same type are indicated by the same colored arrow. Peaks that cannot be
explained by J-coupling are assumed to be due to NOE interactions and are circled.

In Figure 2.11, four strong cross-peaks are in evidence and were assigned to axS-eqS
coupling.

The four cross-peaks of intermediate intensity were assigned to axS-axC

coupling. This allowed the assignment of strong cross-peaks to axC-eqC coupling, of
which only three were observed. Only one axS-eqC cross-peak could be assigned, the
remaining positions where these couplings would show up are noted based on the axSeqS, axS-axC, and axC-eqC assignments. Based on the peak assignments, this structure is
consistent with another isomer with NB-substituent having replaced an equatorial proton
on a corner carbon.
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The axial-axial cross-peaks are not of uniform intensity. The axS proton with the weakest
axC coupling is the one missing an eqC cross-peak on its ethylene bridge. This axC proton
is coupled to a benzylic proton. One of the peaks corresponding to a methyl group on a
pendant arm is shifted upfield significantly compared with the other three methyl
resonances. These observations would be explained by an arm “forced” into a helicity
which is opposite to the preferred orientation for its chirality. Since the arms in DOTAtype chelates must bind cooperatively; three arms in a particular orientation (δ or λ) are
enough to select for a particular geometry regardless of the chirality of the fourth arm.
The cross-peak observations are indicative of an ethylene bridge which is significantly
distorted, strongly suggesting an inverted (S-) stereocenter on the pendant arm closest to
the nitrobenzyl group. The chelate in this spectrum was assigned as Eu-S-SRRR-2, corner
regioisomer.
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Figure 2.12: COSY spectrum of a minor isomer isolated from the synthesis of Eu-SRRRR-2. Off-diagonal peaks indicate through-bond proton-proton coupling (J-coupling).
Cross peaks of the same type are indicated by the same colored arrow. Peaks that
cannot be explained by J-coupling are assumed to be due to NOE interactions and are
circled.

The final isomeric chelate isolated from the synthesis of Eu-S-RRRR-2 has three crosspeaks assigned to axS-eqS coupling and four peaks assigned to axC-eqC coupling. Three
NOE peaks were identified. This spectrum also shows an arm methyl substituent which
is shifted significantly away from the peaks corresponding to the other methyl-substituted
arms. Based on these observations, the chelate whose COSY spectrum appears in Figure
2.12 was assigned to Eu-S-SRRR-2, side isomer.
In Figure 2.9, the uncoupled axC proton shows an NOE peak to a benzylic proton (teal
circle). The presence of a Bn'-Me NOE peak as well, based on the above assignments,
indicates a similar yet not equivalent spatial relationship between the NB group and the
macrocyclic ring as for the corner isomer of Eu-S-SSSS-2 (Figure 2.4). Either or both the
smaller distance between N-O planes and the larger twist angle between the arms and the
macrocycle may be the source of this additional NOE peak. The axC-Bn and Bn'-Me
NOE peaks are also observed in Figure 2.11. The axS-eqC cross peaks are notably weak
or absent in this isomer, suggesting a more strained ring. The similarity of the NOE
coupling peaks in the COSY spectra of each corner isomer studied indicates a structural
similarity among the orientations of the NB groups in each of these chelates.
MM+ geometry models were again employed for the SAP chelates (Figure 2.11). The
positions of the substituents reflect the particular NOE cross-peaks observed and their
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The position of the NB group was again placed above the

macrocycle but close to it, reflecting the greater number of NOE peaks in SAP vs. TSAP
corner isomers. The less intense Me-axC peaks support the increased distance between
the NB group and the ring in the second isomer. The Me-Bn' peaks show the interaction
between the NB group and the 1-N arm in both isomers. The models are in good
agreement with the racemization hypothesis, with the S arm positioned further from the
nitrobenzyl substituent than its homochiral analogue. From these models it is predicted
that the corner isomers each have the NB substituent above and perpendicular to the
macrocyclic ring, as in the case of the TSAP corner chelate of Eu-2.

Figure 2.13: Molecular models of the proposed diastereoisomeric structures. a) is the
view from the top of the chelate, looking down the principal axis at the Eu3+ ion. b) is the
view from the side of the chelate. The dotted lines correspond to NOE peaks observed
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in the COSY spectra (Figures 2.9 and 2.10). Bn-axS interactions are in teal and Bn’-Me
interactions are in gold. The nitro groups are not shown.

The synthesis of 2 and its chelates yielded two different outcomes depending on the
stereochemistry of the starting materials. For Eu-S-SSSS-2 (TSAP), only regioisomers
were observed. For the SAP chelates, the second-most abundant species is the product of
racemization during ligand species, Eu-S-SRRR-2. Two isomers each were identified in
which the NB substituent in an equatorial conformation is located on a corner carbon or
side carbon, respectively.
We have unambiguously shown that conformationally rigid Ln-DOTA-type chelates can
form regioisomers with the bulky ring substituent on the corner or on the side of the
macrocyclic ring. The axS peak patterns in the 1H NMR data were found to differ
between corner and side isomers of the same chelate, but are similar between corner
isomers (or side isomers) of related chelates. Three pairs of regioisomeric Eu-2 chelates
were obtained and thoroughly characterized. For a cyclen ring in which a single proton is
replaced by another substituent, there are 7 possible 1H geminal through-bond (2J)
couplings. All but one of the 8 carbons in the macrocycle should show a cross-peak in
the COSY between ax and eq protons. Though absence of some expected cross-peaks
does not prove that the anticipated coupling is not occurring, it is telling that in the COSY
spectrum of each isomer of Eu-2 obtained, 7 cross-peaks are present which represent 2J
coupling. There are either three axS-eqS (red arrows) and four axC-eqC (blue arrows)
peaks, representing a side isomer, or four and three, representing a corner isomer,
respectively.
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Even though two coordination geometries complicate the spectra of Ln-NB-DOTA
chelates, it can be determined that regioisomers are not present.21 It appears that the
previous racemization hypothesis was correct but incomplete. Diastereoisomeric chelates
were observed to form in syntheses of Eu-S-RRRR-2, but not for Eu-S-SSSS-2 by the
author. The isomeric chelates of Yb-S-SSSS-2 studied previously are now believed to be
regioisomers rather than diastereoisomers.14,16 In prior syntheses of Ln-2 or related
chelates where only one (major) isomer was reported, regioisomers may have formed, but
were not resolved or efforts were not made to purify them by HPLC. To our knowledge,
no further study of the phenomenon has been published since Desreux and co-workers in
2002. Regioisomerism could also explain the presence of two non-exchanging isomers
from a ligand of single stereochemistry which were observed for Cu-1,4,7-triazanonaneN,N',N''-triacetate (Cu-NOTA) with a ring substituent.22
Additionally, the NOE peaks allow us to model the positions of the nitrobenzyl
substituents for the regioisomers – the positions are appreciably different for the corner
isomer versus the side isomer. This becomes noteworthy if we explore functionalizing
the nitrobenzyl group with a molecular “probe” and study the chelate when bound to a
slowly rotating system. A functional group linked to the NB substituent pointing closer
to or further from, and parallel versus perpendicular to the ring, will likely have different
binding behavior with respect to its macromolecular target. This behavior may include
but is not limited to binding kinetics (the likelihood and duration of a binding event) and
τM of the chelates in the system. The relaxation properties of regioisomeric chelates may
differ depending on the local and global rotation of the chelate and the orientation of the
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exchangeable inner-sphere water site when bound to a macromolecular target. These
possible variations in binding, τR, and τM would each influence the observed relaxivity.
2.4 Investigation of the chelation mechanism as it relates to regioisomer formation
2.4.1 pKa and conformational changes of the ligand 2 in solution
An earlier paper describes Ln3+ chelates of S-NB-DOTA (Scheme 2.1).21 Two isomeric
chelates were identified by 1H NMR – one SAP and one TSAP chelate. Analysis of the
isomeric mixture by COSY confirmed that for both isomers, the NB substituent is on a
carbon on the corner of the macrocycle, having replaced an eqC proton. The EXSY
spectrum shows exchange between the two types of axial proton (axS-axC) and between
the two types of equatorial proton. No exchange peaks between axial and equatorial
protons are observed.

These findings confirm the hypothesis that SAP and TSAP

geometries can interconvert via arm rotation (Δ to Λ) but not via ring inversion. No other
isomers of S-NB-DOTA were observed for any of the lanthanide chelates. To investigate
why regioisomers of Ln-2 form but regioisomers of NB-DOTA do not, the synthetic
conditions, stability constants, and conformational analysis were considered for these and
related chelates.23 A recent study to determine the stability constants of Ln3+ ions with
two stereoisomeric ligands led to an interesting result which may be related to
regioisomerism. Titration studies with KCl were performed to determine the protonation
constants of 2 and 3 (Table 2.1). These analyses were performed in the laboratory of
Prof. Gyula Tircso at the University of Debrecen in Debrecen, Hungary. The fourth pKa

CHAPTER 2. Regioisomerism in conformationally rigid NB-DOTA-type chelates

81

is higher than the third for 3 and for NB-DOTA, a highly unusual result that at first seems
impossible.
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S-RRRR-2

S-SSS-3

DOTAb

NB-DOTA

NB-DOTAc

Titration
medium

1.0 M KCl

1.0 M KCl

1.0 M KCl

1.0 M KCl

0.1 M Me4NCl

log K1H

11.81

11.30

12.09

10.00

10.93

log K2H

8.23

9.96

9.68

9.54

9.14

log K3H

4.00

4.60

4.55

4.29

4.5

log K4H

3.46

5.41

4.13

4.72

4.19

log K5H

2.13

1.99

2.28

2.33

log K6H
Σ log KiH
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1.4
29.62

33.26

30.45

30.83

32.49

Table 2.1: Acid dissociation constants (Ka) of DOTA-type ligands. (b),(c) data taken from
respective references21,24 Chelates with determined 4th pKa with higher values than the
3rd pKa are highlighted in bold.

This pKa “inversion” suggests that via successive addition of acid, protonating the ligand
a third time makes it more basic. One possible explanation for this increased basicity is a
change in conformation as a result of the third protonation step. The chance of observing
a conformational change due to protonation is greater in rigid systems. The conformation
adopted following a third protonation could be more basic than the conformation adopted
prior to the third protonation. Specifically, a conformational change could render the 4th
protonation site on the ligand more basic than in its conformation prior to titrating to the
3rd pKa.
An apparent pKa inversion in related (polyaza crown) ligands has been published
previously.25 The authors report a significant ring strain in their molecular mechanics
simulation upon addition of a third proton to the ligand due to electrostatic and van Der
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Waals repulsion. The pKa inversion was interpreted as leading to a conformational
change after the third pKa was reached. If this conformational change is leading to the
pKas determined, the pH at any point in the chelation reaction will affect the basicity of
the ligand and may affect the conformation of the ligand. The rates of formation for
regioisomeric chelates may depend on what conformation the ligand is in during the
chelation steps. However, the pKa “inversion” is not observed for S-RRRR-2.
We investigated chelate formation of Yb-S-RRRR-2 to determine whether different ligand
conformations in solution arising from different protonation states give rise to different
isomers. The mechanism for Ln3+ chelate formation with 2 was assumed to mimic that of
Ln-DOTA. The intermediate chelate, where Gd3+ binds only to the carboxylate groups of
the ligand, was identified by Prof. Tirsco by potentiometric titration for the reaction of
Gd3+ with 2, 3, and NB-DOTA.
The following experiments were designed to examine whether formation of regioisomers
of Yb-S-RRRR-2 was due to different ligand conformations in solution, and if conditions
could be found which produced only one regioisomer. It was hypothesized that if the pH
determined the conformation of the ligand, regioisomer production could be controlled by
maintaining the chelation reaction at the proper pH.

S-RRRR-2 was synthesized

according to established procedures and purified by preparative HPLC. From the HPLC,
this ligand is isolated in the acid form H6NB-DOTMA. Yb-S-RRRR-2 formation at a
variety of pH and concentration conditions was assayed to see if the chelation (and
resulting isomerism) is dependent on these factors.
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There is an optimal pH range to produce Ln3+ tetraacetate complexes. A pH below 3
results in very slow chelate formation (ligation is much stronger with free carboxylates
than their protonated analogues), and the chelation reaction releases protons from the
ligand. Le Châtelier’s principle thus favors the forward reaction more strongly at higher
pH. Ln3+ salts have low water solubility at pH higher than 6.0, constraining the efforts to
prepare DOTA-type chelates at high pH. The apparent pH range for the inverted pKas
determined by Tircso et. al. is approximately 4-6. The pH range 3.0-6.0 in increments of
0.5 pH units was chosen for the study.
For each sample, the concentration of Yb3+ was twice the concentration of S-RRRR-2,
which was the case for prior syntheses of Ln-2. A single buffer system could not be
found for the entire range of pH conditions tested where the counter ion does not chelate
Ln3+, so various non-coordinating buffers were used (as described in the Experimental)
depending on the desired pH. Each solution was buffered at 1M to control against pH
changes resulting from H+ released as a result of chelate formation. All solutions were
sealed in vials and incubated for 64 days at 70°C. An LC/MS method was developed in
order to resolve isomeric chelates present following this incubation period and to
calculate their relative proportions. The proportion of each regioisomer produced in each
reaction was determined by monitoring at m/z = 765. The sample set from the incubation
study was analyzed, paying specific attention to the isomeric peak ratios. These ratios
were computed using the areas under the appropriate peaks on the LC trace. In order to
confirm which peak corresponds to which regioisomer, the concentration study samples
were combined and freeze-dried, and an NMR spectrum of the combined sample showed
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multiple chelate. These chelates were separated by prep. HPLC, and the identity of each
HPLC peak was confirmed by NMR. Two chelates were resolved, each with a distinctive
peak pattern in the axS region matching earlier Yb-S-RRRR- and Eu-S-RRRR-2 chelates
(Figures 2.1, 2.9 and 2.10, previously identified as regioisomers). The effect of pH on
the distribution of isomers produced during chelate formation is shown in Figure 2.14.

Area ratio, NB on the corner /
NB on the side

Dependence of isomeric ratio on pH
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Figure 2.14: The relationship between pH and regioisomeric ratio, holding [Yb3+] and [SRRRR-2] constant; [2] = 7.1 mM

The ratio of corner/side regioisomers produced after the incubation study was
approximately 0.5:1 at the highest pH, increasing to approximately 1:1 at the lowest pH
tested. There is a gradual change in isomer ratio with a change in chelation reaction pH.
If the pKa inversion is due to a conformational change, and if the conformation of the
ligand determines which regioisomer is formed, there should be an abrupt change in the
regioisomer ratio at a pH around the pKa. We did not observe this to be the case. It
appears that the pH does play some role in chelate formation, and possibly the buffer
used as well.

It is likely that the protonation states of the various amines and

carboxylates affect the solution configuration of the ligand, slightly favoring one
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nitrobenzyl position over the other. The high concentrations of salts may be competing
with 2 and Yb3+ for electron density, altering the kinetics relative to an unbuffered
reaction.

Area ratio, NB on the corner / NB
on the side

The results of the concentration dependence study are shown in Figure 2.15.
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Figure 2.15: The relationship between the log10 of S-RRRR-2 concentration and
regioisomeric ratio, holding [Yb3+]:[2] constant and pH at 5.0

The relative amounts of regioisomeric Yb-2 chelates formed indicate a clear trend
between the concentrations of Yb3+ and S-RRRR-2 and the regioisomeric ratio obtained
(Figure 2.15). A high concentration of both leads to a greater portion of corner isomer
formed. None of the conditions assayed select for a single regioisomer or even a large
excess of one regioisomer.
A pKa-dependent conformational change may be related to regioisomerism, but the data
above do not suggest that this is the cause of regioisomerism. Also, the chelation
reaction was allowed to progress over a much longer time than in prior syntheses, which
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were done over less than a week. The rate of formation of corner regioisomer is likely
faster than that of side isomer at first: a higher corner : side ratio resulted from a shorter
reaction time, and from a higher concentration of both reactants. The rate of de-chelation
is extremely slow for substituted Ln[DOTA] chelates, but de-chelation and
reincorporation of Yb3+ occur on a time scale which is fast enough relative to the 64 day
study duration. The results provide some insight into the kinetic and thermodynamic
preference between corner and side isomer, but it cannot be determined from the above
study whether the reaction conditions truly produce the kinetically or thermodynamicallyfavored isomer.
In a later experiment23, the pKa determination was repeated, titrating with Me4NCl in
place of KCl (Table 2.2, not all data are shown). For this ionic system, a decrease of pKa
was observed for each protonation step for each ligand.

Association of the non-

protonated amines in the ligands with K+ is a more likely explanation for the inverted pKa
behavior than conformation dependence, so the reason for regioisomer formation must be
found elsewhere.
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2.4.2 Modeling the solution conformation and the position of the NB substituent to gain
insight into the chelation mechanism.
As mentioned earlier, crystal structures of NB-DOTA and -DOTMA are unavailable. In
order to analyze the conformation of 2 in solution, molecular models were constructed
based on the crystal structures of H6DOTMA or H2DOTMA2-.

H6DOTMA and

H2DOTMA2- are the maximum and minimum protonation state of the ligand during
chelate synthesis.

Figure 2.16: Crystal structure of H4DOTMA·2HCl·3H2O, 50% thermal ellipsoid plot.
Hydrogen atoms, water molecules and counter ions are omitted for clarity. All
carboxylates are protonated on O2, O4, O6, and O8.
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A nitrobenzyl substituent was placed on each equatorial position for each carbon on the
macrocycle, and the energies were computed.

According to modeled configuration

energies, positioning the NB (or other large) group on the C3 or C7 carbon on the corner
of the ring is most favorable. To form logical structures which minimize configuration
energies, these models assume that all four pendant arms cannot be located on one side of
the macrocyclic ring (unlike in Figure 2.16 and in the crystal structure of H4DOTA).26
Having the Ln3+ ion approach 4 arms on a single face of the macrocycle was thought to
be essential in the first step of DOTA-type chelate formation.

Again, there is no

explanation for the observed regioisomerism in the models based on crystal structure.
The modeled energies of substituents positioned on a side carbon are still much higher
than for the corner position. One aspect the model does not take into account is distortion
of the macrocyclic ring due to the steric strain from the NB group. The structure of TCEDOTA (Figure 2.17)15, a ligand which affords predominantly SAP Ln3+ chelates, related
to 2, was considered for a configuration which fits with the models above and our
observations of the prevalence of two isomers.
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Figure 2.17: Crystal structure of (RRSS)-TCE-DOTA

In this structure, there are two arms above and two arms below the macrocyclic ring, a
possible conformation of H42 in solution. In this arrangement, two of the ethylene
bridges on the macrocycle have δ helicity and two bridges have λ helicity. Let’s assume
that the Ln3+ ion approaches this ligand from the face opposite the NB substituent (the
“bottom,” Fig. 2.18). If this metal ion approach and ligand conformation, or something
akin to it, resembles the predominant solution state collision leading to chelation, then
two pendant arms must flip over to the other side of the ring to generate the H2LnL+
species. The chelate can only exist in the Λ(δδδδ) conformation with all arms adopting
the same helicity, and all ethylene bridges doing the same. For a pendant arm to flip to
the other side of the ring to chelate the metal, its ethylene bridge must reverse helicity
from λ to δ. Once all four arms are coordinated to the metal, no further conformational
changes can take place – the geometry is locked at this stage. The regiochemistry must
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be determined in this first chelation step; even for the intermediate chelate, the arms and
rings cannot invert their helicities.

Figure 2.18: Proposed chelation mechanism when Ln3+ approaches the ligand from the
face opposite the NB group. The solution conformation of S-SSSS-2 is modeled after
the crystal structure of RRSS-TCE-DOTA. The NB group is in the lowest energy
substitution position (eqC) according to the modeling study with HxDOTMA. The two
pendant arms on the face opposite the Ln3+ direction of approach must flip around via
inversion of helicity for their ethylene bridge. This is shown in the first structure of the
“top view” (blue arrows).

But there is a chance the Ln3+ approaches from the opposite direction relative to the
macrocycle (the “top”, Fig 2.19).

The ethylene bridges are still locked into the δ

orientation by the equatorial NB substituent. In this case, the two opposite-face arms
would have to flip their ethylene bridges to λ in order to reorient and ligate the metal,
which they are sterically unable to do as the S-NB group would be forced into an axial
position. A positional shift must occur, retaining the orientation of the two arms initially
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bound to the metal, but ensuring the ring helicity is δδδδ. This shift moves each of the
atoms in the [3333] arrangement one position counterclockwise, as shown in the figure.
The “face-of-approach” explanation is the most logical one which yields two
regioisomeric chelates of single coordination geometry. It is possible that one face of the
macrocycle has 3 arms, not two, but this possibility does not invalidate the previous
explanation. The ligand and Ln3+ ions are diffusing and tumbling freely in solution, so
the chance of approach of the metal should be equal from either side. Since the ratio of
isomers was not 50:50 in all cases, there must be another factor or factors which
determine chelate formation other than direction of Ln3+ approach. It was concluded that
the regioisomer formed depends on the direction of approach of the metal – via the “top”
or “bottom” of the plane of the ring (Figures 2.18, 2.19).23

CHAPTER 2. Regioisomerism in conformationally rigid NB-DOTA-type chelates

93

Figure 2.19: Mechanism for forming Ln-S-SSSS-2 with nitrobenzyl group on the side.
Each atom in the [3333] square must rotate one position to accommodate a δ, equatorial
nitrobenzyl group on the side.

2.4.3 Thermodynamic stability of conformationally rigid SAP and TSAP Ln3+ chelates
The later lanthanides show a preference for the smaller coordination “cage” of SAP
geometry. TSAP geometry is preferred for the earlier lanthanides (Table 2.2) – Yb-SRRRR-2 (SAP) has a stability constant more than two orders greater than Yb-S-SSS-3
(TSAP).
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S-RRRR-2

S-SSS-3

DOTA‡

SAP

TSAP

SAP

Ce3+

19.79

24.04

23.4

3+

23.86

21.53

24.7

Yb3+

24.12

21.91

25

Gd
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Table 2.2: log values of thermodynamic stability constants of Ln[DOTA]-type chelates.23
‡Data for DOTA taken from the reference.27

A Yb3+ chelate known to adopt TSAP geometry (Yb-S-SSS-3) was selected for study to
see if it could be converted to the more thermodynamically stable SAP geometry. The
possibility for geometric isomer conversion arises via epimerization. Previously, it has
been shown that the chiral centers on substituted acetate pendant arms can be epimerized
in TCE-DOTA via acid-induced epimerization (Figure 2.20).15

Figure 2.20: reversal and retention of configuration at the α-carbonyl carbon due to acidinduced epimerization in H4TCE-DOTA
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Over time, this can allow conversion of any other diastereoisomer to the most stable
homochiral stereoisomer.

It was hypothesized that this mechanism would facilitate

conversion of the TSAP isomer of Yb-S-SSS-3 to the more thermodynamically stable28
SAP isomer.
The corner isomer of Yb-S-SSS-3 was purified by HPLC. A 20 mM sample of this
chelate was sealed in an NMR tube to ensure that the concentration of chelate solution
did not change. The sample tube was then heated in acid (DCl in D2O, pD ~1) at 90°C.
NMR spectra of this sample were acquired at regular intervals for 15 weeks – every week
for the first 7 weeks, and every two weeks thereafter until the NMR peaks and their
respective areas appeared to stabilize. A second set of peaks was observed to grow in
over the duration of the study (Fig. 2.21). This species also showed axS shifts indicating
a TSAP Yb3+ chelate. It was expected that either no new species would be produced, or
that TSAP→SAP conversion would be observed. Instead, an apparent TSAP→TSAP
conversion occurred. The evidence for regioisomerism in Ln-2 chelates points to the side
isomer of Yb-S-SSS-3 as the second species formed.
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Figure 2.21: A second Yb-S-SSS-3 chelate increases in intensity over time, as seen by
the methyl arm peak pattern in the hyperfine shift region. Spectrum 2.21c was a
different TSAP chelate isolated as a byproduct of Yb-S-SSS-3 synthesis.

The area ratio of methyl peaks between the two species was calculated. This ratio
seemed to stabilize at ~1:0.8 after 15 weeks (Fig. 2.22).

Figure 2.22: Ratio of Yb-S-SSS-3 TSAP isomers as a function of time, heating under
acidic conditions

The acid-catalyzed epimerization method breaks the ac C-H bond at the stereogenic
center. By conducting the experiment in deuterated solvent, the occurrence of acidcatalyzed enolization can be assessed by examining for deuteration of the chelates.
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Epimerization would induce chemical exchange of the ac protons. If the first reaction in
Figure 2.23 (forming the tautomer) occurs, the ac proton lost from the α-methyl carbon
can be replaced with either H+ or D+, and there is much more D+ available. Epimerization
would be indicated by the loss of ac proton peaks in the NMR spectrum from deuterium
incorporation.

Figure 2.23: Acid-induced epimerization mechanism of a Ln-NCCO chelate ring

The intensity of the ac proton resonances remained constant throughout the experiment,
indicating that no incorporation of deuterium, and therefore enolization, was occurring.
This observation was verified by mass spectrometry at the conclusion of the experiment,
which showed no increase in the mass of the chelate, again consistent with no deuterium
incorporation. These results explain why no conversion of the TSAP Yb-S-SSS-3 to the
more thermodynamically stable Yb-S-RRR-3 was observed, even under these relatively
harsh conditions. A mechanism involving removal and re-chelation of the metal was
proposed as the only logical explanation of the above observations.23 If the metal is
removed, it can either form the original regioisomer, or reapproach the ligand in such a
way that the NB position shifts as in Figure 2.19. The two regioisomers will eventually
reach equilibrium via acid-induced displacement of the metal and re-chelation. The
relative proportions of the two regioisomers appear to approach 1:1, similar to the
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regioisomeric ratios of Yb-2 in Figures 2.14 and 2.15. Whereas the regioisomer ratios
found in the concentration/pH dependence study cannot be said to be definitively
kinetically or thermodynamically driven, the ratio in Figure 2.22 is indicative of a
thermodynamic relationship.
The significance of regioisomeric chelates arises from the possibility of tuning of the
physical properties of a prototypical MRI CA. These regioisomeric chelates of Gd-2 and
Gd-3 have stability constants on the order of those of Gd-DOTA, which is considered
safe for clinical applications.
2.5 Conclusions and future directions
To date, it has not been possible to find conditions for synthesizing a single regioisomer
of Ln-2. Though the regioisomers can be resolved by HPLC, this requires multiple
purification steps and is expensive and time-consuming. For a CA based on Ln-2 to be
viable for clinical use, it must both be cost-effective to make and be safe and effective in
vivo. If a potential clinical compound is to be administered as multiple isomers (i.e.
regioisomers), it must be demonstrated that the isomers on the whole generate better perdose contrast than existing treatments, and are stable and viable both separately and as
formulated under physiological conditions. It is possible to produce the majority of the
chelate as either corner or side regioisomer by optimizing pH, reactant concentration, and
reaction time. The relative proportions, though, vary depending on the coordination
geometry formed (SAP vs. TSAP) and the lanthanide used (Yb3+ yields more of the side
isomer than Eu3+).

Our current understanding of maximizing relaxivity in
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conformationally rigid chelates is incomplete but was studied further as described in the
next chapters.
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CHAPTER 3. TEMPERATURE DEPENDENCE OF THE PARAMAGNETIC
SHIFTS OF LN-2 AND EVIDENCE FOR TIME-AVERAGED STRUCTURAL
CHANGES AS A FUNCTION OF WATER EXCHANGE RATE
The isolation of conformationally rigid chelates with well-defined coordination
geometries afforded a unique opportunity to study subtle differences between
coordination isomers, free from complications arising due to coordination and/or
geometric exchange processes. As described previously, a great deal of useful structural
and electronic information about Ln3+ chelates can be determined by NMR.

The

broadened lines of the 1H NMR peaks in the spectra of Ln3+ chelates with anisotropic
ligand fields (such as Eu3+) are indicative of fast proton relaxation. The transverse
relaxation (T2) of an individual proton in these chelates can be estimated by measuring its
line-width in NMR spectra at different temperatures. Narrower lines would indicate
longer values of T2, corresponding to greater flexibility in that portion of the molecule.
The line-widths of the 1H NMR peaks of Eu-2 chelates are not uniform.

It was

speculated that comparison of the NMR spectra of Eu-2 chelates (Figure 3.1) at different
temperatures might bring to light some novel insight into their structural and/or electronic
behavior, including detection of the relative rigidity of portions of the chelate (whether
parts of molecule were more susceptible to movement or less so). This might lead to a
greater understanding about chelate motion, specifically changes in the conformation of
the molecule. It was initially thought that these motions might be due to intermolecular
collisions, but these changes could be due to any process causing a conformational
change. If geometric isomers (SAP and TSAP) can interconvert, a process which occurs
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for all other very rapidly exchanging Gd3+ chelates reported, the small differences in linewidths or shift that could give insights into the structural behavior of the chelates would
be obscured.

Due to the inverse relationship between Eu-induced shifts (LIS) and

temperature (scales as T-1 up to T-2), it was expected that each peak’s shift would
decrease proportionately and uniformly with an increase in temperature.

Figure 3.1: Chelates referred to in this chapter
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3.1 Unexpected trends in 1H NMR spectra of Eu-2 chelates at varying temperatures
Six isomeric Eu3+ chelates of 2 were isolated and characterized as described in Chapter 2.
A variable-temperature (VT) study of these chelates by 1H NMR was then initiated.
Proton spectra were acquired for each available Eu-2 isomer from 5 to 40 °C in 5 degree
increments. All VT spectra for a given isomer were acquired using the same prepared
NMR sample to avoid observing shift differences due to pH or concentration. The pD of
the Eu-2 NMR samples was not adjusted but was found to lie between 3 - 4. Tetraacetate
chelates are known to be the conjugate bases of strong acids and no protonation equilibria
occur in this pH range. The temperatures of the NMR probe and sample tube were
equilibrated for 5 minutes before acquiring spectra, and the temperature was controlled to
within 0.05 °C over the course of an acquisition. Longer equilibration times prior to
acquisition did not lead to statistically significant differences in the resultant spectra.
Each peak in each NMR spectrum was assigned to a proton in the structure of Eu-2 based
on the COSY analysis detailed previously. The axS, axC, eqS, eqC, Me, and ac resonances
were tracked carefully across the temperature series based on their shift frequency at 5
°C, peak area, and peak width (Figures 3.2 and 3.3).
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Figure 3.2: Variable temperature 1H NMR spectra recorded in D2O at 400 MHz of the
‘corner’ (left) and ‘side’ (right) isomers of Eu-S-SSSS-2. The spectral assignment from
COSY data (Chapter 2) was used to show the shifts each proton on a particular ethylene
bridge in the same color using open symbols according to the scheme: axS (diamond),
eqS (square), axC (triangle), and eqC (circle). The acetate protons, ac, are shown as
closed red circles; the benzylic protons as black open circles; and the aromatic protons
as black open squares. For clarity the temperature dependence of the methyl
substituents is not shown.
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Figure 3.3: Variable temperature 1H NMR spectra of the side isomer of Eu-S-RRRR-2
(top left), the corner isomer of Eu-S-RRRR-2 (bottom left), the side isomer of Eu-SSRRR-2 (top right), and the corner isomer of Eu-S-SRRR-2 (bottom right).
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Each proton peak showed an extraordinarily linear temperature dependence over the
range of temperature values studied. After careful examination of the spectra, it was
observed that the sequences of the resonances for Eu-S-SSSS-2 corner and side isomers
were changing over the range of temperatures studied. Multiple peaks were observed to
change places in the upfield region over the temperature series. The assignments of the
rearranged peaks were confirmed by COSY at 40 °C. For each axS, axC, eqS, eqC, Me,
and ac peak, the absolute difference in the shift (in ppm) from 5 to 40 °C was calculated.
This difference value was plotted against the chemical shift (in ppm) at 25 °C of each
peak for the two Eu-S-SSSS-2 isomers (Figure 3.4).

Figure 3.4: Absolute change of chemical shift, 5 – 40 °C, as a function of shift at 25 °C.
Macrocyclic ring protons (axS, axC, eqS, and eqC) and their regression fits are shown in
blue. Arm protons (Me and ac) and their regression fits are in red.

Further analysis led to the recognition of a pattern where the percent change in shifts of
the arm protons with changing temperature was significantly greater than the percent
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change in shifts of the ring protons over the same temperature range. The percent change
of the shifts follow the trends particularly closely for the most highly shifted (to either
lower or higher frequency) axS and ac proton resonances. The shifts of Eu-S-RRRR-2 and
Eu-S-SRRR-2 chelates were observed to change with a lesser temperature dependence
than for the Eu-S-SSSS-2 chelates.
3.2 Changes in Eu3+-induced 1H NMR shifts between closely related structures have a
spatial dependence
Variable-temperature NMR studies of Ln[DOTA]-type chelates have been reported
previously, for chelates that undergo conformational exchange.1,2 These chelates, which
possess both carboxylate and phosphonate pendant arms on the same ligand, were
observed to exchange by 1H and 31P NMR spectroscopy between SAP and TSAP forms,
and in some cases, between hydrated and dehydrated forms.
There is only one set of shifts in each spectrum of Eu-2. The shifts do not broaden
toward coalescence as the temperature increases. These observations indicate that only
one chelate is present and not in exchange with any other chelate over the temperature
range studied. However, the differing rates of change of the proton shifts cannot be
explained solely by the temperature dependence of nuclear relaxation by paramagnetic
electrons. Subtle structural changes that occur rapidly and do not change the positions of
the shifts substantially could explain the line-width and temperature-dependent shift
change behavior. Prototopic exchange and solvent (water) exchange occur too rapidly
for distinct structures to be observed by NMR.
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3.2.1 A crystal structure containing a unique type of unit cell provides a basis for
structural comparison of q = 1 and q = 0 chelates
Crystal structures of Ln3+ chelates having both acetate and phosphonate pendant arms on
the same ligand can be found in the literature.3-7 Some of these chelates are structurally
related to Ln-S-SSSS-2 in that they adopt TSAP geometry; like Ln-S-SSSS-2 they also
have fast water exchange relative to Ln[DOTA]-.
Chelates of the same ligand have been studied across the Ln3+ series. With decreasing
Ln3+ ionic radius, rLn-O increases until there is no inner-sphere water molecule. Crystal
structures of chelates have been found that are effectively isostructural over the course of
this change in q and r. Several interesting aspects of the coordination geometry of these
chelates came to light. There are at least four examples of crystals with a unit cell
containing two structures with slightly different geometries (one each for Pr3+, Nd3+,
Sm3+, and Y3+, which typically exist as q = 1 DOTA-type chelates). These structures
differ in the length of rLn-O, the “bite” angle of the axial water coordination site, and the
relative position of the metal ion between the plane containing the macrocyclic nitrogen
atoms (the N4 plane) and the plane containing the chelating pendant arm oxygen atoms
(the O4 plane). An explanation for the apparent paramagnetism-temperature anomaly
described above was found in crystal structures of a chelate related to Eu-2 and in our
understanding of the solution behavior of q = 0 and q = 1 Ln3+ chelates of DOTA
derivatives.
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Hermann, Lukeš, and co-workers obtained a crystal structure of YDO3AP(ABn) (Figure
3.1) with both q = 1 and q = 0 TSAP chelates in the same unit cell, a previously unknown
phenomenon.4 The two chelates in the crystal are structures which differ with respect to
q and the Y3+ position within the coordination cage. In these chelates, the Y3+ ion is
closer to the N4 plane and further from the O4 plane in the dehydrated chelate in
comparison to the Y3+ position in the hydrated chelate.

Presumably, without a

coordinated water molecule, the Y3+ has shifted position closer to the N atoms to satisfy
its demand for electron density.
3.2.2 Comparison of the structural information given by the LIS with the principal axis of
a Ln3+ chelate and its paramagnetic field
Interpretation of the LIS trends in the variable-temperature NMR data yielded qualitative
structural information about the chelates.

As described previously, the lanthanides’

contact and dipolar contributions to NMR shifts have spatial and temperature
dependence, according to the equation δobs = δdia + δc + δd. For Eu3+ there is a modest
through-bond nuclear spin interaction (the contact contribution (δc)).8,9

The contact

contribution precludes a quantitative calculation of Eu-H distances from the NMR shifts.
It has been shown, however, that the most strongly shifted axS and ac protons in a EuDOTA-type chelate are only minimally affected by the contact contribution.10 For the
axial component of the predominating dipolar contribution δd, the spatial dipolar
contribution dependence is described by Equation 3.1:
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Equation 3.1: where D is a ligand-field dependent parameter, and r and θ are the
distance from the metal center and the angle from the axis of the nucleus affected by the
dipole shift.

We can superimpose the dipolar magnetic field induced by the Ln3+ paramagnetic
electrons upon the central axis of the chelate. Consider the relevant protons in the
hydrated versus dehydrated YDO3AP(ABn). Changing from the former structure to the
latter moves ligand protons with respect to the orientation of the Ln’s magnetic dipole –
some shifts will move upfield and some downfield in the NMR. The nuclei in the blue
regions of NMR spectra will experience a shift to lower frequency (upfield), and the
nuclei in the red will shift to higher frequency (downfield); the extent of the shift is
proportional to the color intensity. By extension, this assumption is applied to the
conformationally rigid chelates Eu-2. The protons whose dipolar contributions to their
chemical shifts will be affected most are the axS and ac protons, due to their respective
positions in the magnetic field induced by the paramagnetic electrons (superimposed
density map, Figure 3.5).
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Figure 3.5: Structural comparison of the isomeric q = 1 and q = 0 YDO3AP(ABn)
chelates contained in the crystal structure. The axial contribution of the dipolar shift is
shown superimposed in a “heat map.” The hydrated structure is shown in front and the
shadowed structure (rear) is the q = 0 structure.

The angle and distances of hydrated and dehydrated YDO3AP(ABn) relative to the
central axis of the chelate have been computed, and combined into one axial geometric
parameter (G) (Table 3.1), where G = (3cos2θ–1)/r3, the same axial dependence as δd:
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mono-hydrated

dehydrated

q

1

0

Y-OH2 (Å)

2.485

N/A

c (Å)

2.421

2.559

d (Å)

1.660

1.531

d/c

0.69

0.60

N4-O4 (˚)

26.79

-26.08

N-C-C-N (˚)

56.67

-57.95

Area of O4 plane (Å2)

9.55

8.31

rY-H (Å)

3.43

3.47

 (˚)

81.68

82.85

G (×103)

-22.88

-23.21

ac

Gq=1 – Gq=0 (×103)

-0.33

axS
rY-H (Å)

3.66

3.68

 (˚)

14.55

25.07

G (×103)

29.26

36.88

Gq=1 – Gq=0 (×103)

7.62

Table 3.1: Calculation of geometric parameters in the crystal structures of
YDO3AP(ABn). The values represent averages of the four axs and ac protons.
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With respect to the central chelate axis, it is apparent from the table that the average
position of the ac protons (described by the G value) changes little from hydrated to
dehydrated chelate compared with the average position (G value) of the axS protons. A q
= 1 DOTA-type chelate is not hydrated all of the time; it is rapidly exchanging water
molecules in solution. There must be some point in time at which this q = 1 chelate is
dehydrated. If the two solid state structures of YDO3AP(ABn) above are representative
of the solution structures, the dehydrated version of a q = 1 chelate in solution closely
resembles its hydrated structure but differs by G values calculated as above. Though
there are a limited number of data points, the line-widths of the ac proton peaks are
greater than those of the axS peaks in Eu-S-SSSS-2, indicative of faster relaxation and a
closer spatial relationship (compared with average rY-H values of 3.43 Å (ac) vs. 3.66 Å
(axS) in the hydrated YDO3AP(ABn) chelate).
3.2.3 Comparison of the temperature dependence of Eu-2 chelates to a chelate with no
inner-sphere water exchange
To examine whether the shift change patterns were related to an exchange process in Eu2 chelates, the variable-temperature spectra of the q = 0 chelate Eu[DOTP]5- (Figure 3.1),
were acquired. The DOTP ligand was purchased as its acid (H8DOTP) from which the
corresponding Eu3+ and Yb3+ chelates were synthesized as described in the experimental
section. For each NMR sample of Ln[DOTP]5-, the pD was set in the range 10-11 to
ensure complete deprotonation of the phosphonates, eliminating the possibility that
protonation equilibria of the phosphonates could interfere with the change in shifts of the
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chelate.7 The percent shift change (calculated using the average shift, in ppm) of the axS
(ring) and ac (arm) protons from the 278 K shifts was plotted against temperature for
each of the 6 isomeric Eu-2 chelates studied, as well as for Eu[DOTP]5- (Figure 3.6).
Error bars represent the variance across the four protons for each type being averaged.
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Figure 3.6: Comparison of the temperature
dependence of SAP S-SRRR (top), SAP SRRRR (middle), and TSAP S-SSSS
(bottom) regioisomeric Eu-2 chelates with
Eu[DOTP]5-. Peaks from the side isomers
are in red, from the corner isomers are in
blue, and for DOTP are in black. The arm
(ac) protons are the open symbols and the
ring protons (axS) are the closed symbols.
∆LIS is the percent difference of the
average magnitude of the axS or ac shifts
between the 278 K spectrum of a particular
isomer and the average of the same proton
shifts at a higher temperature. For example,
∑

%

∑
∑

278
278

100%
S

where (Σax δ)/4 gives the average of four
shifts of a particular proton type, either axS
or ac at a specific temperature. Dividing
each sum term in the above expression by 4
reduces to the same equation.

For the non-water-exchanging chelate Eu[DOTP]5-, shifts of both arm and ring protons
vary uniformly as a function of temperature. The temperature-shift dependence of the
axS and ac protons for chelates undergoing water exchange deviated from the shift
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dependence of the continuously dehydrated chelate.

The average temperature

dependence of the axS shifts are similar for all 6 Eu-2 chelates studied, changing at a
lesser rate with temperature than the Eu[DOTP]5- axS protons.

The temperature

dependence of the ac proton shifts are similar for all 6 Eu-2 chelates studied, changing at
a nearly identical or slightly greater rate with temperature than the Eu[DOTP]5- ac
protons. The regiochemistry does not seem to affect the overall trends observed. The
Gq=1 - Gq=0 ac values in YDO3AP(Bn) are of opposite sign and an order of magnitude
smaller than for the axS G value difference. Comparison of the VT data with the G value
and δd relationship above suggests that temperature-dependent structural changes are
occurring in Eu-2 which are not occurring for Eu[DOTP]5-.
3.3 VT data for Yb-2
If it were possible to use the NMR data to calculate the G values of each proton using
Equation 3.1, the structure of the ligand in solution could be determined. The structures
of SAP and TSAP isomers of Eu-2, or of the same isomer at different temperatures, could
be calculated and compared with the crystallographic data of YDO3AP(ABn) above. In
this way, the progression of time-averaged rLn-O could be estimated based on the
relationship between d/c ratio and r.11 It is unfortunately not possible to calculate T2
values from the line-widths of Eu3+ chelates, but it is possible for Yb3+ chelates.
A VT series of 1H NMR data for Yb-2 (corner isomers, SAP and TSAP) were analyzed to
see if the same trends in %ΔLIS vs. temperature would be observed. If so, quantifying
the average position of the lanthanide in the coordination cage with changes in water
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exchange rate might be possible. In Yb[DOTP]5-, the percent change in arm and ring
shifts are also identical as a function of temperature. A plot (Figure 3.7) of percent shift
change of axS and ac protons compared with the 5 °C spectrum shows a trend similar to
that of Eu-2.

Figure 3.7: Shift change as a function of temperature in Yb-2 vs. Yb[DOTP]5-

The difference between the slopes obtained for the arm (ac) and ring (axS) protons of Yb2 chelates are not as great as for the Eu-2 chelates, but the difference in the change in the
shifts of each are statistically significant. As the Yb3+ ion is approximately 10% smaller
than Eu3+, it is likely that increasing the temperature over the same relatively narrow
range does not accelerate water exchange proportionally for complexes of the two
lanthanides, even considering the same geometric and regio- isomer. The water exchange
rate for Yb-2 is already very fast and cannot be accelerated much further. Unfortunately,
the data do not tell us anything about the relative activation energies for water exchange
in Eu3+ vs. Yb3+ chelates. The macrocyclic ring may be significantly more distorted
about a smaller ion from the steric strain induced by the nitrobenzyl group, leading to the
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large variability of the four axS and ac shifts relative to the average shift temperature
dependence. The VT data of the Yb3+ analogues are more difficult to interpret with
respect to solution-state structural parameters in Gd-2 owing to the smaller ionic radius of
Yb3+.
3.4 Examination of the prevailing view of hydration state of MRI CAs in light of new
evidence
The exchange of water molecules in Ln[DOTA]-type chelates is known to occur by a
dissociative mechanism.12,13 The picture (Figure 3.8) of solvent exchange by dissociative
mechanism in inorganic chemistry has held constant for over 40 years.14 In this picture,
the following occurs in discrete steps: a solvent molecule is lost, reducing the
coordination number by one, to form an intermediate that closely resembles the initial
state. Then, a new solvent molecule is bound, increasing the coordination number to its
original value. There is no mention in this mechanism of the time or distance progression
of the leaving solvent molecule or of the newly ligating solvent molecule. It is almost as
if the water molecule transitions between two quantum states.

The dissociative

mechanism picture is the widely accepted way in which Ln[DOTA]-type chelates behave
in solution.15-17
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Figure 3.8: Dissociative exchange of a water molecule from Ln[DOTA]-

Under our current understanding, NMRD data are interpreted in terms of single values for
each parameter18 and rarely are fits using more than one value reported.19 The parameter
rLn-H in particular is treated as a constant in development of Ln[DOTA]-type chelates
except in a few isolated studies.20,21 However, solution structure is never without motion
for Ln3+ chelates which are bound by electrostatic forces, even in highly ordered,
symmetric, rigid systems.
3.4.1 The treatment of q and r as separate, static parameters provides an incomplete
description of solution structure and dynamics
The properties of the chelates examined above can be used as a model to help us to revise
our understanding of the relationships between temperature, water exchange, structure,
and 1H shifts.

Let us assume that the q = 1 and q = 0 crystal structures of

YDO3AP(ABn) represent the structural extremes of the dissociative exchange model. In
solution, the water exchange process would lead to a transformation of the q = 1 structure
to resemble the q = 0 structure on the time scale of τM. The Ln3+ “drops” in the
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coordination “cage” from its position closest to the O4 plane to its position closest to the
N4 plane in this same time span.
We can look at the differences between q and rLn-H in slower and faster exchanging
chelates in attempt to fill the gaps in our understanding of how these parameters are
related. Using what information could be gained from the crystal structures, the rLn-O
values for structurally related TSAP and SAP chelates were compared in Table 3.2.22,23
These data were compared with Eu3+ (as a surrogate for Gd3+) luminescence data in
solution, in which rLn-O is slightly longer than in the crystal, regardless of chelate.24,25

Chelate
Gd-TCEDOTA
Eu-SRRRR-2

Coordination
Geometry

rGd-O (Ǻ)

q

SAP

2.43

-

SAP

Gd-DOTMA

TSAP

Eu-SSSSS-2

TSAP

0.97
2.50

0.74

Table 3.2: Differences in q and rLn-O dependent on coordination geometry. rTSAP/rSAP =
102.8% in the crystal.

How can we rationalize a q value of approximately 0.75? One explanation which gives
this value physical meaning is if a chelate has an inner-sphere water molecule only 75%
of the time. To look at another way, by the ergodic principle, at a given moment ¾ of the
chelates in the solution are hydrated. This population explanation has been given as a
reason for the coordination chemistries of some smaller lanthanide ions26, but never
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before for Gd3+ or for the larger lanthanides including Pr3+, Nd3+ or Sm3+. Work from
Parker and co-workers provides an alternate explanation for the luminescence data – that
the quenching of Eu3+ excited states is dependent on both q and rLn-O.25 The -OH
oscillators proximal to Eu used to determine q by Horrocks’ method also have an r-6
distance dependence. On this basis we can calculate that rLn-O is approximately 4.5%
longer in the TSAP vs. SAP chelates in solution by data in Table 3.2 and Equation 3.2:

r TSAP
r SAP

 q TSAP 
  SAP 
 q




6

Equation 3.2: qSAP/qTSAP = 131.1% from the data in Table 3.2. q and rLn-O were
determined to have a direct relationship based on Horrocks’ method and modifications to
correct for other luminescence quenching mechanisms.

Clearly there are difficulties in measuring q and rLn-H separately. When the Ln-OH2
interaction is in the process of a bond “breaking” or “forming” event (Figure 3.9), one
can consider the hydration state of the metal as a function of rLn-O in two ways – both
descriptions of the same process. The chelate is either always q = 1 as the water
molecule moves further away from Ln3+ until it is no closer to the metal than the next
closest water molecule. Or, the value of q decreases proportionately with rLn-O during
this process. The first view does not provide a complete description of the hydration state
during water exchange, while the second describes parameters that cannot be measured
independently in solution.
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Figure 3.9: A representation of the dissociative inner-sphere water exchange
mechanism in Ln[DOTA]-type chelates

However, a single parameter could be used to describe both aspects of the inner-sphere
water molecule. The parameter q/r6 is appropriate for describing the hydration state of
Ln[DOTA]-type chelates in solution. Precedent for this parameter exists27, and can be
used to differentiate between geometries which exchange water at different rates.
3.4.2 Variable-temperature NMR data yield a time-averaged coordination geometry and
hydration state
The length of time a chelate which exchanges inner-sphere water is in the fully
dehydrated state (the structure which has the maximum r value, represented in the bottom
structure in Figure 3.9) is very short (but finite). The amount of time a particular chelate
spends in the fully dehydrated state is not expected to change substantially with changes
in the water exchange rate. This picture of hydration equilibrium also means that τM is
not exactly the inverse of water exchange rate where water exchange (1/kex) is extremely
fast, as is commonly assumed in these systems. τM will be slightly shorter as it does not
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include the time in the q = 0 state; kex includes the time required for a new water
molecule to “bind.” The kex of any ligand increases with increasing temperature, and
there will be more dissociative events for a fast-water-exchanging complex than a slowwater-exchanging complex in a given amount of time (Figure 3.10).

Figure 3.10: Color bars representing the distance of the inner-sphere water molecule
from Ln3+ as a function of time. The color in the overall observation represents an
average r across the entire hypothetical time window.

1
  on   off
k ex

We are not making any claims about the progression of metal-water distance; the
simplistic model above accounts only for the fact that there is a minimum and maximum
rLn-O and that the water molecule’s position cycles between the two more often with faster
water exchange. The modeled distance (rLn-O) over a hypothetical time interval (t) was
averaged (depicted in the final bar in Figure 3.10 with color matching the time-averaged
rLn-O). Regardless of rLn-O and t, it is clear that the chelate spends more time in the state
with the water furthest from the metal ion when the exchange rate is increased (due to
coordination geometry of the ligand or due to temperature).
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Changing the water exchange rate, either by changing the temperature or selecting a
different coordination geometry, is assumed to be the prime determinant of the portion of
time the chelate spends in its maximum hydration state (distance of closest inner-sphere
water molecule approach). The relative amounts of time the water is in the hydrated
versus the dehydrated state over the entire chelate population is what leads to the
observed time-averaged structure and rLn-H (alternatively, q/r6) and by extension the
observed LIS.

The axS and ac shifts would only vary uniformly with temperature

provided that the coordination geometry does not change with changes in temperature (a
static structure). We propose that the differing LIS temperature dependence of the axS
and ac protons are direct evidence for a time-averaged coordination geometry that does
change with changes in temperature. As the temperature increases, the water exchange
rate increases and the time-averaged conformation of the chelate becomes closer to that
of the dehydrated structure (Figure 3.11).

Figure 3.11: A model for average Ln-OH2 distance as a function of exchange rate under
dissociative exchange conditions.
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The time-averaged conformation of the chelate is dependent upon the water exchange
rate, which has a temperature dependence. The main force acting upon the temperature
dependence of the shifts of protons in Eu-2 is a geometry-specific dynamic behavior (the
percent of the time the chelate exists in the dehydrated state or the state with the largest
value of rEu-O).

It is unsurprising that the ac shifts in Eu-2 follow a temperature

dependence close to Eu[DOTP]5- – the G value does not change significantly from the
hydrated to the dehydrated form of YDO3AP(ABn).

However, there is a more

substantial change in axS G value between the hydrated and dehydrated chelates. This is
manifest in the overall structure of the population of chelates, averaged over time,
bearing greater resemblance to a structure with longer r. Therefore, there is greater
deviation of the temperature dependence of the axS shifts in Eu-2 from those of
Eu[DOTP]5- with a greater change in water exchange rate from the reference point for
shift change calculation. Further, the divergence of the Eu-2 shifts from Eu[DOTP]5shifts with increasing temperature is more pronounced in the TSAP chelates (which
exhibit faster water exchange) than in the SAP chelates. In summary, the deviance in the
shifts from simple temperature-dependent paramagnetic behavior indicates a change in
time-averaged structure due to changes in water exchange rate. These observations are
the first, to our knowledge, to provide evidence for movement of the Ln3+ within the
macrocyclic cage for an isostructural chelate in solution.
Eu3+ luminescence can also be used to determine the number of hydrated species in
solution.28 Each luminescence spectrum of Eu-2 reported29 shows only one 5D0 → 7F0
transition, meaning either that the hydration equilibrium is fast in comparison to the
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luminescent time scale, or the energies of multiple species are not sufficiently different to
distinguish between hydration states. This finding coincides with the argument for the
structural similarity and rapid equilibrium between q = 0 and q = 1 chelates above. The
analytical techniques employed can be compared to the use of a camera. It has become
clear that the difficulty of observing and quantifying structural changes in solution
relating to q and r is a problem of “shutter-speed.”

Water exchange and the

corresponding structural changes of ligand and metal ion are occurring too rapidly to be
observed directly by NMR and luminescence spectroscopy for the Ln-2 chelates studied.
We can see only a time-averaged “snapshot” of these dynamic processes. Due to the lack
of other motions (such as conformational or coordination geometry changes) on the same
time scale in our “rigid” chelates, the picture we see is sharply defined as opposed to
poorly resolved.
The Yb3+ VT data suggest that the generally held assertion that TSAP Yb-DOTA-type
complexes are q = 0 (primarily stemming from crystallographic studies) is incomplete (q
values of up to 0.54 have been determined for these chelates by luminescence
studies).25,30,31 The time-averaged hydration state (q/r6) for Yb-DOTA-type chelates may
be too small to be considered as having an inner-sphere water molecule. However, our
data suggest that the coordination cage is “breathing” in solution in a similar way to that
of an inner-sphere water-exchanging Eu3+ chelate. The likeliest explanation for this
dynamic behavior is an exchanging inner-sphere water molecule which does not
approach the metal closely, and for any given moment in time, the population of chelates
with an inner-sphere water molecule is small compared to chelates without.
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Crystallographic data for the heavier (smaller) lanthanides in mixed acetate/phosphonate
chelates, as mentioned earlier, and in Ln[DOTMA]- complexes32 provide additional
support for these interpretations. It would be interesting to look for a trend across the
lanthanide series of VT changes in LIS for axS and ac protons in Ln-2 or another
conformationally rigid chelate. The magnetic susceptibilities of most of the paramagnetic
lanthanides make this impractical; the resonances are significantly broadened in
comparison with those of Yb3+ and Eu3+ LIS and would lend a great deal of inaccuracy to
plots of absolute shift changes.
3.4.3 Reviewing the relaxivity behavior of conformationally rigid SAP and TSAP chelates
bound to slowly tumbling species
Two isomeric, conformationally rigid chelates (Gd-S-SSS- and Gd-S-RRR-6(-1-Me))
having differing water exchange rates were prepared and their relaxivities measured.33
The slower-exchanging isomer afforded greater relaxivity, in direct opposition to models
derived from SBM theory and accepted by the MRI CA community at large. The plots of
relaxivity versus magnetic field strength (NMRD profiles, Figure 3.12), make it clear that
the relevant difference arises from a parameter which scales with r1 at all fields; either q
or rLn-H (top spectrum).
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Figure 3.12: The NMRD profiles of S-RRR-Gd-6(-1-Me) (SAP, diamonds) and S-SSSGd-6(-1-Me) (TSAP, circles). The top profiles were obtained at 0.2 mM Gd3+. The
dashed line in the top profile is the diamagnetic relaxation rate of pure water. The
bottom profiles were obtained at 0.17 mM Gd3+ and in the presence of 6 mM poly-β-CD
at 25 °C. The bottom dashed line is a simulated profile using the fitting parameters from
the profile of S-RRR-Gd6(-1-Me) but applying the water exchange parameters τM and
rGd-H from the S-SSS-Gd6(-1-Me) profile. The ligand is referred to as compound 4 in the
reference.33

When bound to slowly tumbling molecules human serum albumin (HSA) and poly-βcyclodextrin, the slower-exchanging isomer again showed higher relaxivity (bottom
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spectrum).

Our results show that the time-averaged q/r6 may be longer than was

previously assumed, particularly for the fastest-exchanging Ln[DOTA]-type chelates, and
this is almost certainly leading to depressed r1 values in comparison to that which is
predicted by SBM theory. In light of this evidence, it is not wholly accurate to assign
values to the parameters q, r, and τM based on static structures. To optimize, fit, or treat
q, r, and τM independently in solution relaxation measurements is an incomplete
description of the system; they should be considered ensemble. A major consequence of
this work is the realization is that the optimum water exchange rate may be slower than
previously calculated for a given imaging field strength, and that it may not be possible to
achieve the maximum relaxivity gains modeled in the SBM curve (Figure 1.8). This
realization is likely the explanation for the higher relaxivities observed for the SAP
isomers of Gd-6(-1-Me)33 and Gd-6 (this work) in comparison to those of the TSAP
isomers when bound to slowly tumbling species. Additionally, the temperature and
isomer dependence of water exchange rates should vary differently between systems; the
optimal value for τM for contrast agents based on Ln[DTPA]2- or other chelates should be
determined independently and cannot be predicted based on the Ln[DOTA]- system. A
thorough understanding of how the critical parameters q, rLn-H, and τM may vary and be
interrelated in a compound undergoing exchange is necessary for the design of more
effective CAs.
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3.5 Further research/future directions
3.5.1 Measuring q/r6 by variable-temperature luminescence and X-ray absorbance
spectroscopy
In an attempt to obtain additional evidence for a change in time-averaged q as a function
of water exchange rate, homochiral corner SAP and TSAP isomers of Eu-2 were sent to
the laboratory of Dr. Ana de Betancourt-Dias for variable-temperature luminescence
lifetime analysis. Using Parker’s modifications to Horrocks’ method, q values will be
calculated for these chelates in solution.28,29 These data may confirm our theory that q/r6
varies differently in solution with differing coordination geometry and temperature. We
believe that the inner-sphere water molecule spends increasingly less time associated
with the lanthanide as the temperature is increased, and that these changes will be more
evident for the TSAP isomer, both leading to lower experimental values for q.
Further research into the structural changes due to varying water exchange rates will be
conducted on the conformationally rigid Gd-2 chelates. These chelates, purified as single
regio- and diastereoisomers, were sent to the laboratory of Dr. N. Blackburn at Oregon
Health and Sciences University. Collection of EXAFS data will be attempted at the
Stanford synchnotron (SSRL) in collaboration with Dr. Blackburn’s lab, and the median
Gd-O distance as well as the Gaussian distribution could be determined for isomeric Gd2 species. The resolution of this technique may or may not be sufficient to distinguish
between isomeric chelates. q and rGd-H (estimated from rGd-O) parameters obtained from
these measurements could be used to re-fit NMRD profiles and from variable temperature
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O NMR data determined in collaboration with Dr. M. Botta. Activation volumes (from

variable-pressure NMR data) will be determined in the laboratory of Dr. L. Helm at the
École Polytechnique Fédérale de Lausanne in Lausanne, Switzerland, and the energetics
of water exchange will be computed.
3.5.2 Assessment of water exchange rate and molecular probe capability of a DOTA-type
chelate with phosphonate pendant arms
DOTA-derivatives with four phosphonate pendant arms show very fast water exchange.
Previous phosphonate/phosphinate chelates possessing achiral pendant arms were studied
and determined to be octacoordinate and adopt TSAP geometry. They do not have an
inner-sphere relaxivity contribution as they are q = 0 chelates. If a macrocyclic ligand
with phosphonate pendant arms of appropriate chirality could be synthesized, it might be
possible to “force” the chelate to adopt SAP geometry (Figure 3.13). In addition to the
relaxivity benefits of a conformationally rigid, τM-optimized chelate, changing the
ligating group from carboxylate to phosphonate monoester arms is projected to endow the
agent with molecular ‘probe’ capabilities.
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Figure 3.13: Design of a DOTP-type chelate with possible SAP geometry and q = 1

The SAP geometry has a more “open” O4-plane in general for DOTA-type chelates and a
SAP analogue of Ln[DOTP]5- is predicted to have a greater hydration state than the TSAP
Ln[DOTP]5-, which could increase the relaxivity. Work was begun on the synthesis of a
chiral phosphonate arm (Scheme 3.1). The first step in this synthesis was to prepare
enantiomerically pure (> 98% enantiomeric excess (ee)) phosphonate esters.

The

resulting α-hydroxy chiral phosphonates would be activated and used to alkylate
macrocyclic ligands.

Enantiomeric enrichment was attempted by converting one

stereoisomer of the racemic alcohol to an acetate (in the presence of an enzyme)34 or
benzoate (in the presence of a chiral catalyst).35
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Scheme 3.1: Preparation of enantiomerically enriched phosphonate esters where R =
Methyl or Phenyl. Note that the reaction is not enantiospecific – several enrichment
steps and subsequent purifications are required to obtain >98% ee.

The percent ee could not be verified for the enzymatic resolution experiment. The
benzoyl chloride route leads to enantiomeric enrichment on a very small scale, but is not
applicable to scaling up. Future work on chiral phosphonates will employ different
starting materials.
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CHAPTER 4: RELAXOMETRIC STUDIES OF REGIOISOMERIC GD-NB-DOTMA
CHELATES
The relaxivities of clinical agents are comparatively low (4-8 mM-1s-1 under
physiological conditions). From previous studies of slowly rotating TSAP isomers, it
was not expected that high relaxivities would be observed for Gd-2.1 The goal of
measuring relaxivities was not to obtain a chelate with the highest relaxivity. Studying
the NMRD profiles of isomers of Gd-2 should allow subtle differences between chelates,
such as variations in electron spin relaxation and τR, to be extracted from the data. It was
expected that this set of experiments would lead to some understanding about the
coordination chemistries of each regioisomer and how they might vary in terms of their
structure and dynamics.
The regioisomeric Eu-2 chelates studied exhibited very similar NMR spectra. Due to the
spatial relationship (δ = D[3cos2θ/r3]) between the ligand protons and their NMR shifts
and line-widths, it was anticipated that the Ln3+ coordination environment in
regioisomers of the same coordination geometry would differ only slightly. Therefore, it
seemed likely that regioisomeric chelates would possess similar physicochemical
properties. The properties of regioisomeric Gd3+ chelates with macromolecule-binding
functionalities were investigated. The strategy was to look at the regio-, diastereo-, and
geometric isomers of Gd-2 to assess their relaxation behavior relative to one another and
then to investigate how any differences manifest when rotation is slowed.
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4.1 Relaxometric studies of Gd-2 chelates
The two regioisomers of each diastereoisomer of Gd-2 were prepared as previously
described for the Eu3+ analogues. Isomeric assignments following HPLC purification
were made on the basis of the retention times of their respective Eu3+ analogues. These
chelates were sent to the laboratories of Prof. M. Botta (Università del Piemonte
Orientale, Alessandria, Italy), a leading expert in the analysis of
measurements of Gd3+ chelates.

17

O NMR and NMRD

These methods are the established techniques for

analysis of water exchange and relaxation behavior. For τM determination by 17O NMR,
spherical NMR sample containers and a probe that can accommodate them are necessary
to ensure homogeneity of the sample, diffusion, and magnetic field. NMRD requires the
use of a field-cycling relaxometer.
According to SBM theory, low field (<1 MHz) relaxivity is primarily determined by τR
and the electron spin relaxation characteristics of the chelate.2 The Gd-2 chelates studied
are isomeric, have the same mass and are therefore expected to have identical
hydrodynamic volumes and τR values. For chelates that undergo fast water exchange,
relaxivity scales with hydration state across all fields.

In terms of the electronic

relaxation components Δ2 (a measure of mean zero-field-splitting (ZFS) energy) and τv
3+

(the ZFS), even if the coordination environments are similar, the shifts of the Eu

complexes are distinct from one another and therefore there differences in the ligand
field, which affects the ZFS. Based on the difference in shifts and coupling patterns, the
position and orientation of the NB group is expected to be different between
regioisomers, which could also have some influence on electronic relaxation.
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Due to the complexity of simultaneously fitting at least 7 parameters in an NMRD
profile, some of these are usually constrained. The constrained parameters typically
chosen do not vary significantly between systems, or fluctuate seemingly at random to
values outside of the physically plausible if allowed to vary in the fit. In our experiments,
q, a (second-sphere Gd-water distance), A/ħ (the scalar coupling constant), and D
(diffusion coefficient) were constrained. R values were constrained and the difference in
hydration states, as evidenced by the VT NMR studies of Eu-2 and the luminescence
studies of Eu-2 and related chelates as described in Chapter 3, was taken into
consideration. It could not be determined whether q is smaller for the TSAP chelates
(compared with the SAP chelates), or if r is larger. By constraining both q and r for
fitting the NMRD profiles, we have accounted for the difference in hydration state as
much as possible from the available data. Values for r were constrained to 3.0 Ǻ for SAP
chelates and 3.1 Ǻ for TSAP chelates.

The NMRD measurements performed and

respective fitting curves generated are shown in Figures 4.1 and 4.2.

Figure 4.1: NMRD profiles of the SAP chelates Eu-S-RRRR-2 corner (blue diamonds)
and side (green) isomers, and Eu-S-SRRR-2 corner isomer (yellow) at 25 °C.
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From inspection of the NMRD profiles, relaxivity is greatest at low fields (< 1 MHz),
goes through a dispersion between 1 and 10 MHz, and is lowest at high fields (> 20
MHz). These data are typical of low-molecular-weight (rapidly tumbling) Gd3+ chelates.
Since the regioisomers have the same mass, τR values are very similar as expected. The
profiles of the three SAP isomers analyzed have a largely uniform difference in
magnitude in Figure 4.1 at low fields. The SAP side isomer (green diamonds) has higher
relaxivity than the corner isomer (blue), which has a higher relaxivity than the
diastereoisomer (S-SRRR, orange) below 1 MHz.

The low-field relaxivity data are

indicative of a parameter which scales independently from magnetic field strength,
possibly indicating a difference in hydration state between the three isomers. The side
isomer could have the largest q/r6 with the S-SRRR isomer having the smallest. At high
fields, the relaxivities observed for the two corner isomers have nearly identical values,
with a somewhat greater value observed for the side isomer.

The fact that the NMRD

curves are not offset at all fields indicate that the corner and side isomers could have
different electronic relaxation properties. Recent NMR data indicate that corner and side
regioisomers are distorted from idealized square antiprismatic geometry differently3 – the
degree of symmetry of the ligand field affects the ZFS. Or, the rigidity of the chelate for
the side isomer’s NB orientation may lead to more favorable τv.

Lastly, some

combination of the above explanations could be the cause of the difference in relaxivity.
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Figure 4.2: NMRD profiles of the TSAP chelates Eu-S-SSSS-2 corner (green diamonds)
and side (red) isomers at 25 °C.

Similar relaxation behavior was observed over the range of magnetic field strengths for
the TSAP isomers. The curves are offset at low fields, but the corner isomer has higher
relaxivity than the side isomer, the opposite result from the SAP. It is therefore unlikely
that the shape of corner or side isomer intrinsically leads to higher relaxivity. The highfield relaxivity values are slightly greater for corner vs. side isomer, but the difference is
not nearly as large as for the regioisomeric SAP chelates. The hydration states are thus
likely to be very similar, and the differences in the profiles are probably due to electronic
factors. Unexpectedly, the relaxivities for SAP isomers are slightly higher than those of
the TSAP isomers.
Based on these observations, values for the five non-constrained parameters were
optimized to generate fitting curves to the above data, and these values are shown in
Table 4.1. Values for the parameters varied to produce the fits are based on data from
related systems4 and not on independent measurements.
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r
Å

Gd-S-SRRR-2 (corner isomer)

6.3

2.0

18 112 70 3.0

Gd-S-RRRR-2 (corner isomer)

6.3

1.6

16 111 70 3.0

Gd-S-RRRR-2 (side isomer)

7.1

1.6

18 112 70 2.9

Gd-S-SSSS-2 (corner isomer)

5.9

1.7

18 118

8

3.1

Gd-S-SSSS-2 (side isomer)

5.6

1.8

20 112

8

3.1

[a]

recorded at 20 MHz
For all the complexes q = 1, a (second-sphere Gd-water distance)=
4.0 Å and D = 2.24 (298 K) and 3.10 (310K) ×10-5 cm2 s-1.

Table 4.1: Relaxometric parameters obtained from the fit of the 1H NMRD profiles

The relaxivities observed are statistically distinct from one another. The SAP (RRRR)
side isomer has slow water exchange (but faster than Gd[DOTA]-), and higher relaxivity
than the SAP corner isomers (RRRR and SRRR). The TSAP (SSSS) side isomer has fast
water exchange, but lower relaxivity than the TSAP corner isomer. The fits reflect the
belief that τR values are essentially the same. Though dominated by similar, rapid fitted
values for τR and τM, the relaxation properties of regioisomeric chelates were shown to be
subtly different. The difference in structure could alter ligand rigidity and therefore τv –
the structure of the side isomer may lead to more favorable electronic relaxation in the
SAP chelates but slightly less favorable electronic relaxation in the TSAP chelates (which
have different rigidity and distortion from idealized geometry). Differences in τM affect
relaxivity at 20 MHz, with the slower-exchanging isomer predicted to have lower
relaxivity. Though there seemed no reasonable cause to expect that there would be
differences in q/r6 or the water exchange kinetics of regioisomeric chelates, the NMRD
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data suggest that these differences are real. A lower r value for the S-RRRR side isomer
yielded the best fit to the NMR data. There is no way to tell just from the NMRD profiles
above if this isomer actually has a higher hydration state than the other isomers, or if the
fit is due to inaccuracies in values for the other parameters.
The fits to the NMRD data indicate that electronic properties lead to relaxivity
differences between the 5 Gd-2 isomers studied, but the high field differences cannot be
due to electronic relaxation differences alone. These findings indicate that a difference in
hydration state is affecting relaxivity. There is no explanation in the NMRD data of Gd-2
for the SAP chelates possessing higher relaxivity than the TSAP chelates. The potential
differences in relaxivity behavior between regioisomers should be more clearly
observable and interpretable when bound to a slowly tumbling species in comparison to
the rapidly tumbling chelates.
4.2 Measurement of τM in Gd-2 chelates by variable-temperature 17O NMR shift and T2
The 17O NMR measurements inform on whether τM is affecting the relaxivity of isomeric
Gd-2 chelates (Figures 4.3). τM values were measured by

17

O NMR spectroscopy if

sufficient amount of a given isomer was present. The fitting data are shown in Table 4.2.
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Figure 4.3: Variable temperature T2 (left) and chemical shift (right) 17O data for Gd-SRRRR-2 corner isomer (top), Gd-S-SSSS-2 side isomer (middle), and Gd-S-SSSS-2
corner isomer (bottom)
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SSSS-corner

SSSS-side
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Table 4.2: Fitting parameters used in the fitting of the NMRD and 17O relaxation profiles
of the complexes. a) parameter fixed during fitting
17

O data could not be acquired for Gd-RRRR-2 side or Gd-SRRR-2 chelates due to

insufficient amounts of sample. It is important to note that the data analyses of these 17O
NMR profiles are only preliminary. For instance, the shape of the R2 profile for S-RRRRisomer, which reaches a maximum and begins to decrease at lower temperatures,
indicates that exchange is actually slower than reflected in the fitting, in line with
previously published work.5 Nonetheless, these data confirm that the TSAP isomers
indeed have the fastest water exchange kinetics as expected. Interestingly, the 17O data
for Gd-S-SSSS-2 chelates show that the side isomer and corner isomers do not have
identical τM values, though the NMRD profiles in section 4.1 were fit with τM = 10 ns as
those values were the best available data at the time. The TSAP corner isomer has a
water residence lifetime that is twice as long as that of the side isomer. However, owing
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to very fast exchange and to the 1/(τon + τoff) = kex relationship outlined in Chapter 3, the
exchange rates are actually very similar. There is a field dependence for the optimal
water exchange rate.6 This is a possible explanation for the slightly higher relaxivities
observed for the SAP chelates over the TSAP (Table 4.1). Faster water exchange appears
to lead to a decrease in the hydration state and this in turn affects relaxivity over the
whole NMRD profile.
4.3 Relaxometric properties of regioisomeric, slowly tumbling biphenyl analogues of
Gd-2
A recent paper detailed the investigation of two slowly tumbling chelates with very
similar electronic relaxation properties but different water exchange kinetics.1 Though
fast water exchange and slow tumbling led to high relaxivities, the more slowly
exchanging (SAP) chelate unexpectedly showed higher relaxivity than its TSAP isomer.
The relaxivity differences observed between coordination geometries have thus been
investigated for confirmationally rigid chelates with similar electronic relaxation, but no
studies are known where the relaxivities of regioisomers were compared. It was expected
that for slowly tumbling derivatives of Gd-2, a difference in macromolecular binding
would be evident due to the predicted orientations of the NB group and the question of
whether this could result in differences in relaxivity was probed.
One complication with using human serum albumin (HSA) to quantify relaxivity
enhancement of different chelates is that HSA does not exhibit 1:1 binding of a Gd3+
chelate with binding functionality.7,8 The conformation of HSA changes upon binding
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and at least one of the binding sites could accommodate more than one chelate. This can
obscure the contributions of a particular chelate to observed relaxation rate. Polymers of
cyclodextrins have also shown to be useful for demonstrating increased relaxivity of
slowly-tumbling complexes.9-11 The biphenyl group has been shown to bind to biological
macromolecules in vivo within detectable limits (nM range).12,13
Biphenyl conjugates of Gd-S-SSSS-2 were prepared based on literature procedures1 for
study by NMRD. The nitrobenzyl group in 2 was reduced to the corresponding amine 4
by catalytic hydrogenation. Subsequent reaction with thiophosgene converted the amine
4 to the isothiocyanate 5 which could then be coupled to 4-phenylbenzylamine, yielding
the biphenyl substituted ligand 6.

This ligand was used to form the Gd3+ chelate,

generating an amphiphilic molecular probe (Scheme 4.1).

Scheme 4.1: Conversion of the nitrobenzyl group in 2 to confer macromolecular binding
ability
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An HPLC method was developed to resolve regioisomers of Gd-S-SSSS-6. The corner
and side isomers of Gd-S-SSSS-6 (biphenyl-conjugated) chelates were purified by HPLC.
The isomers of Gd-S-SSSS-6 were again identified by synthesizing and purifying the Eu3+
analogues, which were analyzed by 1H NMR. The order of HPLC elution and the axS
peak patterns in the downfield region of the spectra of Eu-S-SSSS-6 clearly align with
corner and side isomers of Eu-S-SSSS-2 (data not shown), as characterized above. This
also shows that the coordination environment and ligand field between the same
regioisomer of Gd-2 and Gd-6 are analogous for the purposes of comparing relaxation
properties.
To test if the orientation of the bulky ring substituent with respect to N/O planes affects
the binding and relaxation properties of regioisomeric Gd-6 chelates (via potential
differences in τR and τM), NMRD profiles of the free and poly-β-cyclodextrin-bound
complexes were analyzed. With faster water exchange, the relaxation properties of the
TSAP biphenyl conjugates of Gd-2 (Gd-6) should be more sensitive to changes in water
exchange rate than the SAP, and should have τM values closer to the optimal predicted by
SBM theory. Or, the relaxivities may be limited by τM for slowly tumbling species if
water exchange rate is not optimal. In the event of varying binding behavior between
regioisomers, water exchange or local rotation (as evidenced by differences in τR) could
be more restricted in one isomer over the other.
The longitudinal relaxation rate was determined at a series of concentrations to find the
critical micelle concentration (cmc) for each isomer (Fig. 4.4). Chelates conjugated to
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biphenyl or other hydrophobic groups have previously been shown to form micelles
above a certain concentration in solution. These micelles act as higher-relaxivity (via
long τR) “clusters” with their hydrophilic (Gd-acetate) groups facing the bulk water, and
the hydrophobic (biphenyl) groups forming the core.14-16 It is important to determine the
cmc17,18 for each chelate to separate the relaxivity effects of τR due to binding from
effects due to micelle formation, particularly when the aim is to then titrate in a binding
target and measure r1.
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Figure 4.4: Relaxation properties of Gd-S-SSSS-6 above and below critical micelle
concentration (cmc). Isomer 1 = Gd-S-SSSS-6 corner (left) and Isomer 2 = Gd-S-SSSS6 side (right). The cmc was determined to be 0.24 mM (± 0.01) for both corner and side
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isomers. The y-axis is the background relaxation rate ( ) of water subracted from the
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observed relaxation rate with the chelate (R1obs-R1d)

The cmc was determined to be 0.24 mM for both corner and side isomers of Gd-S-SSSS6.

Above this concentration, the relaxivity is substantially higher due to micelle

formation. The regiochemistry does not seem to substantially affect the concentration
range at which micelles form. The relaxivity is higher for the corner TSAP isomer than
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for the side isomer below the cmc, consistent with the TSAP Gd-2 NMRD data above.
This again could be related to differences in electronic relaxation properties between
regioisomers. Above the cmc, however, the relaxivities are higher for the side isomer.
Micelles of the side isomer may be larger or have a different shape, leading to greater τR.
Or, micelles of the corner isomer may orient the inner-sphere water site in such a way
that τM is restricted or the hydration state is smaller in comparison to the free chelate or to
micelles of the side isomer.
It was assumed that the relaxivities of both chelates will be greater with increasing
concentration of macromolecule, due to binding of the chelate and reduced rate of
molecular tumbling, until no further binding can occur with a subsequent increase in
macromolecular concentration. NMRD profiles for the samples were determined for GdS-SSSS-6 (Figure 4.5).

24

isomer 1
isomer 2

r1p / mM -1 s -1

20
16
12
8
4
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0,01
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Figure 4.5: NMRD profiles of Gd-S-SSSS-6 corner (filled diamonds) and -side (open
diamonds) at 0.15 mM and 298 K
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The relaxivity of the TSAP corner isomer is lower than the relaxivity of the side isomer at
low fields, in contrast to the Gd-2 data. The “hump” around 20 MHz in the relaxation
data for the corner isomer indicates that the chelate continues to aggregate to some degree
even at 0.15 mM, below the cmc. At that same concentration, the lack of a hump for the
side isomer indicates no aggregation. Now the picture we are getting is one where the
hydration state is greater, or τM or electronic relaxation is more favorable for the side
isomer, dominating the low field behavior, but the greater τR of the corner isomer (due to
aggregation) dominates the relaxivity at high fields. The cmc profiles in Figure 4.4 and
the NMRD profile in Figure 4.5 suggest that if the concentration of the chelates were low
enough, the side isomer would have greater relaxivity at all fields. Optimized fitting
values for the NMRD profiles of the biphenyl chelates are shown in Table 4.3.

[Gd3+] = 0.15 mM
Gd-S-SSSS-6
corner (isomer 1)

Gd-S-SSSS-6
side (isomer 2)

rGd-H / Åb

3.0

3.0

M / nsb

10

10

2 / 1019 s-1

2.4

1.7

V / ps

27

23

R / ps

200

168

Table 4.3: Best-fit parametersa,b of the NMRD profiles of Gd-S-SSSS-6 (corner, isomer
1) and Gd-S-SSSS-6 (side, isomer 2) a) Fitting used a = 4.0 Å, 298D = 2.24×10-5 cm2 s-1
and q = 1. b) parameter fixed during fitting.
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The fitting of the NMRD profile gives the corner isomer a significantly larger value for
τR. This may indicate that the side isomer is more compact and therefore has less
restricted tumbling. However, the τR values obtained from the fit may be due to the
assumed values of other parameters, or are more reflective of an aggregate rather than a
monomeric chelate. The low-field relaxivities are overall slightly higher than the TSAP
Gd-2 values, which is to be expected as Gd-6 chelates are more massive and therefore
tumble more slowly. τM values were again fixed to 10 ns for both regioisomers as those
were the best available data to produce a fit at the time. The 17O NMR data indicate that
the regioisomers should have different τM values, but the poor fits to the NMRD profiles
of Gd-S-SSSS-6 are more likely due to aggregation.
The potential difference in binding between regioisomeric Gd-S-SSSS-6 chelates was
probed by titration of chelate solutions with poly-β-CD. The degree of binding of the
two isomers of Gd-S-SSSS-6 was assayed by titration with poly-β-cyclodextrin (Figure
4.6). The binding constant and relaxivity data are shown in Table 4.4.
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Figure 4.6: Interaction with poly-β-cyclodextrin (20 MHz, 298 K)
Ka / M-1

r1bound / mM-1 s-1a

Gd-S-SSSS-6
corner

0.61 ± 0.09 × 103

21.7 ± 0.3

Gd-S-SSSS-6
side

0.63 ± 0.06 × 103

21.3 ± 0.2

a) Measured at 20 MHz and 25 ˚C.
Table 4.4: Fitting parameters for the binding of the two isomers of Gd to poly-β-CD

The initial rapid rise in relaxation rate is due to the Gd3+ chelates’ strong relaxation
enhancement when bound to a slowly tumbling species. The more gradual rise as the
poly-β-cyclodextrin concentration increases further indicates an increase in viscosity of
the overall solution.

The shape of the curve indicates 1:1 binding.

The binding

differences between the two regioisomers are not statistically significant. The NMRD
profiles of Gd-S-SSSS-6 bound to poly-β-cyclodextrin (poly-β-CD) are shown in Figure
4.7.
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Figure 4.7: NMRD of the supramolecular adducts (298 K)

The difference in relaxation behavior of the poly-β-CD-bound chelates are similar to
those of the free chelates. At low fields, the side isomer has higher relaxivity due to a
difference in hydration state or electronic relaxation; at high fields, the relaxivities are
similar and typical of long τR values from macromolecular binding. Optimized fitting
values for the NMRD profiles of poly-β-CD-bound chelates are shown in Table 4.5.
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Gd-S-SSSS-6
corner (isomer 1)

Gd-S-SSSS-6
side (isomer 2)

rGd-H / Åb

3.0

3.0

M / nsb

10

10

2 / 1018 s-1

5.9

6.3

V / ps

11

9

g / ns

2.9

2.8

l / ns

0.37

0.42

S2

0.14

0.12

154

Table 4.5: Best-fit parameters of the NMRD profiles (25 °C) of the inclusion
complexes of the two isomers of Gd with poly-β-CD. a) Fitting used a = 4.0 Å, 298D =
2.2×10-5 cm2 s-1 and q= 1. b) parameter fixed during fitting. g is the global reorientation
time constant,l is the local reorientation time constant, and S2 represents the extent to
which local and global rotation are coupled. From the Lipari-Szabo model,19 1 means
entirely coupled and 0 entirely decoupled 8

With poly-β-cyclodextrin, the peak centered around 35 MHz indicates binding of Gd-SSSSS-6, increasing relaxivity at moderately high fields via τR increase and T1e limitation
before decreasing again. The constraining of r and τR to identical values for regioisomers
could be erroneous. τv values are larger for the corner isomer for both free and bound
chelates, and larger in the free species, suggesting that this isomer is more rigid with
respect to vibrational and collisional motions (larger values are more favorable for
increasing relaxivity). 2 values are larger in the bound chelates indicating a more
asymmetric ligand field. The chelates likely distort from idealized geometry further upon
binding, having a small negative impact on relaxivity.
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The data indicate that the relaxivities of the macromolecular adducts of corner and side
isomers are not limited by possible differences in shape, binding kinetics, local rotation,
electronic factors, differences in water exchange, or differences in hydration state at 20
MHz and 25 °C. Alternatively, the differences in local rotation, electronic factors, water
exchange rates, or hydration state may be canceling one another out for the regioisomers
under these conditions, leading to very similar relaxivities at high fields.
4.4 Conclusions and future directions
The NMRD data indicate that the electronic relaxation properties do, as anticipated,
appear to differ between regioisomers.

Unfortunately, our understanding of the

relationship between ZFS, τv, and coordination chemistry is currently quite limited and it
is not currently possible to optimize these factors via rational design. The differences in
relaxivities observed for both Gd-2 and Gd-6 chelates were shown to be proportional to
differences in τM (or possibly hydration state, since these parameters were shown to be
related in Chapter 3). It is interesting that the side isomer has higher relaxivity in the
SAP regioisomers, and lower relaxivity in the TSAP regioisomers. We can speculate that
this is the result of differences in τM and the inherently linked hydration state. τM is
shorter and, according to our results in Chapter 3, associated with a lower hydration state
(q/r6) in the side isomer of Gd-S-SSSS-2. This leads to lower relaxivity for the side
isomer. In contrast, the side isomer of Gd-S-RRRR-2 exhibits higher relaxivity at all
fields in the NMRD profile, and using the same reasoning could be associated with
slightly slower water exchange and therefore an increased hydration state.

The
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relaxivities of Gd-2 and their respective water exchange rates are in the following order:
SAP corner (moderately high relaxivity, slowest water exchange), SAP side (highest,
slightly faster), TSAP corner (moderately low, even faster), and TSAP side (lowest,
fastest). This evidence suggests that the TSAP chelates have faster water exchange than
optimal at 0.5 T, and the faster the exchange is in comparison to that of the SAP side
isomer, the further away from optimal relaxivity. Additionally, the SAP corner isomer
may exchange water too slowly for optimal relaxivity. These are all minor differences
for the rapidly tumbling chelates, but have major implications for CA design and may
show significant differences when bound to macromolecular targets. Gd-6 analogues of
the SAP isomers have not yet been prepared, but the SAP and TSAP properties of closely
related chelates have been analyzed (for which regioisomer data are not available).1
Since it is not possible to measure rGd-H directly in solution, Gd-O measurements will be
assumed to be proportional to Gd-H. Regioisomerically pure Gd-2 chelates were sent for
X-ray fluorescence analysis at the Stanford Synchrotron Radiation Lightsource, which
can probe Gd-O distances, and we hope that the resolution is sufficient to observe
differences between isomers. If these data are obtained, the NMRD data will again be refit using the most accurate values obtainable. Analysis of the τM vs. r data may tell us
which parameter is affecting the relaxivity.
The relaxivities obtained are still below optimal as predicted by SBM theory and are
surprisingly higher for the longer-τM SAP isomers.

Our understanding of how to

maximize relaxivity in conformationally rigid chelates by rational design has been
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improved by the study of hydration state, water exchange, and relaxivity by comparing
regioisomeric and macromolecular-binding conformationally rigid chelates.
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CHAPTER 5. OVERCOMING REGIOISOMERISM: A POTENTIAL PATH
TOWARD

SYNTHETICALLY

EFFICIENT,

CONFORMATIONALLY

RIGID

CHELATES
5.1 Motivation for study and summary of synthetic research plan
Although the corner regioisomer of Ln-2 is generally the more favored position formed
under typical reaction conditions, we have been unable to find synthetic conditions which
yield only one regioisomer. The difference in substituent orientation between corner and
side isomers means that they could function differently as targeted imaging agents, and it
may therefore be necessary to isolate them a single compounds, greatly complicating the
synthesis of agents.

Synthetic efficiency is poor since one regioisomer must be

discarded, and NB-cyclen is an expensive ($2500/g) precursor. The HPLC purification
of regioisomers is impractical on a large scale. Optimizing the synthetic process of
preparing a potential MRI CA would be valuable from a scientific and an economical
point of view. A conformationally rigid chelate (such as one based on the macrocycles 8
or 9) which eliminates the potential challenge of regioisomerism would be preferable for
synthetic efficiency.

Cyclen, Cyclohexylcyclen (8) and Bicyclohexylcyclen (9)

Trans fusion of a cyclohexyl ring to one ethylene bridge of cyclen would occupy both
equatorial positions equivalently and yield a single chelate. A trans-2,3-cyclohexane-
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fused tetraazacrown such as 8 or 9 with appropriately substituted pendant arms would not
be expected to be able to form regioisomers. In this way it should be possible to
synthesize a conformationally rigid chelate with no possibility for regioisomerism. A
synthesis of compound 8 has been reported in a patent, and some synthetic conditions,
yields, and/or characterization data were not reported.1 The major drawback of this work
is the low yield, and ways to improve upon that were explored. Other 2,3-substituted
tetraazacyclododecane compounds have been reported2-7, but are either unsuitable for
converting to a stable Ln3+ chelate which won’t undergo conformational exchange, or
have low yields and/or a large number of synthetic steps. Considerable effort was put
forth toward synthesizing a conformationally rigid, cyclohexyl-bridged macrocycle. The
primary motivation for this work was to achieve an economical, relatively simple
synthesis of a conformationally rigid tetraazacrown for use in development of
prototypical CAs.
5.2 Attempted synthesis of a 1,4,7,10 tetraaza-crown with no potential for
regioisomerism
5.2.1 Efforts to synthesize cyclohexylcyclen based on the Richman-Atkins method
Multiple synthetic routes to 8 were tested, and the approaches were based on successful
syntheses of cyclen and the one reported synthesis of 8. The synthesis of 8 by Desreux
and colleagues (Scheme 5.1), similar to the Richman-Atkins synthesis of cyclen and
based on the synthesis of cyclen published earlier by Stetter and co-workers,8 uses
chloride as the leaving group rather than triflate or tosylate. Compound 10, (1S,2S)- or
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(1R,2R)-1,2-diaminocyclohexane, is advantageous because it is a commercially available,
enantiomerically pure starting material. The S,S and R,R isomers of 10 would yield Δ or
Λ chelate geometries, respectively.

Scheme 5.1: Experimental details of the synthesis from the patent by Desreux and coworkers, as best as can be determined.

We attempted to modify the Richman-Atkins cyclen synthesis9 in order to prepare 8. In
the cyclization step, we tried using both a stronger nucleophile and a more active leaving
group than employed in scheme 5.1.

The di-N-tosyl derivatives of trans-1,2-

diaminocyclohexane (11) and of N,N’-bis(2-hydroxyethyl)-ethylenediamine (12a) were
produced (Scheme 5.2).

The di-triflic-ester of N,N’-bis(2-hydroxytoluenesulfonyl)-

ethylenediamine (12b) was formed and then reacted with 11 in DMF/DCM under inert
atmosphere.
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Scheme 5.2: Attempted adaptation of the Richman-Atkins method to yield 8

This procedure did not lead to cyclization via N-alkylation of 12b; the triflate esters were
instead hydrolyzed back to the N-tosyl diol 12a.

In light of this result, it was

hypothesized that a poorer leaving group might afford the nucleophilic substitution with
the N-tosyl amides to out-compete hydrolysis. In attempt to increase the nucleophilicity
of 11, the disodium salt was pre-prepared using sodium ethoxide. This compound was
again reacted with triflic (12b) or tosyl (12c) esters of 12a, but no macrocycles were
formed. Using equivalent building blocks, cyclization was not achieved using various
solvents, heating times, and leaving groups. Scheme 5.2 was shown to be unreliable,
particularly the cyclization step.

It was decided that effort would be more fruitfully

spent developing a more modern, higher yielding synthesis of substituted cyclen
derivatives to try to produce the target macrocycle.
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5.2.2 Efforts based on the Kiefer-Athey method
As described in the introduction, diimine 13 is reacted with dibromoethane to form a
bridged cyclen macrocycle as reported by Kiefer and Athey. The proposed scheme for
cyclohexane-bridged macrocyclic ring formation started with the reaction of 13 with an
electrophilic trans-1,2-substituted cyclohexane (Scheme 5.3).

Scheme 5.3: Attempted adaptation of Kiefer-Athey method using 14. X is a
leaving group – Br, OTf, or OMs

Triethylene tetramine was reacted neat with N,N-dimethylformamide dimethyl acetal to
form 13 according to the literature procedure. Any remaining volatiles were removed in
vacuo, and the crude product was recrystallized from dry THF, and then isolated by
filtration, all under N2. This procedure was repeated and scaled up successfully several
times. Care must be taken upon scaling up to use gradual heating and an appropriately
large flask; bumping is a problem otherwise. Low yields were obtained when attempting
the reaction with a solvent.
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The ditriflate 14b of trans-1,2-cyclohexanediol (14a) was prepared under N2 by reacting
with triflic anhydride in the presence of 2,6-lutidine and dry dichloromethane. The
solvent was removed in vacuo and the salts precipitated by adding ether. The ethersoluble ditriflate was separated by filtering the salts off, then dried in vacuo and stored
under N2 at -20 ºC until use.
The diimine 13 and ditriflate 14b were heated under reflux for 3 hours in dry acetonitrile
in the presence of 1 equivalent of potassium carbonate (Scheme 5.4). The salts were
filtered off under N2, and solvent removed in vacuo. The resultant oil was used directly
in the next step. It was dissolved in water and transferred drop-wise to a boiling solution
of potassium hydroxide (5.7 M). The solution was heated under reflux for an additional
30 minutes, allowed to cool, and concentrated in vacuo, yielding an aqueous solution
with precipitate. Both the solution and precipitate were analyzed by MS. The target
mass of 8 (227, [M+H]+) was observed in each spectrum, but is not the major ion.
Extraction of 8 from the hydrolysis mixture into chloroform or dichloromethane was
attempted. Recrystallization was also attempted by slow diffusion of ethanol or diethyl
ether into the aqueous mixture. Sublimation of a small portion of the lyophilized residue
was also attempted. None of these techniques resulted in successful isolation of the
target mass.
As attempts to isolate the product from the hydrolysis step were unsuccessful, an effort
was made to isolate the cyclization product prior to the hydrolysis step. The reaction of
13 and 14b was repeated, but not taken on to the hydrolysis step. Unsuccessful attempts
were made to crystallize 8 or its ethylene-bridged precursor from toluene or water.
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Instead, the crude solid was rinsed with cold acetonitrile, and both the solid and extract
were analyzed by MS (representative spectrum in Figure 5.1). A variety of species are
present, including peaks which appear to correspond to the target macrocycle (247,
[M]+), the suspected hydrolysis product 8 (226, [M]+), and a proposed mono-N-alkylated
species (266, [M+H]+) where the second triflate had been hydrolyzed rather than
displaced by a nucleophilic nitrogen. Ions with larger m/z are probably acyclic dimer or
trimer combinations of 13 and 14b.

Figure 5.1: Representative mass spectrum of the reaction of 13 and 14b and proposed
structures corresponding to observed m/z peaks

Following the suspicion that water was inhibiting successful synthesis at some stage,
procedural modifications were adopted to exclude air and moisture over the course of the
reaction and work-up.
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After running the cyclization reaction and preparing its precursors using the above
changes, mass spectrometric analysis of the isolated solid again reveals an ion at m/z 227.
If this product is in fact a 12-membered tetra-aza crown, it should readily form a stable
complex with copper. The material possessing m/z 227 was stirred with Cu(II) triflate
overnight. This substance, however, does not form a polydentate complex with Cu(II)
after heating in water; the solution remained the pale blue-green of copper triflate and did
not turn the deep blue of a copper ethylenediamine species. The product is likely a nonmacrocyclic isomer of the target (cyclohexyl)cyclen 8. Subsequent experiments were
performed on the effect of changing the leaving group and the solvent for the cyclization
reaction.
Effect of the leaving group
X
X

14

14a X = OH
14b X = OTf
14c X = OMs
14d X = Br

The di-mesylate (14c) of trans-1,2-cyclohexanediol showed no reaction with diimine 13
in either dry acetonitrile or dry dimethylformamide after heating at reflux for
approximately 40 h. The use of trans-1,2-dibromocyclohexane (14d) also did not result
in cyclization.
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Effect of the solvent
Chloroform was substituted for acetonitrile in the cyclization reaction. The reaction
progress was monitored by NMR after 3h and 19h. The NMR data showed that almost
exclusively starting materials are present after 3h, and no longer present after 19h. The
organic-insoluble residue was subjected to the hydrolysis procedure, but none if the
intended product was observed by mass spectrometry.
Effect of cyclohexyl group
In order to gain evidence for or against intrinsic problems related to the experimenter or
scale, the reference procedure10 (Scheme 5.4) was performed, forming the diimine 13 and
reacting with dibromoethane in MeCN. Characterization of the resultant material was
performed with similar results to that of the solvent effect experiments – the bridged
tetraamide in Scheme 5.4 is not clearly observed from NMR or MS data, and could not be
extracted with hot toluene.

Scheme 5.4: Attempt to prepare 8 from 1,2-substituted ethylene

Substituting dibromoethane for 1,2-difunctionalized cyclohexane did not yield cyclen or
its cyclized intermediate, nor did changing other reaction conditions including solvent,
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temperature, duration, or salt. Owing to our inability to reproduce the Kiefer/Athey
cyclization method for cyclen, this approach was not investigated further.
A synthetic strategy was tested in which the imine would be formed from the cyclohexyl
portion. In our lab, diamine 10 was reacted neat with N,N-dimethylformamide dimethyl
acetal (scheme 5.5) in dry methanol under nitrogen.

Scheme 5.5: Formylation of 10 in attempt to prepare 9

Solvents were removed in vacuo, and crystallization of the product (15) showed was
attempted using THF. A precipitate formed after approximately 1 week stored under
argon at -20 ºC, but was no more pure than the starting material. The mixture exhibited
peaks which appeared to indicate 15, but a low degree of purity was observed by NMR.
Mass spectrometric analysis reveals the target mass (125.25, [M+H]+) to be present, but it
is not the major ion; many species are observed. Attempts were made to form an
ethylene-bridged dimer (16) of the target imine (15), using 1,2-dibromoethane (with and
without iodine chips), 1,2-dichloroethane, and the ditosyl derivative of ethylene glycol.
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None of the above experiments have resulted in a pure compound. It was postulated that
a more pure imine might be necessary to form the bridged dimer.
Purification of the imine 15 was attempted by column chromatography. The crude
sample could not be eluted from a silica gel column. TLC studies were performed using
cellulose or basic alumina as stationary phases. The major UV-absorbent component had
an Rf which could not be tuned low enough on cellulose with varying solvents. The
alumina-based system showed promise, especially after drying the alumina for
approximately 15 minutes in a 105 ºC oven. The separation method developed consisted
of an initial elution using 50/50 hexane/ethyl acetate, followed by a gradient culminating
in a 50/50 methanol/dichloromethane secondary elution. An alumina column was run on
a large (10 g) batch of crude imine. Mass spectrometric analysis revealed the target mass
to no longer be present in any of the fractions collected. It is likely that 15 is unstable in
the presence of water/air over time, and/or is unstable on the column or binds
irreversibly.
5.2.3 Developments based on the cyclen synthesis published by Weisman et al.
In the cyclen synthesis developed by Weisman and co-workers11, a bridged tetramine is
formed without passing through an intervening formylation step to yield an imine.
Various attempts for preparation of 19 were made, starting with 10. Compound 19 could
lead to cyclization via a Weisman-type synthesis.12
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Scheme 5.6: approach to tetramine 19 for use in a Weisman-type synthesis using an
activated, N-protected amino acid, where PG = protecting group and LG = leaving group.

Keys to the success of this scheme are adding a C-C-N chain to 10 with a minimum
number of high-yield steps, and avoiding cumbersome purification of intermediates as
much as possible.

An N-protecting group such as t-butoxycarbonyl (Boc) or

carboxybenzyl (Cbz) was used on the incoming amino acid derivative 17, and the
cyclohexylamine adduct was prevented from further reaction by forming an amide (18),
(Schemes 5.6 and 5.7) affording mono-alkylation of the amines in 10.
Initially, synthesis of 18a was attempted using Boc-glycine and coupling reagents Nhydroxysuccinimide (NHS) and N-(3-Dimethylaminopropyl)-N’-ethylcarbodiimide HCl
(EDC) (Scheme 5.7).
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Scheme 5.7: Alkylation of 10 using Boc- or Cbz-Gly-OSu (17a or 17b)

The succinimide ester 17a was isolated as a minor product of this synthesis via
successive recrystallization, and reacted with 10.

Deprotection of 18a with

trifluoroacetic acid (TFA) was then attempted. However, this did not yield 20. It was
suspected that the strongly acidic conditions (6M HCl) needed to remove the Boc group
were also hydrolyzing the amides to some degree. The Boc group was replaced with the
Cbz group, which does not require acid deprotection.

N-(carboxybenzyl)-glycine-

succinimidyl ester (Cbz-Gly-OSu, 17b) was obtained commercially. The diamide 18b
was prepared, and the terminal amines deprotected using catalytic hydrogenolysis as
shown in Scheme 5.8. However, it was not possible to reduce the amides in 20 using
BH3·THF even with extended heating. Reduction of 20 and similar amides by a group
member using lithium aluminum hydride resulted in very poor yields.
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Scheme 5.8: Hydrogenation of Cbz groups to yield 20 and subsequent attempts at
reduction of the amides

We suspected that the main obstacle to reduction of 20 arose from the steric hindrance of
the secondary amides. An alternative route to 19 was devised to lower the energy barrier
for ligation of the amide oxygens to boron, as seen in Scheme 5.9.

Scheme 5.9: Approach to tetramine 19 for use a Weisman-type synthesis using an Nprotected 10 (21) and an amide alkylating agent. PG = protecting group
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A promising coupling reaction of bromoacetamide 22 to benzyl-protected trans-1,2diaminocyclohexane (21a) was developed. Advantages of this approach include cheap,
readily available starting materials, a chromatographic handle, and no mechanism for
over-alkylation. Compound 10 was protected by reductive amination (Scheme 5.10).

Scheme 5.10: Alkylation of N-protected 10 with a β-amide

A sample of 22 was prepared from bromoacetylbromide and benzylamine and was used
as the alkylating agent for the protected amine (21a). A series of bases (triethylamine,
diisopropylethylamine (Hünig’s base), 1,8-Diazabicyclo[5.4.0]undec-7-ene (DBU),
sodium ethoxide, and potassium carbonate) and solvents (dry THF, dry MeCN, toluene,
and dry methanol) were tested in effort to find optimal reaction conditions. Organic
nitrogen bases promoted the reaction more than ethoxide or carbonate. However, mass
spectral evidence suggested a tendency for the organic amine bases to also react with the
bromoacetamide, especially in more polar solvents (Scheme 5.11). Hünig’s base, in
theory, is more strongly basic and less nucleophilic than triethylamine, both desirable
attributes, and the product-to-base-adduct ratio was higher with Hünig’s base (5:2 by
ESI-MS ionization intensity) compared with triethylamine (2:5). Complete alkylation of
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both amines of 21a was not observed under any conditions tested. However, the greatest
yields were obtained from heating in Hünig’s base / toluene at ~105 ºC.

Scheme 5.11: Incomplete alkyation of 21a with 22 and reaction of organic nitrogen base
with 22

Modification of protecting group, reaction time, and workup, and lyophilization of 21:
The reaction of 21a with 22 was monitored by mass spectrometry after 2, 5, 7 and 14
days (23a = m/z 589, [M+H]+). The peak at m/z 442 (ESI+, [M+(N-benzyl)acetamide]+)
remained large, indicating that the second alkylation of protected 10 is incomplete even
after a two weeks of heating regardless of solvent, base, and reaction temperature.
Benzil was employed as an alternative protecting group (in 21b) en route to a fused-ring
macrocycle (Scheme 5.12).

The preferred conformation of the cyclohexane /

diazacyclohexane in 21b likely discourages chelation of alkali metals by the mono-
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alkylated species (the adduct of 21b and 1 equivalent of 22), which would reduce the Nnucleophilicity.

Scheme 5.12: Replacement of the benzyl protecting group of 10 with benzil

(

)

The benzil-protected diaminocyclohexane 21b has a slightly greater tendency towards
alkylation of both amines (in comparison to 21a) in toluene with Hünig’s base, heating
over several days.

Additionally, 21b is readily soluble in hot toluene; the benzyl-

protected diamine 21a requires the addition of water to dissolve.
Freeze-drying is advantageous for making the precursors 21a and 21b less colored and
less sticky; a substantial amount of mass loss (as water/solvents) was observed following
lyophilization. It is assumed that the resulting solid was weighed in closer to the desired
stoichiometric amounts when combined with N-alkylating agents. It was also discovered
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that crystallization of the crude residue from the reaction of 21 with 22 could be
accomplished by slow diffusion of hexanes into methanol, but that the crystals are of the
bromoacetamide, not the mono- or di-alkylated product. An acid/base workup was
attempted on the mother liquor from the recrystallization, but the amines could not be
extracted from the aqueous phase, and could not be isolated when this aqueous mixture
was freeze-dried.
DBU was tested in place of Hunig’s base when combined with 21b and 22 in effort to
afford a quicker, cleaner dialkylation. This reaction was done under argon for 4 days.
MS of the isolated residue showed mostly starting material and what seems to be an
alkylation by-product of DBU and acetamide.
Micro-scale and scale-up batches of 21b with 22 were performed and reaction progress
monitored on alumina TLC plates. The reactions were allowed to run for 5 days. The
reaction is observed to progress over 48 hours on alumina plates using 30:70
hexanes/EtOAc. No change in the relative intensity of product is observed between 48
and 120h. The reactants are not completely soluble in toluene at concentrations of ~ 7-30
mM. The reaction seems to produce a greater percent yield when done in dilute fashion.
A ~10% impurity is seen by NMR in some scale-up batches of 21b and 22, but this could
not be removed by extraction or freeze-drying, or separated by TLC. The impurity is not
apparent in the mass spectrum of the crude reaction products. A small portion of the
reaction of 22 with 21b crystallized from ether/hexanes/drop of ammonia. These crystals
were reacted with 17b in DCM. It was later discovered by NMR that the crystals were
again 22. Crude 23b was added to this reaction mixture. TLC indicates that no reaction
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between the succinimide ester and the benzil-protected 2º amine took place after several
hours. The reaction was refluxed overnight, solvents were removed in vacuo, and the
crude residue analyzed by MS. No apparent alkylation product mass was observed.
No conditions were found to afford 23a or 23b without the incomplete alkylation product
present. It was necessary to purify these diamides to remove the partial alkylation
product prior to attempts at reduction.
Purification of diamide 23 by column chromatography:

Purifications of 23a by column chromatography were performed using various solvent
systems and stationary phases. For example, 0.7 g 23a was synthesized and the reaction
was terminated after 3 days’ heating.

Purification was accomplished by silica gel

chromatography (~700 mL 70:30 Et2O / hexanes, then 250 mL Et2O, then ~600 mL 25 :
75 MeOH : Et2O). Approximately 0.1 g purified material was obtained from the column.
Alternatively, 23a was eluted from silica using 80:20 ethyl ether/hexanes followed by
75:25 ethyl ether/MeOH.
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The use of basic alumina as the stationary phase can result in better elution of amines
than use of the silica gel, which is acidic. A column was run on a portion of crude 23b
using a small plug of alumina.

The order of eluents for this column was 50:50

Et2O:hexanes, 90:10 Et2O:hexanes, then 85:15 Et2O:methanol. TLC of the resulting
fractions suggested that an alumina column using 90:10 Et2O:hexanes would resolve the
residue into its respective components, and this chromatography was subsequently
carried out. Mass spectrometric data of the alumina column fractions confirmed that the
reaction is not proceeding to completion, and that the desired product 23 cannot be
separated from 22 on alumina using a mixture of Et2O/hexanes (it co-elutes).
An intermediate-sized batch of the reaction of 21b with 22 was performed. Ammonium
hydroxide was added to the mobile phase to ensure the amines stay de-protonated, which
should lead to narrower resolution bands and more complete elution. A small portion of
the

product

was

run

down

a

micro-scale

column

(silica,

with

100:6:1

chloroform:MeOH:ammonia. Separation of 22 from the product resulted, but mono- and
di-alkylated products co-eluted, and the mono-alkylated was present in much greater
abundance. TLC data suggested that these species could be resolved using 80:20:1
Et2O:hexanes:ammonia on silica. A column was run using this mobile phase. No pure
di-alkylated material was recovered, but mono-alkylated material was obtained from the
column.
To test whether impurities in the protected 10 synthesis were affecting the
chromatography, a quantity of 21b was synthesized and isolated by extraction from
saturated sodium bisulfite solution with DCM. Much of the product is lost in the aqueous
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phase and could not be recovered by freeze drying. The oily residue from the reaction of
this material with 22 was purified by silica gel chromatography (~700 mL 70:30 Et2O /
hexanes, then 250 mL Et2O, then ~600 mL 15:85 MeOH:Et2O). The compound of
interest is not soluble in the mobile phase and was loaded onto the column in THF, which
was then partially evaporated with a stream of air. Some of the crude product is carried
through with the solvent front, likely because of the method of loading.
Reduction of amides from a purified, dialkylated diaminocyclohexane:
Reduction of 23a was done using BH3·THF solution (Scheme 5.13), followed by
MeOH/HCl workup. This reaction is slow – incomplete reduction was still observed
after heating at 60 °C for a week.

Scheme 5.13: Reduction of the amides in 23; PG = benzyl (24a/c) or benzyl (24b/d).

Reaction of 23b with BH3·THF also yielded a mixture of mono- (24d) and di-reduced
products after 1 week. The residue was neutralized and solvents were removed in vacuo.
The product could not be recovered from further attempts at reduction of this material
with BH3·THF.
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A mixture of 24a and 24c was purified by silica gel chromatography (~700 mL 84:14:3
DCM:MeOH:NH4OH, followed by ~100 mL 49:49:3 DCM:MeOH:NH4OH, followed by
a final flush of the column with MeOH). A group of fractions was identified to have a
base peak of m/z 561 ([M+H]+) by MS, indicating the product 24a. These fractions were
combined, solvents removed in vacuo, and crystallization was induced from using slow
diffusion of hexanes into MeOH/trace HCl. The crystalline 24a was dissolved in ethanol
and reacted on the hydrogenator at 60 psi H2 for 3 days in attempt to remove the benzylic
protecting groups (Scheme 5.14).

Scheme 5.14: Removal of benzylic protecting groups in 24a via catalytic hydrogenation

The Pd/C catalyst was filtered off and solvents removed in vacuo. The mass spectrum of
the isolated residue exhibits only one peak at m/z = 220 (positive mode), which does not
correspond to a logical product or fragment. It is possible that the crystals isolated in the
previous step of the synthesis were actually a more weakly ionizing impurity, rather than
the desired above tetramine 24a. A new sample of 24a was prepared and again purified
by column chromatography. A small amount of what appeared to be 19 (a tetraamine) by
NMR was obtained from this reaction by hydrogenation at 60 psi H2. This sample was
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reacted with Cu(II)CO3, but did not form a complex according to the mass spectrometric
data, indicating that this material is not in fact 19.
In summary, 24 cannot be prepared quickly with a high degree of purity and is poorly
resolved from its precursors/byproducts by any chromatographic method tested. The
difficulty of preparing suitable starting materials for a Weisman-type synthesis was not
initially appreciated.

Work on Scheme 5.9 was eventually discontinued as enough

material could not be accumulated for de-benzylation of a laboratory-scale batch of 24.
Synthetic developments by Dr. L. Zhao have led us to shelve the approach based on 21
indefinitely. A 1.0 g scale batch of the butanedione/triethylenetetramine bicyclization
reaction was attempted based on the procedure first published by Boschetti et. al. The
synthetic strategy on which this reaction is based is shown in Scheme 5.15.13

Scheme 5.15: A possible pathway to 8 via glyoxal-type cyclization

Interpretation of the resulting NMR proved difficult, but the product appears to be a
cycloimine rather than the fully formed tricycloamine.

Increasing the reaction
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time/temperature is worth exploring, but there are concerns about stability of the bridged
tetramine reported.
5.2.4 Efforts based on a modified nitro-Mannich reaction
A derivative of the Mannich reaction (modified to replace the enol with an alternate
nucleophile like cyanide or nitroethane) has led to successful cyclization by other
groups,14 and Scheme 5.16 has been reproduced in our lab.

Scheme 5.16: Nitro-Mannich reaction for N-cyclization

Due to the difficulties in reducing 20 and 23, another approach was investigated based on
N-cyclization using paraformaldehyde chemistry.15 A possible alternative pathway to the
sterically cumbersome, benzyl-protected alkylation involved CNR2 addition to an
activated imine (Scheme 5.17).
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Scheme 5.17: A possible pathway to 11 using a modified nitro-Mannich reaction

If an unbranched C-N nucleophile can be added cleanly to a free or protected 10 via with
C-addition, an alternative synthetic pathway to 19 may be available to us. Deprotection
of benzyl amines, reduction of nitriles, and reduction of nitro groups can all be
accomplished by (possibly simultaneous) catalytic hydrogenation.
A number of microscale reactions were performed at room temp. overnight using 21a,
paraformaldehyde, and multiple solvents, catalysts, and nucleophiles – see Table 5.1.
Nitromethane is more difficult to work with, so nitroethane was used in this exploratory
study.
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Acid/base

Solvent

Notes

KCN

HCl (to adj.
to pH 7)

THF/Water

Extracted with ether

KCN

1 drop HCl

THF/Water

KCN

None

THF/Water

KCN

1 drop HCl

THF

KCN

1 drop HCl

THF/Water

EtNO2

1 drop HCl

THF/Water

KCN

None

THF

KCN

None

EtOH

EtNO2

None

THF
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Stirred for 2h before
adding KCN

Added titanium
turnings as lewis acid

Table 5.1: Exploration of Scheme 5.13 using 21a as a starting point.

None of the possible variations of 25 were clearly formed as a result of any of these trials.
Some problems with the above were: paraformaldehyde is not soluble in alcohols or
ethers at room temperature. It is sparingly soluble in water/EtOH at elevated temp. m/z =
393 (ESI MS+, [M+Na]+(?)) was observed in each reaction mixture, but is probably not
the intended product if it is also observed when EtNO2 was the nucleophile (a different
product mass would result). As a result of these trials, it was not possible to isolate the
formylation product of 10 by recrystallization or chromatographic purification, which
could have given us a route to 19. A product band was not observed by TLC if water was
present, but this may not mean that a reaction is not taking place.
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KCN is probably a weak nucleophile by itself (and is not soluble in alcohols or ethers,
either). The reverse reaction is almost certainly taking place – the cyano group would be
a good leaving group under the above conditions. An activated cyano donor (TMSCN or
HCN) and a less sterically hindered electropositive carbon would probably shift the
equilibrium more towards the product. A review of the literature also suggests that a
better Lewis acid may catalyze the reaction (HBr, transition metal salts). Isolating the
imine resulting from reductive amination with a formyl donor may be a workaround for
the reversibility/solubility problems seen above.
5.2.5 Other avenues of approach and future directions
Template-based syntheses of twelve-membered tetraaza rings have been reported.13,16-19
This approach is based on the premise that the coordination of a metal to the O- and/or Natoms in an acyclic precursor leads to “preorganization” of the ligand’s solution structure,
favoring cyclization.

These template-based procedures were adapted in attempt to

synthesize 8. Dihydroimidazole 13 was combined with copper (II)carbonate/copper (II)
hydroxide and trans-1,2-dibromocyclohexane under Argon. No reaction was observed.
A similar synthesis was attempted with triethylenetetramine and iron (III) chloride
hexahydrate. Again, no reaction was observed.
Due to the difficulty in dialkylating 21, attempts were made to alkylate unprotected 10.
Under varying conditions, the full range of available alkylations (1-4) were detected by
MS, with trialkylated predominating. These compounds may be resolvable by column
chromatography.
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Other approaches that were attempted included reaction of 10 with N-tosyl-aziridine
(which polymerized), 10 with glyoxal bisulfite (which failed to form a dimer of 10 akin
to 16), and synthesis of benzylaziridine under Mitsunobu conditions (which failed).
5.3 Conclusions
It is evidently more complicated to synthesize 8 or 9 with optimum yield than was
originally assumed.

In the interest of designing experiments to lead to a logical,

scientifically valuable conclusion within a reasonable amount of time, thesis work
devoted to cyclohexyl fused rings was discontinued. We have decided to move forward
with 2 despite the problem of regioisomerism. There is scientific merit in studying the
properties of each individual isomer which can form from chelation of Ln3+ with 2.
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CHAPTER 6: EXPERIMENTAL SECTION
6.1 General Procedures
6.1.1 Synthesis, purification, and characterization of Ln-2 chelates
For the synthesis of Ln3+ chelates, all glassware was acid-washed (H2SO4) prior to the
introduction of organic chelators in order to remove trace metals. All compounds and
materials for studies of the Eu3+-, Gd3+-, Y3+,- and Yb3+ chelates of α, α', α'', α'''tetramethyl [(S)-2-(4-nitrobenzyl)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetate]
(Ln-S-NB-DOTMA; Ln-2) and their biphenyl conjugates (Ln-S-SSSS-6) were prepared
according to previously described methods.1,2 The HPLC system employed was a Waters
2545 Quaternary Gradient Module with a flow rate of 50 mL min-1 and continuous He
sparge. A Phenomenex Luna C18(2) 250 x 50 mm column was used for all preparative
separations, with a polar phase of 0.037% HCl (w/w), and an organic phase 100%
acetonitrile, with varying gradients as described below. Absorption was monitored at 270
nm (for nitrobenzyl derivatives) or 254 nm (for biphenyl derivatives) using a Waters
2489 UV/Visible detector. All Ln-2 NMR samples were prepared in > 99.9% enriched
D2O and the pD was not adjusted (unless otherwise noted) but found to lie in the region
of 3 – 4 depending upon the concentration of the chelate (each chelate is isolated in its
HEuL(H2O) form by preparative HPLC). 1-Dimensional 1H NMR spectra were recorded
on a Bruker Avance IIa spectrometer operating at 400.13 MHz using a 5 mm broad-band
probe with the temperature controlled using the installed variable-temperature controller
model 2416 with BCU-05 chiller. All spectra were referenced with the HOD at 4.7 ppm.
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Two-Dimensional 1H-1H correlational spectroscopy (COSY) data were acquired on a
Bruker Avance III spectrometer operating at 600.13 MHz.

The temperature was

controlled using the installed variable-temperature controller model 2416 with BCU-05
chiller. A 5 mm broad-band probe was used to acquire 1024 × 1024 points. In cases
where sample was limited (Eu-S-SRRR-2 side isomer and Eu-S-RRRR-2 side isomer), a
1.7 mm microprobe was employed, acquiring 1024 × 1024 points. Coupling constants
were not obtainable from Ln3+ complexes due to the significantly broadened NMR peaks.
6.1.2 Organic syntheses
All reagents were obtained commercially except where otherwise noted. Type I water
(18.2 MOhm·cm) was used in all reactions, workups, and chromatography where
applicable.

Dry solvents were obtained from a solvent still employing adsorption

columns for oxygen and water. Air-free chemistry was performed on a Schlenk line with
Virtis vacuum pump and liquid N2 trap. N2 and argon atmospheres were generated using
gas cylinders with 99.998% purity or greater. Positive pressures were maintained and
monitored using an oil bubbler. Solvent removal in vacuo was accomplished using rotary
evaporation unless otherwise noted. NMR samples were prepared in 0.6 - 1.0 mL
deuterated solvent without pH adjustment in Norad 507HP sample tubes, and spectra
were recorded on a Bruker Avance IIa spectrometer operating at 400.13 MHz using a 5
mm broad-band probe unless otherwise noted. Standard pulse sequences for 1H,
COSY and HSQC analyses were utilized.

13
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6.2 Regioisomeric Ln-2-type chelates
6.2.1 Synthesis and characterization
(R)-methyl 2-(((trifluoromethyl)sulfonyl)oxy)propanoate (R-1)

Methyl D-lactate (0.9 mL, 9.6 mmol) and 2,6-lutidine (1.0 mL, 9.0 mmol) were dissolved
in dichloromethane under inert atmosphere (either N2 or argon). The solution was stirred
and cooled in a dry ice/acetone bath. Trifluoromethanesulfonic anhydride (2.5 mL, 14.4
mmol) was added drop-wise. After one hour, the low-temperature bath was removed,
and the reaction was stirred under inert atmosphere for an additional 2 - 3 hours.
Solvents were then removed in vacuo, affording a brown residue. The salts formed as a
by-product were precipitated from the remaining residue using diethyl ether or hexanes,
and the soluble portion was isolated by decanting. Solvents were again removed in
vacuo, and the title compound was afforded as a colorless liquid. NMR data were
consistent with that previously published:3 1H NMR (400 MHz, CDCl3) δ 5.15 (1H, q,
3

JH-H = 7 Hz, CH), 3.76 (3H, s, OCH3), 1.62 (3H, d, 3JH-H = 7 Hz, CH3CH) ppm.
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(S)-methyl 2-(((trifluoromethyl)sulfonyl)oxy)propanoate (S-1)
The triflate of methyl L-lactate was synthesized following the same protocol as described
for synthesis of R-1 above. NMR data were consistent with that previously published:4 1H
NMR (400 MHz, CDCl3) δ 5.26 (1H, q, 3JH-H = 7 Hz), 3.87 (3H, s), 1.73 (3H, d, 3JH-H = 7
Hz) ppm.
Tetramethyl (1R,4R,7R,10R)-α, α', α'', α'''-tetramethyl (S)-2-(4-nitrobenzyl)1,4,7,10-tetraazacyclododecane-1,4,7,10- tetraacetate (H4[S-RRRR-7)])

Under argon, S-nitrobenzyl cyclen (0.65 mmol, 0.200 g) was added to a suspension of
potassium carbonate (1.43 mmol, 0.197 g) in chloroform and the mixture cooled in a dry
ice/acetone bath. The triflate S-1 (2.86 mmol, 0.674 g) was added drop-wise. The
solution was stirred at -78 ºC for 1 hour, then allowed to warm to room temperature and
stirred for 18 hours. The solution was then heated at 60 ºC for an additional 48 hours.
The reaction mixture was allowed to cool to room temperature and transferred to a
separatory funnel. The organic phase was washed three times with potassium carbonate
solution, pH ~10. The organic extracts were dried (sodium sulfate), and the solvents
were removed in vacuo, affording an oily brown residue (0.153 g, 36% yield). The
residue was taken up in water/acetonitrile, filtered using a 0.2 μm nylon syringe filter,
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and purified by HPLC according to the gradient in Table 6.1. The product was confirmed
by mass spectrometry prior to HPLC purification. HPLC: retention time (RT) = 20.8 min.
m/z (ESMS ESI+): 652.4 (80%, [M+H]+), 566.3 (100%, [tri-ester+H]+). The tri-alkylated
macrocycle was isolated as a by-product (RT = 16.6 min).

Time (min)

% H2O (0.037%
HCl)

% MeCN

0

100

0

5

100

0

10

60

40

35

20

80

36

100

0

41

100

0

Table 6.1: Gradient for the preparative HPLC purification of H4[S-RRRR-7]

Tetramethyl [(1S,4S,7S,10S)-α, α', α'', α'''-tetramethyl (S)-2-(4-nitrobenzyl)1,4,7,10-tetraazacyclododecane-1,4,7,10- tetraacetate] H4(S-SSSS-7)
The triflate R-1 was used to prepare S-SSSS-7 following the same protocol as described
for S-RRRR-7.

The product was purified by HPLC according to the above gradient.

HPLC: RT = 17.8 min. The mass spectrum was obtained prior to HPLC purification; m/z
(ESMS ESI+): 652.4 (20%, [M+H]+).
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(1R,4R,7R,10R)-α, α', α'', α'''-tetramethyl (S)-2-(4-nitrobenzyl)-1,4,7,10tetraazacyclododecane-1,4,7,10- tetraacetate europium(III) complex H[Eu-(SRRRR-2)] corner isomer

A portion of H4[S-RRRR-7] (0.083 g, 0.127 mmol) was dissolved in tetrahydrofuran
(THF, 3 mL) and combined with LiOH solution (3 mL, 5.7 mmol base to neutralize H4L
and 1 equiv. for each arm) with stirring for 24 - 72 hours at 60 - 80 ºC. The product was
not isolated; the ligand solution was allowed to cool to room temp., neutralized with HCl
(pH 7) and used without further purification
Europium (III) chloride hexahydrate (0.023 mg, 0.064 mmol) was added to
approximately one third (1 - 2 mL) of the above S-RRRR-2 solution. The pH was
adjusted to pH 5 - 6 using dilute solutions of HCl or KOH as necessary. The resulting
solution was heated for 48 hours at 60 ºC and the crude product confirmed by mass
spectrometry. The solution was freeze dried, analyzed by 1H NMR, and found to contain
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multiple species. The chelate solution was purified until a single peak remained by
reversed-phase preparative HPLC using a step-wise gradient over a 26 min. run
according to Table 6.2. The HPLC fraction collected was freeze-dried to constant mass.
The title compound was obtained as an off-white amorphous solid. RT = 17.9 min; NMR
data were consistent with that previously published:1 1H NMR (400 MHz, D2O), δ 44.56
(1H), 42.93 (1H), 39.60 (1H), 35.79 (1H), 12.73 (1H), 7.94 (2H), 7.94 (2H), 6.76 (1H),
4.70 (1H), 3.75 (1H), 0.18 (1H), -2.24 (1H), -2.24 (3H), -4.09 (3H), -4.27 (1H), -4.81
(6H), -7.07 (1H), -7.78 (1H), -8.13 (1H), -8.72 (1H), -12.95 (1H), -13.77 (1H), -17.68
(1H), -22.90 (1H), -23.86 (1H), -24.59 (1H) ppm. m/z (ESMS ESI-): 744.2, (100%, [M]-)
with appropriate Eu isotope distribution.
(1S,4R,7R,10R)-α,

α',

α'',

α'''-tetramethyl

(S)-2-(4-nitrobenzyl)-1,4,7,10-

tetraazacyclododecane-1,4,7,10- tetraacetate europium(III) complex H[Eu-(S-SRRR2)] corner isomer
The title compound was prepared according to the method described for Eu-S-RRRR-2
corner isomer. RT = 15 min; 1H NMR (400 MHz, D2O), δ 45.42 (1H), 44.89 (1H), 39.38
(1H), 36.87 (1H), 12.94 (1H), 8.13 (2H), 8.13 (2H), 6.73 (1H), 6.12 (1H) 3.92 (1H),
0.005 (1H), -2.07 (1H), -4.01 (3H), -4.19 (1H), -4.46 (3H), -5.03 (3H), -5.24 (1H), -7.78
(1H), -8.15 (1H), -9.07 (1H), -10.6 (1H), -10.91 (3H), -13.76 (1H), -14.42 (1H), -21.96
(1H), -25.16 (1H), -26.28 (1H) ppm.
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(1R,4R,7R,10R)-α, α', α'', α'''-tetramethyl (S)-2-(4-nitrobenzyl)-1,4,7,10tetraazacyclododecane-1,4,7,10- tetraacetate europium(III) complex H[Eu-(SRRRR-2)] side isomer
The title compound was prepared according to the method described for Eu-S-RRRR-2
corner isomer. RT = 19.1 min; 1H NMR (400 MHz, D2O), δ 48.40 (1H), 41.46 (1H),
38.75 (1H), 36.28 (1H), 13.33 (2H), 11.24 (2H), 9.83 (1H), 4.70 (1H), 2.54 (1H), -0.37
(1H), -0.37 (1H), -2.06 (1H), -3.33 (3H), -3.98 (3H), -4.15 (3H), -4.99 (3H), -5.13 (1H),
-5.72 (1H), -6.55 (1H), -8.40 (1H), -9.42 (1H), -11.66 (1H), -13.12 (1H), -21.67 (1H), 24.76 (1H), -25.93 (1H), -26.53 (1H) ppm.
(1S,4R,7R,10R)-α, α', α'', α'''-tetramethyl (S)-2-(4-nitrobenzyl)-1,4,7,10tetraazacyclododecane-1,4,7,10- tetraacetate europium(III) complex H[Eu-(S-SRRR2)] side isomer
The title compound was prepared according to the method described for Eu-S-RRRR-2
corner isomer. RT = 20.3 min.; 1H NMR (400 MHz, D2O), δ 51.09 (1H), 42.68 (1H),
39.40 (1H), 34.71 (1H), 13.60 (2H), 11.35 (2H), 9.81 (1H), 6.03 (1H), 3.77 (1H), 0.36
(1H), -0.39 (1H), -2.96 (1H), -3.76 (3H), -3.98 (1H), -4.70 (3H), -4.87 (1H), -4.92 (3H),
-7.43 (1H), -7.43 (1H), -9.90 (1H), -10.43 (3H), -11.22 (1H), -12.95 (1H), -15.27 (1H),
-23.39 (1H), -24.88 (1H), -25.79 (1H) ppm.
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Time (min)

% H2O (0.037%
HCl)

% MeCN

0

78

22

3

78

22

18

65

35

20

65

35

20.1

20

80

21

78

22

26

78

22

Table 6.2: Step-wise solvent gradient used during the RP-HPLC purification of Ln-2

(1S,4S,7S,10S)-α,α',α'',α'''-Tetramethyl [(S)-2-(4-nitrobenzyl)]-1,4,7,10tetraazacyclododecane-1,4,7,10-tetraacetic acid europium (III) complex H[(Eu-SSSSS-NB-DOTMA)] H[(Eu-S-SSSS-2)] corner isomer
The title compound was prepared according to the method described for Eu-S-RRRR-2
using europium chloride hexahydrate. The chelate was purified to resolve it from its
regioisomer according to the gradient used for resolution of Eu-S-RRRR-2. RT = 17.6
min; NMR and m/z data were consistent with that previously published:1 1H NMR (400
MHz, D2O), δ 22.55 (1H), 19.84 (1H), 19.50 (1H), 15.58 (1H), 8.40 (1H), 7.89 (2H), 7.65
(2H), 6.73 (1H), 0.85 (1H), 0.29 (3H), 0.15 (1H), -0.74 (1H), -1.72 (3H), -2.04 (3H), 2.20 (1H), -3.28 (3H), -4.56 (1H), -4.73 (1H) ,-5.42 (1H), -5.76 (1H), -6.74 (1H), -6.74
(1H), -6.99 (1H), -10.97 (1H), -11.58 (1H), -11.65 (1H), -12.36 (1H) ppm. m/z (ESMS
ESI-): 744.2 (100%, [M-], appropriate isotopic distribution).
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(1S,4S,7S,10S)-α,α',α'',α'''-Tetramethyl [(S)-2-(4-nitrobenzyl)]-1,4,7,10-

tetraazacyclododecane-1,4,7,10-tetraacetic acid europium (III) complex H[(Eu-SSSSS-NB-DOTMA)] H[(Eu-S-SSSS-2)] side isomer
The title compound was prepared according to the method described for Eu-S-SSSS-2
corner isomer. HPLC: RT = 19.7 min. NMR data were consistent with that previously
published (referred to as Eu-S-RSSS in the reference):1 1H NMR (400 MHz, D2O), δ 28.6
(1H), 23.01 (1H), 18.75 (1H), 18.22 (1H), 10.84 (2H), 9.79 (2H), 8.39 (1H), 4.7 (1H),
0.19 (1H), -0.57 (3H), -1.56 (1H), -1.82 (3H), -1.83 (1H), -2.2 (3H), -2.92 (1H), -3.02
(3H), -5.75 (1H), -6.56 (1H) ,-6.72 (1H), -6.92 (1H), -7.08 (1H), -7.26 (1H), -8.38 (1H), 9.66 (1H), -9.77 (1H), -11.79 (1H), -12.04 (1H) ppm.
(1R,4R,7R,10R)-α,

α',

α'',

α'''-tetramethyl

(S)-2-(4-nitrobenzyl)-1,4,7,10-

tetraazacyclododecane-1,4,7,10- tetraacetate gadolinium (III) complex H[Gd-(SRRRR-2)] corner isomer
Using a portion of the solution of S-RRRR-2 prepared as described above (1 - 2 mL), the
title compound was prepared according to the method described for Eu-S-RRRR-2 using
GdCl3 hydrate (0.024 g, 0.064 mmol), yielding a colorless solid (0.003 g, 10%). The
isomers were identified based on the order of elution of the Eu-S-RRRR-2 and -S-SRRR-2
chelates. RT = 17.1 min. Mass data were consistent with that previously published:1 m/z
(ESMS ESI-): 749.2 (100%, [M-], with appropriate isotope distribution).
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(1S,4R,7R,10R)-α,

α',

α'',

α'''-tetramethyl

(S)-2-(4-nitrobenzyl)-1,4,7,10-

tetraazacyclododecane-1,4,7,10- tetraacetate gadolinium (III) complex H[Gd-(SSRRR-2)] corner isomer
The title compound was prepared according to the method described for Gd-S-RRRR-2
corner isomer, yielding a colorless solid (0.003 g, 10%). RT = 15 min.
(1R,4R,7R,10R)-α, α', α'', α'''-tetramethyl (S)-2-(4-nitrobenzyl)-1,4,7,10tetraazacyclododecane-1,4,7,10- tetraacetate gadolinium (III) complex H[Gd-(SRRRR-2)] side isomer
The title compound was prepared according to the method described for Gd-S-RRRR-2
corner isomer, yielding a colorless solid (0.001 g, 3%). RT = 18.5 min.
(1S,4R,7R,10R)-α, α', α'', α'''-tetramethyl (S)-2-(4-nitrobenzyl)-1,4,7,10tetraazacyclododecane-1,4,7,10- tetraacetate gadolinium (III) complex H[Gd-(SSRRR-2)] side isomer
The title compound was prepared according to the method described for Gd-S-RRRR-2
corner isomer, yielding a colorless solid (0.001 g, 3%). RT = 19.5 min.
(1R,4R,7R,10R)-α, α', α'', α'''-tetramethyl (S)-2-(4-nitrobenzyl)-1,4,7,10tetraazacyclododecane-1,4,7,10- tetraacetate yttrium (III) complex H[Y-(S-RRRR2)] corner isomer
Using a portion of the solution of S-RRRR-2 prepared as described above (1 - 2 mL), the
yttrium chelate was prepared according to the same protocol as for Eu-S-RRRR-2 using
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Y(OTf)3, (0.036 g, 0.067 mmol) yielding a colorless solid (0.010 g, 37%). The product
Y-S-RRRR-2 mass was confirmed. The isomers were identified based on the order of
elution of the Eu-S-RRRR-2 and -S-SRRR-2 chelates. RT = 16.4 min. m/z (ESMS ESI-):
680.2 (100%, [M-], with appropriate isotope distribution).
(1S,4R,7R,10R)-α, α', α'', α'''-tetramethyl (S)-2-(4-nitrobenzyl)-1,4,7,10tetraazacyclododecane-1,4,7,10- tetraacetate yttrium (III) complex H[Y-(S-SRRR-2)]
corner isomer
The title compound was prepared according to the method described for Y-S-RRRR-2
corner isomer, yielding a colorless solid (0.007 g, 26%). RT = 14.9 min.
(1R,4R,7R,10R)-α, α', α'', α'''-tetramethyl (S)-2-(4-nitrobenzyl)-1,4,7,10tetraazacyclododecane-1,4,7,10- tetraacetate yttrium (III) complex H[Y-(S-RRRR2)] side isomer
The title compound was prepared according to the method described for Y-S-RRRR-2
corner isomer, yielding a colorless solid (0.003 g, 11%). RT = 17.3 min.
(1S,4R,7R,10R)-α, α', α'', α'''-tetramethyl (S)-2-(4-nitrobenzyl)-1,4,7,10tetraazacyclododecane-1,4,7,10- tetraacetate yttrium (III) complex H[Y-(S-SRRR-2)]
side isomer
The title compound was prepared according to the method described for Y-S-RRRR-2
corner isomer, yielding a colorless solid (0.003 g, 11%). RT = 19 min.
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(1S,4S,7S,10S)-α,α',α'',α'''-Tetramethyl [(S)-2-(4-nitrobenzyl)]-1,4,7,10-

tetraazacyclododecane-1,4,7,10-tetraacetic acid gadolinium (III) complex H[(Gd-SSSSS-NB-DOTMA)] H[(Gd-S-SSSS-2)] corner isomer
The title complex was prepared according to the method described for Eu-S-RRRR-2
using S-SSSS-7 (0.100 g, 0.153 mmol) gadolinium chloride hexahydrate (0.050 g, 0.128
mmol) yielding a colorless solid (0.013 g, 13%).

The regioisomeric chelates were

purified from one another according to the gradient used for resolution of Eu-S-RRRR-2.
The isomers were identified based on the order of elution of the Eu-S-SSSS-2 and
chelates. RT = 17.6 min. Mass data were consistent with that previously published:1 m/z
(ESMS ESI-): 749.2 (100%, [M-], with appropriate Gd isotopic distribution).
(1S,4S,7S,10S)-α,α',α'',α'''-Tetramethyl [(S)-2-(4-nitrobenzyl)]-1,4,7,10tetraazacyclododecane-1,4,7,10-tetraacetic acid gadolinium (III) complex H[(Gd-SSSSS-NB-DOTMA)] H[(Gd-S-SSSS-2)] side isomer
The title compound was prepared according to the method described for Gd-S-SSSS-2
corner isomer, yielding a colorless solid (0.013 g, 13%). RT = 19.7 min.
6.2.2 Variable concentration and pH conditions for the chelation of Yb3+ with S-RRRR-2
The following stock solutions of Yb3+ and of S-RRRR-2 were prepared in water or buffer:
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Stock

Diluent

Concentration

Ytterbium (III) chloride

1.0 M acetate buffer,

Hexahydrate

pH 5.0

170.3 mM

Hexahydrate

Water

170.3 mM

S-RRRR-2

Water

56.4 mM

Ytterbium (III) chloride

A series of buffer solutions (Table 6.3) were prepared with a concentration of 1.0 M. The
pH of the solutions was adjusted at 60 ºC.
Buffer

pH

bisulfate (K)

3.0

bisulfate / acetate

3.5

acetate (Na)

4.0

acetate (Na)

4.5

acetate (Na)

5.0

MES (hydrate)

5.5

MES (hydrate)

6.0

Table 6.3: where MES = 2-(N-morpholino)ethanesulfonic acid.

Test samples (500 μL) combining ligand and Yb3+ were prepared for incubation; in each
case, the concentration of Yb3+ was twice that of the ligand. For the concentration
dependence study, ligand concentrations of 0.5, 1.0, 2.5, 5.0, 10, 25 and 50 mM in pH 5.0
acetate buffer were tested. For the pH dependence study, the concentration of S-RRRR-2
was 7.1 mM in each of the buffers in Table 5.3. All buffers and stock solutions were
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equilibrated at 60 ºC prior to dispensing. The test samples were incubated at 70 ºC for 64
days.
The chelate solutions were allowed to cool to room temperature and diluted to 50 μM in
1:1 Methanol:Water for LC/MS analysis.

These samples were eluted from a

Phenomenex Luna C18(2) 250 x 2.0 mm column at 375 μL/min with 0.05% Formic acid
and 0 - 80% Acetonitrile over 35 minutes. The entire eluent flowed directly into the
ESMS ESI-MS, which was monitored at 765 m/z in negative ionization mode over the
course of the run. The two largest peaks observed in each chromatogram were integrated
manually and their relative areas were reported. The samples from the concentration
study were combined and resolved by preparative HPLC using the same mobile phase
gradient. The fractions were freeze dried and the resulting solids were analyzed by 1H
NMR to determine which HPLC peak corresponded to which Yb-S-RRRR-2 regioisomer.
NMR and m/z data were consistent with that previously published:5 Corner isomer: RT =
24.34 min; 1Η ΝΜR (400 ΜΗz, D2Ο) δ 144.10, 137.89, 41.37, 41.26, 37.32, 25.12,
23.47, 21.49, 16.84, 13.93, 10.49, 9.46, 9.43, 7.33, 7.31, 3.61, 3.51, -20.60, -22.75, 23.16, -24.38, -24.53, -26.29, -39.82, -43.30, -49.59, -50.75, -69.69 ppm. Side isomer: RT
= 25.68 min; 1Η ΝΜR (400 ΜΗz, D2Ο) δ 145.04, 138.63, 35.78, 33.29, 31.61, 27.39,
25.97, 21.22, 21.07, 20.84, 18.01, 17.11, 12.81, 3.61, 3.53, -20.75, -23.96, -25.19, -30.68,
-37.05, -42.99, -44.68, -56.52, -73.89 ppm.
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6.2.3 Epimerization study of Yb-S-SSS-3
(4S,7S,10S)-α, α', α''-trimethyl (S)-2-(4-nitrobenzyl)-1,4,7,10-tetraazacyclododecane1,4,7,10- tetraacetate ytterbium (III) complex H[(Yb-S-SSS-NB-DO3MA-1A)]
H[(Yb-S-SSS-3)] corner and side isomers

A solution of Yb-S-SSS-3 in D2O (0.5 mL,20 mM) was adjusted to pD ~1 using 35% DCl
solution in D2O. This sample was sealed in an NMR tube and incubated at ~90 ºC using
an oil bath over the course of the study. For a given time point, the sample tube was
removed from the bath and allowed to cool to room temperature, and oil was removed
from the outside of the tube with acetone. 1H NMR scans of the sample were taken at 1
week intervals; later in the study the intervals were 2 - 3 weeks. All scans were recorded
on a Bruker 600 MHz NMR spectrometer with an acquisition time of 0.3 sec, 0 delay
time, and a spectral window of 250 ppm. Line broadening of 50 Hz was used in
processing. After the last time point was obtained, the solution was removed from the
NMR tube and a portion was analyzed to confirm the product as a mixture of isomers. 1Η
ΝΜR (600 ΜΗz, D2Ο) δ 97.46, 96.06, 94.19, 92.06, 90.91, 87.89, 21.50, 18.91, 18.40,
17.23, 16.94, 15.68, 14.85, 14.11, 13.67, 13.26, 11.76, 11.24, 10.96, 8.15, 7.47, 6.82,
6.74, 3.68, 3.41, 3.12, 2.90, 2.79, 1.57, 1.47, 1.29, 1.08, 1.03, 0.08, -0.83, -12.07, -13.08,
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-13.72, -15.79, -16.51, -16.87, -17.59, -21.76, -23.65, -26.51, -27.93, -31.37, -38.23, 41.90, -46.04, -46.58, -56.15, -57.80, -65.03, -68.92, -69.58, -69.94 ppm. m/z (ESMS
ESI-): 751 (100% [M-]).
6.2.4 Modification of S-SSSS-2 to form a bifunctional chelate
(1S,4S,7S,10S)-α, α', α'', α'''-tetramethyl (S)-2-(4-aminobenzyl)-1,4,7,10tetraazacyclododecane-1,4,7,10- tetraacetic acid (S-SSSS-4)

The nitrobenzyl ligand S-SSSS-2 (0.380 g, 0.65 mmol) was added to water
(approximately 50 mL) in a thick-walled 500 mL hydrogenation bottle, affording an
orange suspension.
suspension.

10% weight palladium-on-carbon (76 mg) was added to this

The vessel was attached to a Parr hydrogenator, purged 3 times with

hydrogen, and reacted overnight at 25 psi H2. The catalyst was removed by gravity
filtration yielding a clear orange solution, and solvents were removed by lyophilization,
affording a waxy colorless solid (quantitative yield). 1H NMR (400 MHz, D2O) δ (ppm)
= 7.00 (2H, br s, Ar), 6.71 (2H, br s, Ar), 1.7 - 4.0 (24H, br m, NCH2CH2N, NCHCH3,
benzylic, aryl NH2), 1.09 - 1.23 (12H, overlapping doublets, CH3); 13C NMR (100 MHz,
D2O), δ (ppm) = 16.7, 18.4, 18.6, 20.0 (CH3), 24.9, 25.2, 27.1, 28.4, 29.3, 29.5, 34.0,
57.4, 61.5, 61.6, 68.5, 116.9, 118.0, 121.2, 129.7, 129.9 (Ar), 181.7, 181.8, 182.5, 183.1
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(CO2); Infrared νmax / cm-1 (thin-cast film from water); 3363 (NH/OH), 2958, 2846, 1588
(CO2), 1365, 1254, 1165, 1125, 1030.

m/z (ESMS ESI+): 608.4 (100%, [M+H,

tri(methyl ester)]), 594.4 (20%, [M+H, di(methyl ester]), 622.4 (30%, [M+H,
tetra(methyl ester)]), and 644.4 (<5%, [M+Na, tetra(methyl ester)]). The tetraacid is not
believed to ionize appreciably in the mass spectrum. The product was hydrolyzed further
(to remove remaining esters), then taken directly to the next synthetic step.
(1S,4S,7S,10S)-α, α', α'', α'''-tetramethyl (S)-2-(4-isothiocyanatobenzyl)-1,4,7,10tetraazacyclododecane-1,4,7,10- tetraacetic acid (S-SSSS-5)

The aminobenzyl ligand S-SSSS-4 was taken up in water (approximately 20 mL) and the
pH adjusted to 2 using dilute HCl. In a round-bottom flask, chloroform (30 mL) was
added to the aqueous solution of ligand. Thiophosgene (0.270 g, 2.36 mmol) was added
to the biphasic mixture while stirring vigorously. The mixture was stirred for 18 h then
the layers were transferred to a separatory funnel and allowed to separate. The organic
layer was removed and the aqueous layer was washed twice with chloroform and then
freeze-dried, yielding a waxy colorless solid (0.286 g, 68%). 1H NMR (400 MHz, D2O)
δ (ppm) = 7.24 (4H, m, Ar), 3.4 - 4.4 (34H, br m), 1.09 - 1.40 (12H, overlapping
doublets, CH3); 13C NMR (100 MHz, D2O), δ (ppm) = 16.9, 18.0, 19.3, 21.6 (CH3), 25-
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33 multiple peaks, 57.5, 58.7, 59.9, 61.1, 61.6, 66.4, 114.9, 118.0, 121.2, 124.3, 126.4,
130.5 (Ar), 139.3 (SCN) 161.3, 165.7, 177.0, 178.5 (CO2); m/z (ESMS ESI+): 608.4
(25%, [M+H]), 622.3 (37%, [M+H mono(methyl)ester]), 636.3 (85%, [M+H, di(methyl
ester)]), 650.3 (100%, [M+H, tri(methyl ester)]), 664.3 (37%, [M+H, tetra(methyl
ester)]). Infrared νmax / cm-1 (thin-cast film from water); 3393 (NH/OH), 2953, 2103
(SCN), 1717 (carbonyl), 1635, 1457, 1249, 1165, 1124, 1030.
(1S,4S,7S,10S)-α, α', α'', α'''-tetramethyl ((S)-2-(4-(3-([1,1'-biphenyl]-4ylmethyl)thioureido)benzyl)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetate
gadolinium (III) complex H[(Gd-S-SSSS-6)] corner isomer

The isothiocyanate S-SSSS-5 was dissolved in water and the pH was adjusted to 8 using
1M NaOH and dilute HCl, for a final volume of approximately 35 mL. The solution was
stirred at room temperature. A separate solution of 4-phenylbenzylamine (0.121 g, 0.661
mmol) in dioxane (15 mL) was added to the solution of isothiocyanate. After 6 hours, the
pH was confirmed to be between 8 and 9. After 18 hours, 5 equivalents of GdCl3·6H2O
(0.878 g, 2.36 mmol) were added to the reaction, which turned cloudy. The pH was held
constant at 6 for 6 days. Solvents were then removed in vacuo, and the residue was

207

CHAPTER 6: Experimental

freeze-dried, affording a yellow-orange residue. The crude residue was dissolved in
THF/water/MeCN, filtered, and purified by preparative HPLC according to the gradient
in Table 6.4. The HPLC fraction was freeze-dried to constant mass, again affording a
yellow-orange residue. The product mass was confirmed prior to HPLC purification: RT
= 37.7 minutes.

m/z (ESMS ESI-): 299.8 (90%, unidentified), 301.8 (100%,

unidentified), 944.3 (50%, [(M-H)-], with appropriate Gd isotope distribution), 994.3
(25%, [(M(trimethylester)-H)-], with appropriate Gd isotope distribution).
The sample of Gd-S-SSSS-6 isolated via HPLC purification above was then resolved from
its regioisomer using the following gradient (Table 6.5). Purification was repeated until a
single peak remained in the HPLC trace, affording a colorless solid (< 1 mg). The
regiochemistry was determined by synthesizing the Eu analogues. The mass spectrum
was acquired after purification. RT = 27.4 min. m/z (ESMS ESI-): 944.3 (100%, [(M-H)-]
with appropriate isotope distribution).
Time (min)

% H2O (0.037% HCl)

% MeCN

0

100

0

5

100

0

40

20

80

40.1

100

0

45

100

0

Table 6.4: Step-wise solvent gradient used during the RP-HPLC purification of crude
Gd-S-SSSS-6
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Time (min)

% H2O (0.037% HCl)

% MeCN

0

63

37

3

63

37

23

53.5

46.5

30

53.5

46.5

30.5

20

80

31.1

63

37

35

63

37

Table 6.5: Step-wise solvent gradient used to resolve corner and side isomers of Gd-SSSSS-6

(1S,4S,7S,10S)-α, α', α'', α'''-tetramethyl ((S)-2-(4-(3-([1,1'-biphenyl]-4ylmethyl)thioureido)benzyl)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetate
gadolinium (III) complex H[(Gd-S-SSSS-6)] side isomer
The title complex was synthesized following the same protocol as for Gd-S-SSSS-6,
corner isomer, affording a colorless solid (< 1 mg). HPLC: RT = 28.6 min.
(1S,4S,7S,10S)-α, α', α'', α'''-tetramethyl ((S)-2-(4-(3-([1,1'-biphenyl]-4ylmethyl)thioureido)benzyl)-1,4,7,10-tetraazacyclododecane-1,4,7,10- tetraacetate
europium (III) complex H[(Eu-S-SSSS-6)] corner isomer
The title complex was synthesized using EuCl3•6H2O (0.200 g, 0.546 mmol) following
the same protocol as for Gd-S-SSSS-6, affording a colorless solid (< 1 mg). The title
complex was purified according to the gradient in Table 5.5 until a single peak remained.
1

H NMR spectra were recorded at 298.15 K on a Bruker Avance III spectrometer

operating at 600.13 MHz. A 1.7 mm microprobe was employed, acquiring 1024 × 1024
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points. The axS peak patterns were matched to those of Eu-S-SSSS-2 corner isomer,
previously identified by COSY. HPLC: RT = 27.0 min. m/z (ESMS ESI-): 939.2 ([M-],
with appropriate Eu isotope distribution).
(1S,4S,7S,10S)-α, α', α'', α'''-tetramethyl ((S)-2-(4-(3-([1,1'-biphenyl]-4ylmethyl)thioureido)benzyl)-1,4,7,10-tetraazacyclododecane-1,4,7,10- tetraacetate
europium (III) complex H[(Eu-S-SSSS-6)] side isomer
The title complex was synthesized following the same protocol as for Eu-S-SSSS-6 corner
isomer, affording a colorless solid (< 1 mg). The axS peak patterns were matched to
those of Eu-S-SSSS-2 side isomer, previously identified by COSY. HPLC: RT = 28.4
min.
6.3 Variable-temperature NMR analysis
6.3.1 Synthesis
((1,4,7,10-tetraazacyclododecane-1,4,7,10tetrayl)tetrakis(methylene))tetraphosphonic
(Eu[DOTP]5-)

acid

europium

(III)

complex
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Europium (III) chloride hexahydrate (0.032 g, 0.089 mmol) was dissolved in water (242
μL). To this was added an equal volume of sodium hydroxide solution (1.94 M) while
stirring until a white precipitate was observed. This slurry was diluted with water (3.85
mL) and the Eu(OH)3 which formed was allowed to settle out overnight. The supernatant
was removed, and the slurry was washed three times with water (3.85 mL) each. The
combined supernatant was removed.
H8DOTP (48 mg, 0.0875 mmol) was suspended in water (1.9 mL). To this was added
sodium hydroxide solution (49 μL, 9 M), producing a clear solution. The Eu(OH)3 slurry
was added in small portions to the DOTP solution under constant stirring over 20 hours.
After the DOTP solution had gone clear, any remaining Eu(OH)3 was transferred to the
DOTP solution using water (50 μL). To this was added additional DOTP (2 mg). The
pH was measured to be between 7 and 8. The reaction mixture was then heated under a
stream of Argon overnight, allowed to cool to room temp., and pH again measured at 7 8. The solution was freeze dried, affording the product as a colorless solid. NMR data
were consistent with that previously published:6 1H NMR: (400 MHz, D2O, 25 °C) δ
(ppm) = 29.7, 4.70 (HOD), 3.24 (free ligand, PCH2N), 3.00 (free ligand, NCH2CH2N), 0.90, -5.23, -5.42, -9.66, -15.62.
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((1,4,7,10-tetraazacyclododecane-1,4,7,10tetrayl)tetrakis(methylene))tetraphosphonic

acid

ytterbium

(III)

complex

(Yb[DOTP]5-)
The title complex was synthesized following the same protocol as for Eu-DOTP.
Ytterbium (III) chloride (0.034 g, 0.088 mmol) was used in place of Europium (III)
chloride, affording the product as a colorless solid. NMR data were consistent with that
previously published:7 1H NMR: (400 MHz, D2O) δ (ppm) = 90.2, 18.0, 13.5, 4.71
(HOD), -24.3, -29.8, -61.4.
6.3.2 Variable-temperature NMR studies:
Samples of each isomer of Eu- and Yb-2 were prepared in NMR tubes. NMR solutions
of Yb- and Eu[DOTP]5- were prepared and the pD adjusted to ~11 using KOD. The
concentrations were not measured but kept uniform for all NMR analyses of the same
chelate. The sample tube was adjusted to the target temperature (with a temperature
change gradient no steeper than 3 K per minute) in the probe and allowed to equilibrate
for 1-20 minutes once the probe temperature and target temperature had become
identical. The length of this additional equilibration time did not affect the spectra.
Spectra were acquired in 5 degree increments from 278.15 - 313.15 K. Acquisition
parameters were adjusted as the temperature was increased to account for the change in
magnetic properties with changing temperature: the acquisition time varied from 0.210.23 s (0.32 s for Yb[DOTP]); the relaxation delay varied from 0.5-1.4 s; and the number
of scans varied from 64 to 256. All spectra were referenced with the HOD peak at 4.7
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ppm. Spectral assignments were made on the basis of COSY NMR spectra recorded for
each chelate at 278.15 and 313.15 K.
6.4 Synthesis of precursors to a fused-ring macrocycle
N,N'-((1R,2R)-cyclohexane-1,2-diyl)bis(4-methylbenzenesulfonamide) disodium salt
(11)8

(1R,2R)-1,2-diaminocyclohexane (0.78 g, 6.84 mmol) was dissolved in acetonitrile (100
mL) and potassium carbonate (1.46 g, 10.6 mmol) was added, producing a suspension
which was heated to 70 °C while stirring. p-Toluenesulfonyl chloride (2.875 g, 15.1
mmol) was added to this suspension in small increments over a period of 30-60 min. The
reaction was heated at 70 °C for 18 h, then allowed to cool to room temperature. The
solvents were removed in vacuo, affording an off-white residue.

The residue was

extracted into dichloromethane under basic conditions (potassium carbonate solution).
Crystals were formed by slow evaporation at -20 °C, and were filtered and recrystallized
from MeOH/H2O, affording a colorless solid. NMR was taken at this stage. The ditosylamide (1.0 g, 2.36 mmol) was dissolved in 21% sodium ethoxide in dry ethanol
(1.53 g, 4.72 mmol) and diluted with dry methanol (50 mL). This solution was heated at
reflux for 1 h, then allowed to cool to room temperature. Solvents were removed in
vacuo first by rotary evaporation and then on a Schlenk line. The residue was used
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without purification in attempts to cyclize with 15b, but a successful procedure was not
found. 1H NMR (400 MHz, CDCl3): δ 7.68 (4H, d, 3JH-H = 8 Hz, Ar), 7.24 (4H, d, 3JH-H =
8 Hz, Ar), 4.83 (2H, d, 3JH-H = 6 Hz, NH), 2.67 (2H, m, CHNHTs), 2.36 (6H, s, tolyl),
1.77 (2H, d, cyclohexyl), 1.48 (2H, d, cyclohexyl), 1.03 (4H, m, cyclohexyl) ppm.

13

C

NMR (CDCl3): δ (ppm) 143.6 (Ar), 137.1 (Ar), 129.8 (Ar), 127.3 (Ar), 56.6 (CHNHTs),
33.4, 24.3, 21.6.
(Ethane-1,2-diylbis(azanediyl))bis(ethane-2,1-diyl)

bis(4-methylbenzenesulfonate)8

(12a)

2,2'-(Ethane-1,2-diylbis(azanediyl))diethanol (5.00 g, 33.7 mmol) was dissolved in
acetonitrile (200 mL) and heated to 70 °C while stirring. Potassium carbonate (4.89 g,
35.4 mmol) was added, resulting in a white suspension. p-Toluenesulfonyl chloride
(12.85 g, 67.4 mmol) was added to this suspension in small increments over a period of
30-60 min. The reaction was heated at 70 °C for 18 h, then allowed to cool to room
temp. Solvents were removed in vacuo and the residue taken up in potassium carbonate
solution and extracted into dichloromethane). Crystals were formed by slow evaporation
at -20 °C, and were filtered and recrystallized from MeOH/H2O.

1

H NMR (400 MHz,

CDCl3): δ (ppm) 7.71 (4H, d, 3JH-H = 8 Hz, aryl), 7.33 (4H, d, 3JH-H = 8 Hz, aryl), 4.80
(4H, s, TsNCH2CH2NTS), 3.81 (4H, t, 3JH-H = 5 Hz, CH2OH), 3.25 (4H, t, 3JH-H = 5 Hz,
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OCH2CH2NTs), 2.44 (6H, s, tolyl). 13C NMR (100 MHz, CDCl3): δ (ppm) 143.9, 134.9,
129.9, 127.4, 61.0, 53.1, 50.3, 21.5.
(Ethane-1,2-diylbis(azanediyl))bis(ethane-2,1-diyl)

bis(trifluoromethanesulfonate)9

(12b)
A 2-necked round-bottomed flask with stir bar was purged with argon. To this flask was
added 75 mL dry dichloromethane by cannulation. 12a (0.5 g, 1.1 mmol) was added
under argon. 2,6-lutidine (0.255 mL, 2.2 mmol) was next added via syringe and the
mixture was stirred at -78 °C. Trifluoromethanesulfonic anhydride (0.37 mL, 2.2 mmol)
was then added drop-wise via syringe, and the reaction mixture was stirred at -78 °C for
one hour. The solution was then allowed to warm to room temperature, followed by
stirring at room temperature for 3 h. Solvents were removed in vacuo, and the residue
taken up in ethyl ether. The insoluble portion was removed using a separatory funnel and
the ether solution was evaporated in vacuo, affording the title compound as a colorless
solid (0.864 g, 55%). 1H NMR (400 MHz, CDCl3): δ (ppm) 8.24 (4H, overlapping
doublets, 3JH-H = 8 Hz, aryl), 7.57 (4H, overlapping doublets, 3JH-H = 8 Hz, aryl), 4.68
(4H, t, 3JH-H = 5 Hz, CH2OTf), 3.51 (4H, t, 3JH-H = 5 Hz, OCH2CH2NTs), 3.37 (4H, s,
TsNCH2CH2NTS), 2.46 (6H, s, tolyl).

13

C NMR (100 MHz, CDCl3): δ (ppm) 154.0,

145.9, 144.6, 134.3, 130.2, 127.4, 124.9, 75.2, 50.3, 49.8, 21.6, 19.6.
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1-[2-(4,5-dihydroimidazol-1-yl)ethyl]-4,5-dihydroimidazole (13)

Triethylene tetramine (2.0 g, 13.6 mmol) was combined with N,N-dimethylformamide
dimethyl acetal (3.46 g, 27.2 mmol) in an N2-purged, 2-necked round-bottom flask fitted
with screw tap. Under N2, the mixture was heated to reflux and magnetically stirred for
approximately 40 minutes.

The product was dried in vacuo using a Schlenk line,

affording a colorless solid. These solids were recrystallized from dry THF and isolated
by filtration under nitrogen to afford the title compound as a colorless solid (1.5 g, 66%).
NMR data were consistent with that previously published:10 1H NMR (400 MHz, CDCl3)
δ 6.7 (2H, s, N=CHN), 3.8 (4H, t, NCH2CH2N), 3.2 - 3.3 (8H, 4 overlapping signals,
C=NCH2CH2N) ppm;

13

C NMR (100 MHz, CDCl3) δ 157.3 (CH), 55.0 (CH2), 48.6

(CH2), 46.6 (CH2) ppm.
Trans-[2-(trifluoromethylsulfonyloxy)cyclohexyl] trifluoromethanesulfonate (14b)

A 2-necked round-bottom flask fitted with screw tap was charged with trans-1,2cyclohexanediol 14a (0.5 g, 4.3 mmol) and purged with N2. Dry dichloromethane and
2,6-lutidine (0.92 g, 8.6 mmol) were added to the reaction flask by cannulation. The

216

CHAPTER 6: Experimental

mixture was cooled in a dry-ice/acetone bath, and triflic anhydride (2.43 g, 8.6 mmol)
was added dropwise, under N2. The reaction was stirred magnetically at approximately
-78 ºC for one hour, then allowed to warm to room temperature and stirred an additional
3 hours. Solvents were removed in vacuo, and the residue taken up in ethyl ether. The
insoluble portion was removed using a separatory funnel and the ether solution was
evaporated in vacuo, affording the title compound as an off-white solid (5.5 g, 76%).
NMR data were consistent with that previously published:11 1H NMR (400 MHz, CDCl3)
δ 4.87 (2H, td, CHOTf), 2.41 (2H, m, cyclohexyl), 1.7 - 1.9 (4H, overlapping signals,
cyclohexyl), 1.43 (2H, m, cyclohexyl) ppm;

13

C NMR (100 MHz, CDCl3) δ 118.3 (q,

CF3, 2JC-F = 319 Hz), 86.0, 31.3, 22.1 ppm.
Trans-(1,2)-cyclohexane-1,2-diyl dimethanesulfonate (14c)

Triethylamine (2.61 g, 25.8 mmol) was added to a solution of trans-1,2-cyclohexanediol
14a (43 mL, 0.2 M) in dichloromethane, which was then cooled in an ice water/methanol
bath. Methanesulfonyl chloride (2.27 g, 19.8 mmol) was added to this solution over 5 10 minutes. The reaction was stirred an additional 10 - 15 minutes then was transferred
in one portion to a separatory funnel. The organic layer was washed with cold water,
cold 10% HCl, saturated sodium bicarbonate and saturated NaCl solutions. The organic
extracts were dried (sodium sulfate), and the solvents were removed in vacuo to afford
the title compound. 1H NMR (400 MHz, CDCl3) δ 4.58 (2H, m, CHOMs), 3.09 (6H, s,
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SO3CH3), 2.30 (2H, m, cyclohexyl), 1.60 - 1.84 (4H, overlapping signals, cyclohexyl),
1.38 (2H, m, cyclohexyl) ppm;

13

C NMR (100 MHz, CDCl3) δ 80.6, 39.0, 31.7, 23.1

ppm.
(trans-3,7)-3a,4,5,6,7,7a-hexahydro-1H-benzo[d]imidazole (15)

10 (1.902 g, 16.7 mmol) was combined with N,N-dimethylformamide dimethyl acetal
(2.0 g, 16.8 mmol) in an N2-purged, 2-necked round-bottom flask fitted with screw tap.
Under N2, the mixture was heated to reflux and magnetically stirred for approximately 40
minutes. The product was dried in vacuo using a Schlenk line, leaving an oily residue.
Recrystallization from dry THF was attempted, but the NMR spectrum indicates a
product which is still impure. 1H NMR (400 MHz, CDCl3) δ 7.33 (1H, s, NH), 7.17 (1H,
s, imine CH), 2.76 (1H, m, CHN=C), 2.44 (1H, t, CHNH), 1.87 - 1.05 (8H, overlapping
signals, cyclohexyl) ppm; 13C NMR (100 MHz, CDCl3) δ 155 (CH), 55.0 (CH), 37 (CH),
35 (4 peaks, CH2 in conformational exchange), 25 ppm (4 peaks, CH2 in conformational
exchange).
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Benzyl-N-[2-[[(1R,2R)-2-[(2benzyloxycarbonylaminoacetyl)amino]cyclohexyl]amino]-2-oxo-ethyl]carbamate
(18b)

Z-Gly-OSu (0.613 g, 2.0 mmol) and R,R-10 (0.114 g, 1.0 mmol) were dissolved in
dichloromethane and stirred at ambient temperature for 18 h. The reaction mixture was
transferred to a separatory funnel and extracted twice with an aqueous solution of
potassium carbonate (pH 11 - 12) and once with a dilute acetic acid solution (pH 3). The
organic extracts were dried (sodium sulfate), and the solvents removed in vacuo, yielding
a colorless solid (99% yield). 1H NMR (400 MHz, CDCl3) δ (ppm) 7.24 (10H, m, aryl),
6.42 (2H, br d, 3JH-H = 5 Hz, NH), 5.68 (2H, br s, NH), 5.02 (4H, overlapping triplets, 2JHH

= 12 Hz, PhCH2COON), 3.70 (4H, qd, 2JH-H = 31 Hz, 3JH-H = 6 Hz, NCOCH2N), 3.63

(2H, m, cyclohexyl CHNH), 1.89 (2H, br d, J = 9 Hz, cyclohexyl), 1.68 (2H, br d, J = 6
Hz), 1.2 (4H, m, cyclohexyl).
2-amino-N-[(1R,2R)-2-[(2-aminoacetyl)amino]cyclohexyl]acetamide (20)
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Compound 18b (2.7 g, 0.4 mmol) was added to a 500 mL hydrogenation bottle and
dissolved in a minimal volume of methanol or ethanol by gentle heating. The solution
was cooled and Palladium-on-carbon (10% w/w) (0.20 g, 2 x 10-4 mmol) added carefully.
The reaction vessel was stoppered and clamped into position on a Parr hydrogenator, and
purged and refilled with 50 Psi H2. The reaction was agitated for 3 days. The reaction
mixture was filtered, and solvents were removed from the filtrate in vacuo, affording the
title compound as a yellow oil (0.96 g, 77%). 1H NMR (400 MHz, CDCl3) δ (ppm) 7.31
(2H, br s, amide NH), 3.63 (2H, m, cyclohexyl CHNH), 3.2 (4H, br s, NCOCH2N), 1.92
(2H, br d, J = 9 Hz, cyclohexyl), 1.70 - 1.68 overlapping (8H, br s, amine and
cyclohexyl), 1.2 (4H, m, cyclohexyl).
N,N’-dibenzyl-trans-1,2-diaminocyclohexane (21a)

NH2
NH2

1. Benzaldehyde, MeOH (dry)
2. NaBH4, MeOH/MeCN (dry)

NH
NH

10

21a

Benzaldehyde (0.2 mL; 2.0 mmol) was added drop-wise to a stirred solution of 10 (0.12
mL, 1.0 mmol) in dry methanol. The reaction was stirred at room temperature for 2
hours. The solvents were removed in vacuo, affording a white precipitate. The solid was
dissolved in dry methanol/acetonitrile (1:1) and sodium borohydride (1.0 g, 26 mmol)
added in tablet form. The solution was stirred at room temperature for 4 hours. Solvents
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were removed in vacuo to afford the product as a colorless solid. NMR data were
consistent with that previously published:12 1H NMR (400 MHz, CDCl3) δ (ppm) 7.31
(10H, m, aromatic), 3.85/3.61 (4H, a aa' doublets, benzylic), 2.22 (4H, m, cyclohexyl),
1.76 (2H, m, cyclohexyl), 1.17 (4H, m, cyclohexyl).
2,3-diphenyl-1,2,3,4,4a,5,6,7,8,8a-decahydroquinoxaline (21b)

Benzil (0.94 g, 4.4 mmol) was added to a stirred solution of 10 (0.53 mL, 4.4 mmol) in
dry methanol. The reaction was heated to reflux and stirred for 7 hours. The reaction
was allowed to cool to room temperature, and the solvents were removed in vacuo. The
residue was heated in a minimum volume of methanol, affording a colorless solid which
was isolated by filtration. Following dissolution of this solid in dry methanol, sodium
borohydride (0.5 g, 12.7 mmol) was added in tablet form. The solution was heated to 40
°C for 18 h. The reaction was quenched with water and the solvents removed in vacuo to
afford the product as a yellow solid. NMR data were consistent with that previously
published:13 1H NMR (400 MHz, CDCl3) δ (ppm) 7.12 (10H, m, aromatic), 3.86 (2H, s,
benzylic), 2.64 (2H, m, cyclohexyl), 1.3 - 1.9 (8H, m, cyclohexyl). 13C δ = 141 (Ar), 128
(Ar), 127 (Ar), 68 (NCH-Ar), 61 (NCH-cyclohexyl), 32 (CH2CHN), 25 (CH2CH2CHN)
ppm. m/z (ESMS ESI-) 293 ([M-H]-)
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N-benzyl-bromoacetamide (22)

A stirred solution of benzylamine (1.07 g, 10.0 mmol) in dichloromethane was cooled in
an ice bath. Potassium carbonate (0.69 g, 5.0 mmol) was added, resulting in a white
suspension. Bromoacetyl bromide (2.02 g, 10.0 mmol) was added drop-wise using an
addition funnel. After 1 hour, the ice bath was removed, and the reaction was stirred for
18 h at room temperature. The reaction mixture was added to a separatory funnel and
washed three times with water, ensuring that the pH was moderately acidic (pH~3 - 5).
The organic extracts were dried (sodium sulfate), and the solvents were removed in
vacuo. The crude product was recrystallized at -20 °C via slow diffusion of hexanes into
methanolic solution. Crystals were isolated by vacuum filtration, affording the title
compound as an off-white solid (yield = 1.15g, 50%). NMR data were consistent with
that previously published:14 1H NMR (400 MHz, CDCl3) δ (ppm) 7.26 (5H, m, aryl), 6.68
(1H, br s, NH), 4.42 (2H, d, 2JH-H = 6 Hz, benzylic), 3.88 (2H, s, BrCH2CON).
2,2'-(trans-cyclohexane-1,2-diylbis(benzylazanediyl))bis(N-benzylacetamide) (23a)
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21a (0.2 g, 0.69 mmol) added to a solution of N,N-diisopropylethylamine (Hünig’s base)
(0.48 mL, 2.76 mmol) in toluene (125 mL), and the resulting suspension heated to 75 ºC.
Approximately 1 mL DI water was added to the mixture to dissolve the 21a. The
bromoacetamide 22 (0.64 g, 2.76 mmol) was added to the hot solution as a solid in one
portion. The temperature was increased to 105 ºC and heating and stirring continued for
7 days. Reaction progress was monitored after three days by mass spectrometry. The
reaction was then allowed to cool and the solvents were removed in vacuo. The residue
taken up in ethyl ether and the resulting cloudy solution washed with saturated sodium
sulfite solution. The product was extracted three times from the ether phase. The organic
extracts were dried (sodium sulfate), and the solvents were removed in vacuo. The
colorless solid residue was purified by column chromatography (silica gel, 80:20 ethyl
ether/hexanes followed by 75:25 ethyl ether/MeOH), affording the title compound as a
colorless solid (0.32 g, 79%). Rf = 0.43 (75:25 ethyl ether/MeOH, SiO2). m/z (ESMS
ESI+) 589.3 (100%, [M+H]), 532.3 (45%, possible reduction of cyclohexyl group to
yield an ethenyl amine bridge)). 1H NMR (CDCl3) δ (ppm) 7.45 (2H, br t, NH), 7.30 6.97 (20H, m, aryl), 4.46 and 4.24 (4H, a aa' dd, 2JH-H = 15 Hz, 3JN-H = 6 Hz,
CONHCH2Ph), 3.43 and 3.26 (4H, a aa' d, 2JH-H = 12 Hz, NCH2CON), 2.82 and 2.62 (4H,
a aa' d, 2JH-H = 16 Hz, NCH2Ph), 2.29 (1H, d, 3JH-H = 9 Hz, cyclohexyl CHN), 1.92 (1H,
d, 3JH-H = 11 Hz, cyclohexyl CHN), 1.69 (1H, s, cyclohexyl), 1.61 (1H, d, 3JH-H = 9 Hz,
cyclohexyl), 1.18 (1H, q, 3JH-H = 6 Hz, cyclohexyl), 0.90 (1H, t, 3JH-H = 10 Hz,
cyclohexyl), 0.75 (1H, m, cyclohexyl)
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2,3-(2,3-diphenyl-1,2,3,4,4a,5,6,7,8,8a-decahydroquinoxaline)bis(Nbenzylacetamide) (23b)

A 2-necked round-bottom flask with stir bar containing toluene (100 mL) was purged
with argon. 21b (0.112 g, 0.38 mmol) and Hunig’s base (0.098 g, 0.76 mmol) were
added to the flask at room temperature and allowed to dissolve fully. Bromoacetamide
22 (0.349 g, 1.5 mmol) was then added to the mixture in one portion. The temperature
was slowly increased to 100 °C, adding additional Hunig’s base (0.095 g, 0.74 mmol) in
small portions. The reaction progress was monitored by TLC (9:1 ethyl ether:hexanes on
alumina) over 5 days. The reaction was then removed from the heat, allowed to cool, and
decanted. The yellow supernatant was concentrated in vacuo. The crude residue was
purified by column chromatography (basic alumina, 9:1 ethyl ether:hexanes), affording
the title compound as a yellow oil. Rf = 0.45 (9:1 ethyl ether:hexanes, Al2O3). 1Η ΝΜR
(400 ΜΗz, CDCl3) δ 7.38 (4H, ddd, m-Ar), 7.36 (4H, d, o-Ar), 7.33 (4H, ddd, m-Ar),
7.20 (4H, d, o-Ar), 7.04 (2H, dd, p-Ar), 6.97 (2H, dd, p-Ar), 6.84 (2H, br s, NH), 4.55
(1H, dd, PhCH2NHCO), 4.51 (2H, d, COCH2N), 4.25 (1H, dd, PhCH2NHCO), 4.15 (1H,
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s, COCH2N), 3.58 (1H, s, COCH2N), 3.17 (1H, d, NCHPh), 2.85 (1H, d, NCHPh), 2.40
(1H, d, CH2CHN), 1.91 (1H, d, CH2CHN), 1.73 (2H, m, cyclohexyl), 1.4 - 1.22 (6H, m,
cyclohexyl) ppm. m/z (ESMS ESI+): 587.3 [(M+H)+]
N1,N1'-(trans-(1,2)-cyclohexane-1,2-diyl)bis(N1,N2-dibenzylethane-1,2-diamine) (24a)

A 2-necked flask containing diamide 23a (0.639 g, 1.1 mmol) and a magnetic stir bar was
evacuated and purged with argon three times. Dry THF (100 mL) was added to the flask
containing 23a, and the mixture was cooled in an ice bath. Ice-cold BH3·THF (30 mL,
1M) was added to the 23a solution via cannulation. The Suba-seal plugging the flask was
replaced with an air condenser under positive pressure of argon. The solution was
allowed to warm to room temperature over 30 minutes, stirred for 1 hour, then heated at
40 °C for 3 days. A portion was removed and quenched with MeOH, then analyzed by
mass spectrometry. The reduction was found to be incomplete. The reaction was heated
at 60 °C for another 5 days, then allowed to come to room temperature. The reaction was
cooled in an ice bath, and methanol was added drop-wise to quench any remaining
borane. Solvents were removed in vacuo. Two additional portions of methanol were
added followed by removal in vacuo each time.

The residue was dissolved in

hydrochloric acid (30 mL, 2N) and heated to boiling for 18 h. The solution was allowed
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to come to room temperature, then solvents were removed in vacuo. The greenish
residue

was

purified

by

column

chromatography

(silica

gel,

84:14:3

DCM:MeOH:NH4OH), affording the title compound as a brownish oil (0.2 g, 32%). Rf =
0.66 (84:14:3 DCM:MeOH:NH4OH, SiO2). m/z (ESMS ESI+): 561.3 (100%, [M+H]+),
428.4 (50%, [M-EtNHCH2Ph]+).
2,3-(2,3-diphenyl-1,2,3,4,4a,5,6,7,8,8a-decahydroquinoxaline)bis(dibenzylethanamine) (24b)

The title compound was synthesized in crude form from 23b (0.75 g, 1.28 mmol)
following the same protocol as described for 24a, affording the title compound as a
colorless gel. Column chromatography was not performed. 1H NMR (400 MHz, CDCl3)
δ 7.2 (20H, m, aryl), 3.6 - 2.2 (16H, br m, NCH2CH2N, NCHPh, cyclohexyl CHN,
benzylic), 1.5 - 0.8 (8H, br m, cyclohexyl) ppm.
(1S,2S)-N1,N2-dimethylenecyclohexane-1,2-diamine (27)
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Trans-10 (0.2 g, 1.75 mmol) was dissolved in THF with stirring. To this was added
paraformaldehyde in solid form (0.126 g, 4.2 mmol). The temperature was increased to
60 ºC. Water was added drop-wise until the paraformaldehyde dissolved. The reaction
was heated for 1 hour, allowed to cool to room temp., and stirred an additional 2 hours.
The solvents were removed in vacuo. The resulting slurry was suction-filtered and the
product was freeze dried, affording the title compound as a waxy pink solid (0.2 g; 82%
yield). 1H NMR (400 MHz, CDCl3): δ 4.05 and 3.85 (2H each, dd, imine protons), 2.5
(2H, m, NCH-cyclohexyl), 1.9 - 1.7 (4H, m, cyclohexyl), 1.4 - 1.1 (4H, m, cyclohexyl)
ppm.
This material was reacted overnight at room temp. with KCN (2 equiv) in THF with a
drop of HCl and enough solvent to solubilize the salts. Solvents were removed in vacuo,
yielding a colorless oily residue. Extraction of the product from DCM was attempted
using potassium carbonate solution. The combined organic extracts were dried (sodium
sulfate) and solvents were again removed in vacuo, yielding a colorless oil.

13

C NMR of

the resulting oil shows a peak at 107 ppm, which is somewhat in the right range for
nitriles. Addition of a couple of drops of this oil to Cu(II)CO3 in water showed no
change, but upon heating, the solution turned deep blue. Analysis of the oil and of the
copper solution by MS did not show any logical product peaks, however.
It was also discovered in the literature that an organic base such as 1,8Diazabicyclo[5.4.0]undec-7-ene (DBU) can be used to catalyzed nitro-Mannich
reactions. A ~6-7 hour reaction of 27 with nitroethane in THF at room temp. was
performed using 20 mol% DBU. The reaction was worked up in the same way as 27 with
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KCN. MS of the extracted residue shows no product masses, though the sample may
have been too dilute. It may be necessary to do the reaction longer or with heat, or to use
a different catalyst (acid or base).
N-[trans-(1,2)-2-(benzylideneamino)cyclohexyl]-1-phenyl-methanimine (28)

Diamine 10 (1.0 g, 8.70 mmol), benzaldehyde (1.9 g, 17.50 mmol), and Na2SO4
(anhydrous) (2.5 g, 17.50 mmol) were heated in EtOH (40 mL) at reflux for 2 h. The
resulting mixture was filtered hot and the filtrate concentrated in vacuo. Crystals were
formed after allowing this solution to cool to room temperature. The mother liquor was
decanted, affording the title compound as yellow, needle-like crystals.

1

H NMR (400

MHz, CDCl3) δ 8.2 (2H, bs, HC=N), 7.6 (4H, m, o-aryl), 7.3 (6H, m, m,p-aryl) 3.2−3.6
(2H, overlapping signals, HC-N=C) 1.0-2.0 (8H, overlapping signals, cyclohexyl) ppm.
(lit. 1H NMR (200 MHz, CDCl3) δ 1.03–2.07 (m, 8H, CH2, Cyclohexane), 3.21–3.45 (m,
2H, CH, Cyclohexane), 7.12– 7.64 (m, 10H, Ar), 8.15 (s, 2H, –N=CH).15
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6.5 Synthesis and kinetic resolution of pendant arms
6.5.1 Synthesis
Diethyl (1-hydroxyethyl)phosphonate (26a)

Potassium carbonate (5.53 g, 40.0 mmol) was added to a 100 mL 2-necked round bottom
flask fitted with screw-tap, and the flask was purged with N2. Dry dichloromethane (50
mL) was added, and the flask was cooled in an ice bath. Diethyl phosphite (5.00 g, 36.2
mmol) and acetaldehyde (4.80 g, 109 mmol) were subsequently added to the reaction
flask, and the mixture was then stirred for approximately 45 minutes. The reaction was
allowed to warm to room temperature and was stirred for 1 additional hour. The soluble
portion was transferred to a separatory funnel by decanting and was washed twice with
2N HCl. The organic extracts were dried (sodium sulfate), and the solvents were removed
in vacuo, affording the title compound as a colorless to slightly yellow liquid (4.81 g,
72.5%). 1H NMR (CDCl3) δ 4.2 (4H, qt, 3JH-H = 7 Hz, 3JH-P = 4 Hz, OCH2CH3), 4.0 (1H,
dq, 3JH-H = 7 Hz, 3JH-P = 4 Hz, PCHOH), 1.4 (3H, dd, 3JH-H = 7 Hz, 4JH-P = 18 Hz,
CH3CH(OH)P), 1.3 (6H, td, 3JH-H = 7 Hz, 4JH-P = 3 Hz, OCH2CH3) ppm
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4-chlorophenyl acetate

4-chlorophenol (3.86 g, 30 mmol) was dissolved in dichloromethane (250 mL). To this
was added 1,8-Diazabicyclo[5.4.0]undec-7-ene (DBU) (5.023 g, 33 mmol), and the
solution was cooled in an ice bath and the flask purged with argon. Acetyl chloride (4.4
mL, 60 mmol) was added drop-wise while stirring. The solution was allowed to warm to
room temperature and stirred for 18 h. The reaction mixture was added to a separatory
funnel containing diethyl ether and an aqueous solution of potassium hydroxide (pH
~10). The product was extracted into the organic phase. The organic extracts were dried
(sodium sulfate), and the solvents were removed in vacuo.

DBU was removed by

washing the neat product with water (pH 5.5 from equilibrating with air), affording the
title compound as a clear, yellow liquid (4.58 g, 89.4% yield). NMR data were consistent
with that previously published:16,17 1H NMR (CDCl3) δ 7.36 (2H, dt, 3JH-H = 7 Hz, 4JH-H =
2 Hz, Ar), 7.06 (2H, dt, 3JH-H = 7 Hz, 4JH-H = 2 Hz, Ar), 2.31 (3H, s, ac)
6.5.2 Enantiomeric enrichment using enzymatic resolution
Enzymatic resolution of phosphonate 26a and was attempted using C. Antarctica lipase B
and 4-chlorophenyl acetate according to the reference procedure.18 However, the acetate
of 26a is difficult to separate from the alcohol. Chromatographic purification of the
crude mixture (phosphonyl alcohol, phosphonyl acetate, and acetylating agent/free
alcohol) was attempted. No satisfactory method of purification was found. Acetylating
agents including acetyl chloride, 4-nitrobenzylacetate, and 4-chlorophenylacetate were
tested. The enzyme is also expensive and seemed to acylate the substrate slowly.
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6.5.3 Kinetic resolution of phosphonyl alcohols with copper catalyst
Enantiomeric resolution experiments with a metal catalyst were performed according to
the literature procedure19 on a previously-synthesized and -purified racemic sample of
26a. The use of a copper (II) salt with a chiral 4-phenyl-bisoxazolidine ligand promoted
selective benzoylation of the R isomer. This reaction was performed repeatedly using
K2CO3 as the base and DCM as solvent, either at the scale in the reference (0.5 mmol) or
scaled up (5 mmol). Enantioselective benzoylation was also performed on 26c (5 mmol
scale).
1-(diethoxyphosphoryl)ethyl benzoate (26b)

Initial (test) reaction: Cu(II) triflate (0.009 g, 0.025 mmol) and (+)-2,2’-isopropylidenebis[(4R)-4-phenyl-2-oxazoline] (abbreviated R,R-Ph-BOX) (0.008 g, 0.025 mmol) were
weighed directly into a tared 20 mL scintillation vial and taken up in dichloromethane (3
mL). The solution was stirred for 10 minutes and cooled in an ice bath. Potassium
carbonate (0.069 g, 0.5 mmol), 26a (0.091 g, 0.5 mmol), and benzoyl chloride (0.035 g,
0.25 mmol) were added to the reaction mixture. The solution was allowed to warm to
room temperature and stirred for 12 hours. Water (3 mL) was added and the biphasic
mixture transferred to a separatory funnel. The crude product was extracted three times
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with dichloromethane into the organic phase. Solvents were removed in vacuo. The
benzoate 26b and the alcohol 26a were recovered by silica gel chromatography (1:1
hexanes:ethyl acetate followed by 1:1 ethyl acetate:methanol). Typical yield: 0.2 g
alcohol (73% yield) + 0.5 g (50%) of the title compound as a colorless solid. Rf = 0.43
(1:1 EtOAc:hexanes, SiO2). 1H NMR (400 MHz, CDCl3) δ (ppm) 8.1 (2H, d, aryl), 7.5
(1H, dt, aryl), 7.4 (2H, t, aryl), 5.5 (1H, dq, chiral α-hydroxy H), 4.2 (4H, dq, P-O-CH2CH3), 1.6 (3H, dd, α-hydroxy CH3), 1.3 (6H, dt, P-O-CH2-CH3).
A solution of the alcohol was prepared in an NMR tube (CDCl3) and proton spectra were
obtained with 0, 0.1, and 0.2 equivalents of a Eu3+ chiral shift reagent (Europium tris[3(heptafluoropropylhydroxymethylene)-(+)-camphorate]) (Eu(hfc)3).
The reaction was repeated with modification (underlined). Cu(II) triflate (0.090 g, 0.25
mmol) and R,R-Ph-BOX (0.084 g 0.25 mmol) were weighed directly into a 250 mL
round-bottom flask and taken up in dichloromethane (125 mL). The solution was stirred
for 10 minutes and cooled in an ice bath. Potassium carbonate (0.69 g, 5 mmol), 26a
(0.91 g, 5 mmol), and benzoyl chloride (0.49 g, 3.5 mmol) were added to the reaction
mixture. The solution was allowed to cool to room temperature and stirred for 18 h. The
crude product was extracted three times from the organic phase after mixing thoroughly
with water. Solvents were removed in vacuo. The benzoate was resolved from the
alcohol by silica gel chromatography (1:1 hexanes:ethyl acetate followed by 1:1 ethyl
acetate:methanol). A solution of the alcohol was prepared in an NMR tube (CDCl3) and
enantiomeric excess was determined to be ~60% (4:1 S:R) using Eu(hfc)3.
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Kinetic resolution with alternative base/solvent: Cu(II) triflate (0.090 g 0.25 mmol,) and
R,R-Ph-BOX (0.084 g, 0.25 mmol,) were weighed directly into a 100 mL round-bottom
flask and taken up in chlorobenzene. The solution was stirred for 10 minutes and cooled
in an ice bath. Barium carbonate (0.987 g, 5 mmol), 26a (0.91 g, 5 mmol), and benzoyl
chloride (0.49 g, 3.5 mmol) were added to the reaction mixture. The solution was
allowed to come to room temperature and stirred for 18 h. The reaction mixture was
transferred to a separatory funnel containing DCM/water (~pH 7), forming an emulsion.
The aqueous phase was adjusted to pH ~5.5 with triflic anhydride to try and break the
suspension, but this was unsuccessful. The crude product was extracted with successive
additions of DCM and solids were removed by suction filtration. Solvents were removed
in vacuo with heating and a dry ice trap. The benzoate was resolved from the alcohol by
silica gel chromatography (1:1 hexanes:ethyl acetate followed by 1:1 ethyl
acetate:methanol). Yield: 0.13 g alcohol (48%) + 0.6 g benzoate (60%). A solution of
the alcohol was prepared in an NMR tube (CDCl3) and enantiomeric excess
determination was attempted using Eu(hfc)3, but the enantiomeric proton peaks were
overlapping significantly, deterring precise quantitation.
Kinetic resolution of S-enriched 26a: The isolated alcohol from both potassium/DCM
and barium/chlorobenzene chiral separations were combined and again subjected to
enantioselective benzoylation (same procedure as for racemic alcohol, 1.65 mmol scale).
The benzoate and alcohol were separated by flash chromatography(1:1 hexanes:ethyl
acetate followed by 1:1 ethyl acetate:methanol). A solution of the alcohol was prepared
in an NMR tube (CDCl3) and enantiomeric excess determination was attempted using
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Eu(hfc)3, but the enantiomeric proton peaks were overlapping significantly, deterring
precise quantitation. It appears that the amount of the S isomer has been enriched further,
but this could not be confirmed.
Results indicate that this reaction is reproducible and robust with respect to variations to
scale, %ee of starting alcohol, and between methyl or phenyl groups at the chiral center.
In each case, the extracted products were separated by column chromatography.
(Eu(hfc)3) was used to determine enantiomeric ratios for each of the two products
(benzoate and alcohol).

The extraction using BaCO3 / chlorobenzene was more

challenging – a difficult-to-break emulsion formed and chlorobenzene requires a harder
vacuum to evaporate off. The enantiomeric excess of (S)-alcohol seemed to be higher
using BaCO3 / chlorobenzene, but the yield was lower and the Eu-shifted peaks in the
%ee determination NMR spectra were very broad (possibly due to incomplete removal of
salts/solvent), making precise quantitation impossible. The enriched alcohol products
were combined and reacted a second time using the potassium/DCM conditions,
extracted, and resolved by flash chromatography. NMR peaks representing Eu-shifted
protons are not baseline resolved from the non-shifted enantiomeric peaks, but the %ee is
conservatively estimated at 60% (4:1 S isomer). Acquisition at higher field strength or a
different sample:shift reagent ratio may improve spectroscopic resolution. Deprotection
of 26b. Under argon, the benzoate (2.4 mmol, 0.7 g) was dissolved in dry methanol. A
1% solution of NaOH in methanol (2.5 equiv) was added dropwise via addition funnel.
The reaction was stirred for 1 hour, then solvents were removed in vacuo. The residue
was taken up in ethyl acetate, which was washed twice with water. Solvents were
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removed in vacuo and the residue was analyzed by 1H NMR. The phosphonate alcohol
26a peaks are present, as are mono-substituted phenyl peaks and a large singlet ~1.6
ppm.

No shifts from the parent compound are observed at 5.5 or 1.6 ppm.

The

procedure appeared to convert the compound back to the alcohol, but unidentified
impurities were also present (~15% of peak area in 1H NMR).
Diethyl (hydroxy(phenyl)methyl)phosphonate (26c)

A 100 mL 2-necked RB flask with stir bar was evacuated and purged with argon. To this
was added K2CO3 (2.0 g, 14 mmol) under a positive pressure of argon. Dry THF was
added by cannulation and the suspension was cooled in an ice bath. Diethyl phosphite
(2.32 g, 18 mmol) was injected via Suba-seal, followed by drop-wise injection of
benzaldehyde (2.12 g, 20 mmol). The reaction was stirred in an ice bath for 45 min.,
allowed to warm to room temp. with stirring over one hour, then heated at 45 °C for two
hours. Solvents were removed in vacuo. The residue was taken up in DCM and added to
2N HCl (20 mL) in a separatory funnel. The product was extracted from the organic
phase three times. The combined organic extracts were dried (sodium sulfate), and
solvents were removed in vacuo, affording an off-white solid.

Instead of column

purification, this compound was recrystallized from THF at -20 °C, affording the title
compound. NMR data were consistent with that previously published:20 1H NMR (400
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MHz, CDCl3) δ (ppm) 7.5 (2H, dd, ortho(aryl)), 7.3 (3H, dd + dt, m/p(aryl)), 5.0 (1H, d,
α-hydroxy), 4.0 (4H, dq, P-O-CH2-CH3); 1.3 (6H, dt, P-O-CH2-CH3).

13

C δ (ppm) 136.7

(d, β-hydroxy quarternary C) 127-128.2 (3 peaks, d, aryl C) 68, 70, 71, 63 (dd, 2JC-P = 31,
7 Hz ethoxy), 16 (dd, ethyl).
This reaction was previously attempted without the heating step and using 10 mmol base,
and was determined to be incomplete based on 1H NMR scan of the extracted residue.
Kinetic resolution of 26c:

Cu(II) triflate (0.090 g, 0.25 mmol) and R,R-Ph-BOX (0.084 g, 0.25 mmol) were weighed
directly into a 250 mL round-bottom flask and dissolved in dichloromethane.

The

solution was stirred for 10 minutes and cooled in an ice bath. Potassium carbonate (0.69
g, 5 mmol), 26c (1.22 g, 5 mmol), and benzoyl chloride (0.49 g, 3.5 mmol) were added to
the reaction mixture.

The solution was let come to room temperature and stirred

overnight. The reaction progress was monitored by 1H NMR and determined to be
incomplete – an additional 24 h stirring was done prior to workup. The crude product
was extracted 3 times from the organic phase after mixing thoroughly with water. The
combined organic extracts were dried (sodium sulfate) and solvents were removed in
vacuo. The benzoate was resolved from the alcohol by silica gel chromatography (60:40
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hexanes:ethyl acetate followed by 1:1 ethyl acetate:methanol), affording the title
compound. Rf = 0.3 (1;1 EtOAc:hexanes, SiO2). NMR data were consistent with that
previously published:19

1

H NMR data (400 MHz, CDCl3) δ (ppm) 8.1 (2H, d,

benzoate(ortho); 7.6-7.3 (8H, d/t/m, benzoate and α-hydroxy phenyl); 6.4 (1H, d, αhydroxy); 4.2 (4H, dq, P-O-CH2-CH3); 1.3 (6H, dt, P-O-CH2-CH3).
A solution of the alcohol was prepared in an NMR tube (CDCl3) and enantiomeric excess
determination was attempted using Eu(hfc)3, but no shift was observed upon successive
additions of this reagent, only broadening of all peaks in the spectrum. Successive
additions of shift reagent to an NMR sample were unable to resolve the enantiomeric 26c
species. The most plausible explanation is that steric hindrance prevents the bulky
Eu(hfc)3 from binding to this phosphonate with α-phenyl chiral center. It is possible,
though, that this steric hindrance produces enantiospecific benzoylation of the alcohol,
leading to only one isomer observed in the NMR.
6.6 DOTAM derivatives to be used for CEST
6.6.1 Synthesis of DOTAM-(Gly)4 for water exchange measurement in liposomes
Ethyl 2-(2-bromoacetamido)acetate (29a)

Glycine ethyl ester hydrochloride (0.698 g, 5 mmol) and potassium carbonate (1.38 g, 10
mmol) were suspended in dichloromethane (50 mL) at 0 °C. Bromoacetyl bromide (1.01
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g, 5 mmol) was added drop-wise at the same temperature. The mixture was stirred at 0 °C
for 1 h then at room temperature for 18 h. The organic layer was transferred to a
separatory funnel and was washed with water (3 × 50 mL), ensuring the pH remained
basic. The organic extracts were dried (sodium sulfate), and the solvents were removed
in vacuo to afford a colorless solid (0.785 g, 70%). NMR data were consistent with that
previously published:21 1H NMR (400 MHz, CDCl3) δ (ppm) 7.04 (1H, br s, NH), 4.24
(2H, q, OCH2), 4.06 (2H, d, CH2CO2), 3.92 (2H, s, BrCH2), 1.30 (3H, t, CH3).
1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetrakis(ethyl-acetamidoacetate) (30a)

A mixture of cyclen (0.15 g, 0.875 mmol), bromoacetamide 29a (0.785 g, 3.50 mmol),
and potassium carbonate (0.483 g, 3.50 mmol) in acetonitrile (250 mL) was heated at
60−70 °C for 18 h. Solvents were removed in vacuo. The residue was used without
further purification. m/z (ESMS ESI+): 745.4 ([M+H]+). NMR data were consistent with
that previously published:22 1H NMR (CDCl3) δ (ppm) 7.5 (4H, br t, 3JH-H = 5 Hz, NH),
4.19 (8H, q 3JH-H = 7 Hz, CO2CH2CH3), 3.99 (8H, d, 3JH-H = 5 Hz, CO2CH2N), 3.10 (8H,
s, NCH2CON), 2.77 (16H, m, NCH2CH2N), 1.30 (12H, t, 3JH-H = 7 Hz, CH3CH2).
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1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetrakis(acetamidoacetate) europium (III)
complex H[(Eu-31a)]

The crude 30a was suspended in tetrahydrofuran (3 mL) and added to a solution of LiOH
(3 mL, 0.29 M) which was heated at 60 °C for 3 days. The pH was monitored and
adjusted to ~14 as needed with LiOH. After 3 days, any remaining THF was removed in
vacuo and the pH was adjusted to 7.2 with HCl. This solution was used to form
complexes with Eu3+ without further purification.
Europium chloride hexahydrate (22.5 mg, 0.875 mmol) was added to the solution of 31a
and the pH found to be between 5 and 6. The sample was heated at 60 °C for an
additional 4 days.

The sample was removed from heat and freeze dried, then

recrystallized from water/methanol at pH 4 - 5. NMR data were consistent with that
previously published:23 1H NMR (D2O): δ (ppm) 26.4, 7.86, -2.51, -5.49, -8.37, -11.1, 13.4.
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These conditions were used in attempt to scale up (~15 g) the reaction, but the alkylation
of cyclen with Ethyl Bromoacetamidoacetate could not be performed reproducibly, and
the ethyl esters could not be removed cleanly.
Benzyl 2-(2-bromoacetamido)acetate (29b)

A suspension of potassium carbonate (27.66 g, 0.2 mol) and glycine benzyl ester pToluenesulfonate salt (33.6 g, 0.1 mol) was prepared in dichloromethane (1000 mL) and
cooled in an ice bath. Under vigorous stirring, bromoacetyl bromide (0.1 mol, 19.8 g)
was added drop-wise to the suspension, which was stirred and allowed to warm to room
temperature overnight. The mixture was transferred to a separatory funnel and washed 3
times with water (150 mL) while holding the pH of the aqueous phase at 10 or above.
The organic extracts were dried (sodium sulfate), and the solvents were removed in
vacuo. The product was recrystallized successively from DCM, DCM/hexanes, and
hexanes, and then washed with hexanes/ethyl ether to yield a colorless solid (9.8 g, 34%).
NMR data were consistent with that previously published:24 1H NMR (400 MHz, CDCl3):
δ 7.39 (5H, m, aryl); 7.02 (1H, br s, NH); 5.23 (2H, s, PhCH2O); 4.13 (2H, d, O2CCH2N);
3.93 (2H, s, BrCH2CO).
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N,N’,N’’,N’’’-[1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayltetrakis(1-oxoethane2,1-diyl)]tetrakis[glycine] Tetrabenzyl Ester (30b)

A solution of cyclen (0.762 g, 4.4 mmol) in acetonitrile (100 mL) was prepared.
Potassium carbonate (2.69 g, 19.5 mmol) was added to this, forming a suspension. The
temperature was increased to 70 °C. After approximately 30 minutes, bromoacetamide
29b (5.6 g, 19.5 mmol) was added as a solution in acetonitrile. The reaction was stirred
at 70°C for 18 h. The mixture was cooled and filtered through a glass frit, and solvents
were removed in vacuo. The crude product could not be crystallized from MeOH/H2O or
from DCM/hexanes. Approximately 0.4 g crude product was purified on silica gel (95:5
chloroform:methanol

first

to

remove

impurities,

elution

CHCl3:MeOH:NH4OH), yielding a yellow oil (0.35 g, 75%).

with

7:2:1

Rf = 0.47 (7:2:1

CHCl3:MeOH:NH4OH, SiO2). NMR data were consistent with that previously published:
1

H NMR: δ (ppm) 7.3 (20H, m, aryl), 5.1 (8H, d, PhCH2O), 4.0 (8H, br s, O2CH2N), 3.65

(8H, d, NCH2CON), 3.2 - 3.6 (16H, br s, macrocyclic CH2). m/z (ESMS ESI+): 497.2

CHAPTER 6: Experimental

241

(100%, [M+H]2+), 993.5 (40%, [M+H]+); 917.4, 841.4, 765.4, 689.4 (trans-esterification
of benzylic with methyl groups, instrumental artifact).
R-2-bromo-(N,N-dimethyl)-propanamide (R-32)

Dichloromethane was added to an Argon-purged, 2-neck flask via cannulation. R-2bromopropionic acid (1.0 g, 6.6 mmol) was added to the flask via Suba-seal while
stirring. Under a positive flow of Argon, N-hydroxysuccinimide (NHS, 1.14 g, 9.9
mmol) followed by 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC, 1.91 g, 9.9
mmol) were added to the reaction mixture. The solution was stirred for 2 hours. A
double-outlet (to inert gas line and from reagent gas cylinder) dry ice trap was connected
over the reaction flask. An excess of dimethylamine was added to the reaction mixture
drop-wise, under argon, as a condensate from the dry ice trap. The solution was stirred
for an additional 2 hours in an ice bath. The reaction mixture was then removed from the
argon line, transferred to a separatory funnel, and washed twice with base (potassium
carbonate in water, pH 12 - 14) then three times with acid (HCl in water, pH 1 - 5). The
organic extracts were dried (sodium sulfate), and the solvents were removed in vacuo.
The title compound was afforded as a clear/pale yellow oil (0.6 g, 50.5% yield).

1

H

NMR: δ (ppm) 4.58 (1H, q, 3JH-H = 7 Hz, α-bromo); 2.91 and 3.10 (3H each, s,
methylamido); 1.81 (3H, d, 3JH-H = 7 Hz, CH3CHBr).
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S-2-bromo-(N,N-dimethyl)-propanamide (S-32)
The title complex was synthesized from S-2-bromopropionic acid following the same
protocol as described for synthesis of R-32. δ (ppm) 4.58 (1H, q, 3JH-H = 7 Hz, α-bromo);
2.98 and 3.10 (3H each, s, methylamido); 1.80 (3H, d, 3JH-H = 7 Hz, CH3CHBr).
N1,N1,N4,N4,N7,N7,N10,N10-octamethyl-(1S,4S,7S,10S- α, α', α'', α'''-tetramethyl-(S)2-(4-nitrobenzyl)-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetamide) (33)

Potassium carbonate (0.2 g, 1.45 mmol) was added to an acid-washed, 2-necked roundbottom flask with magnetic stir bar . The flask was evacuated and purged with argon.
An air condenser was attached, evacuated, and purged with argon as well. The following
were added to the reaction flask, under a positive pressure of argon, in order: chloroform
(50 mL), S-nitrobenzyl cyclen (0.100 g, 0.325 mmol), and R-32 drop-wise (0.261 g, 1.45
mmol). The heat was slowly increased from room temperature to 60 °C over 1-1.5 hours
and stirred at that temperature for 4 days. A 1.0 mL aliquot was then removed, washed
with water, and extracted with dichloromethane. Solvents were removed in vacuo. The
brown, tar-like residue was analyzed by mass spectrometry. m/z (ESMS ESI+): 605.4,
100%, M+H; 506.3, 60%, di-alkylated macrocycle; 407.3, 20%; mono-alkylated). The
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solvent from the entirety of the reaction mixture was removed in vacuo and the residue
re-suspended in acetonitrile and heated at reflux under argon for an additional 4 days,
increasing the ionization proportion of the product: m/z (ESMS ESI+): 605.6 (100%,
[M+H(trialkylated)]+), 506.4 (10%, [di-alkylated macrocycle]), 704.6, (10% ([M+H]+).
The solvent was then changed to N,N-dimethylformamide (DMF), heated for another 7
days, and found to contain the product. Salts were removed by partitioning the reaction
mixture between DCM (200 mL) and water (5 mL). The organic extracts were dried
(sodium sulfate), and the solvents were removed in vacuo. The residue was taken up in
water and divided into 2 equal portions. To these were added Gd3+ and Eu3+ chloride
hydrates (1 equivalent each), adjusted to pH 5 - 6 with HCl/KOH, and stirred at 60°C for
48 hours. The intended chelates were not formed as a result, possibly due to hydrolysis
of the amides or impurities carried through the reaction.
N4,N7,N10-trimethyl-(4S,7S,10S- α', α'', α'''-trimethyl-(S)-2-(4-nitrobenzyl)-1,4,7,10Tetraazacyclododecane-1,4,7,10-tetraacetamide) (S-SSS-34)
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Samples of S- and R-2-bromo-N-methylpropanamide were provided by M. Woods and
were analyzed by 1H NMR: R isomer: δ (ppm) 6.37 - 6.75 (1H, br q, NH); 4.44 (1H, q,
BrCHCO); 2.87 (3H, d, NHCH3); 1.90 (3H, d, BrCHCH3). S isomer: δ (ppm) 6.40 - 6.77
(1H, br q, 3JH-H = 5 Hz, NH); 4.44 (1H, q, 3JH-H = 7 Hz, BrCHCO); 2.87 (3H, d, 3JH-H = 5
Hz, NHCH3); 1.90 (3H, d, 3JH-H = 7 Hz, BrCHCH3).
R-2-bromo-N-methylpropanamide (0.119 g, 0.717 mmol) was added to a tared 20 mL
scintillation vial and dissolved in approximately 10 mL acetonitrile. K2CO3 (0.100 g,
0.717 mmol) and nitrobenzyl cyclen (0.050 g, 0.163 mmol) were then added and the
combined suspension was heated to 60 °C, checking pH (~10) after 24 hours. The
mixture was heated for 72 hours, after which solvents were removed in vacuo, yielding a
colorless solid (0.55 g, product + salts) and the residue stored at -20 °C. m/z (ESMS
ESI+): 563.4 ([M+H]+).
The trialkylated macrocycle (0.092 g, 0.163 mmol) and 2-bromoacetamide (0.025 g,
0.179 mmol) were dissolved in acetonitrile (2 mL). Potassium carbonate (0.045 g, 0.326
mmol) was added, and the reaction was stirred at 60 °C for two days. The reaction was
filtered, and the filter cake was washed with hot acetonitrile. The solvents were removed
from the filtrate in vacuo, and MS analysis revealed a mixture of products. m/z (ESMS
ESI+): 563.4 ([trialkylated macrocycle+H]+), 620.4 ([M+H]+), 648.4 ([M+Nmethylpropanamide]+); all peaks roughly 1:1:1).
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N4,N7,N10-trimethyl-(4R,7R,10R-α', α'', α'''-trimethyl-(S)-2-(4-nitrobenzyl)-1,4,7,10Tetraazacyclododecane-1,4,7,10-tetraacetamide) (S-RRR-34)
The title compound was prepared according to the method described for S-SSS-34. m/z
(ESMS ESI+): 563.4 ([trialkylated macrocycle+H]+), 620.4 ([M+H]+), 648.4 ([M+Nmethylpropanamide]+); all peaks roughly 1:1:1).
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Bioconjugate Chemistry 2009, 20, 2142.
(147) Botta, M.; Tei, L. European Journal of Inorganic Chemistry 2012, 2012, 1945.
(148) Kobayashi, H.; Brechbiel, M. W. Advanced Drug Delivery Reviews 2005, 57,
2271.

TERMINAL REFERENCES SECTION

254

(149) Tweedle, M. F.; Eaton, S. M.; Eckelman, W. C.; Gaughan, G. T.; Hagan, J. J.;
Wedeking, P. W.; Yost, F. J. Investigative Radiology 1988, 23.
(150) Nicolle, G. M.; Helm, L.; Merbach, A. E. Magnetic Resonance in Chemistry
2003, 41, 794.
(151) Gianolio, E.; Giovenzana, G. B.; Longo, D.; Longo, I.; Menegotto, I.; Aime, S.
Chemistry – A European Journal 2007, 13, 5785.
(152) Bornhop, D. J.; Hubbard, D. S.; Houlne, M. P.; Adair, C.; Kiefer, G. E.; Pence, B.
C.; Morgan, D. L. Analytical Chemistry 1999, 71, 2607.
(153) Sarka, L.; Burai, L.; Brücher, E. Chemistry – A European Journal 2000, 6, 719.
(154) White, G. W.; Gibby, W. A.; Tweedle, M. F. Invest Radiol 2006, 41, 272.
(155) Aime, S.; Caravan, P. Journal of Magnetic Resonance Imaging 2009, 30, 1259.
(156) Avedano, S.; Botta, M.; Haigh, J.; Longo, D.; Woods, M. Inorganic Chemistry
2013, 52, 8436.
(157) Miller, K. J.; Saherwala, A. A.; Webber, B. C.; Wu, Y.; Sherry, A. D.; Woods, M.
Inorganic Chemistry 2010, 49, 8662.
(158) Aime, S.; Barge, A.; Batsanov, A. S.; Botta, M.; Castelli, D. D.; Fedeli, F.;
Mortillaro, A.; Parker, D.; Puschmann, H. Chemical Communications 2002, 1120.
(159) Barge, A.; Botta, M.; Parker, D.; Puschmann, H. Chemical Communications 2003,
1386.
(160) Merbach, A. E.; Helm, L.; Tóth, E. v. The Chemistry of Contrast Agents in
Medical Magnetic Resonance Imaging; 2nd ed. ed.; Wiley, 2013.
(161) Brechbiel, M. W.; Gansow, O. A.; Atcher, R. W.; Schlom, J.; Esteban, J.;
Simpson, D.; Colcher, D. Inorganic Chemistry 1986, 25, 2772.
(162) Moi, M. K.; Meares, C. F.; DeNardo, S. J. Journal of the American Chemical
Society 1988, 110, 6266.
(163) Aime, S.; Botta, M.; Fasano, M.; Crich, S. G.; Terreno, E. Journal of Biological
Inorganic Chemistry 1996, 1, 312.
(164) Elst, L. V.; Maton, F.; Laurent, S.; Seghi, F.; Chapelle, F.; Muller, R. N. Magnetic
Resonance in Medicine 1997, 38, 604.
(165) Faulkner, S.; Pope, S. J. A. Journal of the American Chemical Society 2003, 125,
10526.
(166) Di Bari, L.; Pescitelli, G.; Sherry, A. D.; Woods, M. Inorganic Chemistry 2005,
44, 8391.
(167) Ranganathan, R. S.; Raju, N.; Fan, H.; Zhang, X.; Tweedle, M. F.; Desreux, J. F.;
Jacques, V. Inorganic Chemistry 2002, 41, 6856.
(168) Webber, B. C.; Woods, M. Inorganic Chemistry 2012, 51, 8576.
(169) Karplus, M. Journal of the American Chemical Society 1963, 85, 2870.
(170) The Nuclear Overhauser Effect. http://www.chem.wisc.edu/areas/reich/nmr/08tech-02-noe.htm (accessed June 17th, 2013).

TERMINAL REFERENCES SECTION

255

(171) Woods, M.; Kovacs, Z.; Kiraly, R.; Brücher, E.; Zhang, S.; Sherry, A. D.
Inorganic Chemistry 2004, 43, 2845.
(172) Schlesinger, J.; Rajander, J.; Ihalainen, J. A.; Ramesh, D.; Eklund, P.; Fagerholm,
V.; Nuutila, P.; Solin, O. Inorganic Chemistry 2011, 50, 4260.
(173) Tircso, G.; Webber, B. C.; Kucera, B. E.; Young, V. G.; Woods, M. Inorganic
Chemistry 2011, 50, 7966.
(174) Delgado, R.; da Silva, J. J. R. F. Talanta 1982, 29, 815.
(175) Hancock, R. D.; Motekaitis, R. J.; Mashishi, J.; Cukrowski, I.; Reibenspies, J. H.;
Martell, A. E. Journal of the Chemical Society, Perkin Transactions 2 1996, 0,
1925.
(176) Cacheris, W. P.; Nickle, S. K.; Sherry, A. D. Inorganic Chemistry 1987, 26, 958.
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